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The corticospinal drive to the paretic soleus (SOL) and tibialis anterior (TA) is degraded, 
but whether it changes and is task-dependent remains unclear. We examined the 
relationships between corticospinal drive and muscle-specific neuromechanics. We 
collected eight measures of corticospinal drive to SOL and TA in healthy and stroke 
participants, and muscle-specific neuromechanics during walking and isolated task in 
stroke participants. We examined the reliability, and the inter-group differences in 
variance and mean for each corticospinal measure, and the correlations between 
corticospinal drive and neuromechanics of each muscle in both tasks. Only certain 
corticospinal measures were simultaneously reliable and had inter-group differences in 
variance and mean. SOL resting latency was not associated with any neuromechanical 
measure in either task, whereas TA resting and active latencies were associated with only 
the ankle angular velocity during walking. In conclusion, TA latencies may strongly 
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1.1       Background and Need 
 The motoneurons of plantarflexors (PF) and dorsiflexors (DF) have connections 
with their respective areas in the primary motor cortex (MC). Early work using 
transcranial magnetic stimulation (TMS) suggested that corticomotoneuronal (CM) 
connections (i.e., fast corticospinal projections that are monosynapticaly connected with 
spinal motoneurons) to tibialis anterior (TA), which is the primary DF, are numerous and 
strong whereas the CM connections to PF, gastrocnemius (GAS) and soleus (SOL), are 
few and weak (Brouwer & Ashby, 1992; Brouwer & Qiao, 1995). Contradicting the 
assumption that PF had fewer CM connections than DF, subsequent evidence showed 
that PF, in particular SOL, had as many CM connections as TA, yet the strength of the 
input-output relations was found to be weaker in SOL than in TA (Bawa, Chalmers, 
Stewart, & Eisen, 2002). The weaker CM connections to the PF (SOL) led to the 
suggestion that other descending pathways than corticospinal might contribute to the 
control of these muscles (J. Nielsen & Petersen, 1995). This discrepancy in the strength 
of CM connections might be due to the different functional role that each muscle group 
plays. The PF, as high force generating muscles (e.g., active during the stabilization and 
push off periods during the stance phase of walking), may have strong reliance on 
  
subcortical pathways (i.e., corticoreticulospinal, corticorubrospinal) (J. Nielsen & 
Petersen, 1995). In contrast, the DF, as fine motor skill muscles (e.g., foot clearance 
during the swing phase of walking), may rely more on cortical control.  
Regardless of the neurophysiological and functional differences between PF and 
DF, the motor corticospinal excitability (MCE) of both muscle groups can be quantified 
by using TMS (Ackermann, Scholz, Koehler, & Dichgans, 1991). Typically in those 
without neurologic impairment, the resting motor threshold (rMT) is higher for PF than 
DF, the motor evoked potential (MEP) amplitude is smaller in PF than in DF, and the 
MEP latency is similar between PF and DF (Rossini et al., 1999). Furthermore, the MCE 
of PF and DF may be task dependent. The PF (SOL) stimulus response curve was less 
during the stance phase of walking than in maximum voluntary isometric contraction 
(MVIC), whereas the DF MCE was high and similar in the swing phase of walking and 
MVIC in early studies with healthy controls (Capaday, Lavoie, Barbeau, Schneider, & 
Bonnard, 1999). Therefore, MC via the CM connections may strongly contribute to the 
control of DF during the swing phase but not during the stance phase for PF control. 
During MVIC, however, control of both PF and DF may rely heavily on motor cortical 
input. 
Though some evidence of the motor cortical control of PF and DF in healthy 
adults does exist, only a few studies have examined the PF and DF MCE after stroke. In 
order to detect real changes in MCE after stroke, the measure used to quantify MCE 
should meet certain psychometric prerequisites such as reliability and validity. These 
studies, one for each muscle group, reported good reliability for certain PF (SOL) and DF 





reliability studies, few studies tested the changes in PF and DF MCE after stroke using 
several MCE measures. The focus in those studies was on the paretic side in which the 
greatest changes in PF and DF MCE occur. Compared to healthy controls, the active MT 
(aMT) of PF (SOL) increases (i.e., greater stimulus intensity is required to elicit MEP) 
(Lewis et al., 2014) while the MEP latency and amplitude of DF increase and decrease, 
respectively (Beaulieu, Masse-Alarie, Brouwer, & Schneider, 2014). Nevertheless, a few 
gaps still exist in the current knowledge regarding the measurement of PF and DF MCE 
after stroke. No study has investigated systematically the reliability of the most 
commonly used PF and DF MCE measures in either healthy controls or stroke 
participants. In addition, little is known about which PF and DF MCE measures detect the 
differences in central nervous system (CNS) function between individuals with stroke 
and healthy controls.   
 After stroke, the PF and DF function during motor tasks is degraded like their 
motor cortical control is degraded. However, it is not well understood whether the control 
of each muscle group is task-specific and whether these alterations are similar between 
PF and DF. An approach to elucidate these gaps is to investigate the associations between 
the PF or DF MCE and specific measures of PF or DF neuromechanical function (i.e., 
muscle activity, joint kinetics and kinematics) during a functional task (e.g., walking) and 
voluntary motor task (e.g., MVIC). In people with chronic stroke, a positive relationship 
was reported between the amplitude of DF MEP and DF range of motion (ROM) and 
strength during MVIC (Beaulieu et al., 2014). In addition, strong relationships were 
found between the amplitude and latency of DF MEP and forefoot elevation (kinematic 





people with spinal cord injury (SCI) (Barthelemy et al., 2013; Barthelemy, Willerslev-
Olsen, Lundell, Biering-Sørensen, & Nielsen, 2015; Barthelemy et al., 2010). Such 
evidence strengthens the notion that investigating the associations between MCE and 
neuromechanics of PF and DF may contribute to a better understanding of the motor 
cortical control of PF and DF during different tasks in people post-stroke.  
 
1.2 Problem Statement 
 Among the measures used in these associations, the PF and DF MCE measures 
are the least well understood, especially in people post-stroke. Therefore, it is crucial to 
use an MCE measure that has low methodological error (i.e. reliable) and detects the 
differences in both central tendency (i.e., mean) and dispersion measures (i.e., variance) 
between an intact and lesioned CNS (i.e., stroke). Though a few studies reported good 
reliability of certain PF and DF MCE measures in people post-stroke (Cacchio et al., 
2011; Lewis et al., 2014), there is no clear understanding as to which measure clearly 
elucidates changes in PF and DF MCE that result from damage to the nervous system. 
This understanding is essential prior to conducting any sort of correlational analysis to 
determine the relationships between the MCE and the neuromechanics of PF and DF. 
 Investigating the associations between MCE and neuromechanics of PF and DF 
during functional and isolated tasks in people post-stroke may reveal the underlying 
motor cortical control, which, as implied in the early control studies, may not be the same 
for each muscle group. This evidence may provide vital information on how PF and DF 
are controlled after a brain lesion and influence rehabilitation practices to help people 





have not been well investigated in stroke. Limited evidence exists during walking for PF 
and DF; the only existing evidence is for DF during MVIC (Beaulieu et al., 2014). 
 
1.3 Specific Aims and Hypotheses 
Specific aims for this dissertation were as follows: 
Aims 1 and 2: 
The overall goal of Aims 1 and 2 was to quantify eight MCE measures of SOL and TA in 
people post-stroke and in healthy controls. For thorough explanation on the justification 
for Aims 1 and 2 and their hypotheses, see section 3.1.   
 Specific Aim 1: To determine which of the eight SOL MCE measures was 
reliable both in healthy controls and in people post-stroke yet differed in both variance 
and mean between groups. 
When SOL was at resting state: 
 Hypothesis 1.1.a: SOL rMT, latency, and normalized latency of SOL would be 
the most reliable in both groups  
 Hypothesis 1.1.b: SOL rMT would be significantly higher and more variable in 
people post-stroke than in healthy controls.  
 Hypothesis 1.1.c: SOL latency would be significantly longer and more variable in 
people post-stroke than in healthy controls. 
 Hypothesis 1.1.d: SOL normalized latency would be significantly longer and 
more variable in people post-stroke than in healthy controls. 
When SOL was at active state: 





(cSP) would be the most reliable in both groups. 
 Hypothesis 1.2.b: SOL latency would be significantly longer and more variable in 
people post-stroke than in healthy controls. 
 Hypothesis 1.2.c: SOL normalized latency would be significantly longer and more 
variable in people post-stroke than in healthy controls. 
 Hypothesis 1.2.d: SOL cSP would be significantly longer and more variable in 
people post-stroke than in healthy controls. 
 Specific Aim 2: To determine which of the eight TA MCE measures were 
reliable both in healthy controls and in people post-stroke yet differed in both variance 
and mean between groups. 
When TA was at resting state: 
 Hypothesis 2.1.a: TA rMT, latency, and normalized latency of SOL would be the 
most reliable in both groups.  
 Hypothesis 2.1.b: TA rMT would be significantly higher and more variable in 
people post-stroke than in healthy controls.  
 Hypothesis 2.1.c: TA latency would be significantly longer and more variable in 
people post-stroke than in healthy controls. 
 Hypothesis 2.1.d: TA normalized latency would be significantly longer and more 
variable in people post-stroke than in healthy controls. 
When TA was at active state: 
 Hypothesis 2.2.a: TA latency, normalized latency, and cSP would be the most 
reliable in both groups. 





people post-stroke than in healthy controls. 
 Hypothesis 2.2.c: TA normalized latency would be significantly longer and more 
variable in people post-stroke than in healthy controls. 
 Hypothesis 2.2.d: TA cSP would be significantly longer and more variable in 
people post-stroke than in healthy controls. 
Aims 3 and 4: 
 The overall goal of Aims 3 and 4 was to investigate the associations between the 
descending drive, quantified by MCE measures determined in the two previous aims, and 
the specific ankle neuromechanics of the paretic SOL and TA during walking and MVIC 
in people post-stroke. For thorough explanation on the justification for Aims 1 and 2 and 
their hypotheses, see section 3.1.   
 Specific Aim 3: To investigate the associations between the MCE measures 
determined in Aim 1 and the neuromechanics of the paretic SOL during walking and 
MVIC in people post-stroke. 
For the functional task (i.e., walking):  
 Hypothesis 3.1.a:  SOL MCE would not be significantly associated with SOL 
electromyography (EMG) in stance phase. 
 Hypothesis 3.1.b:  SOL MCE would not be significantly associated with 
propulsive impulse (PI). 
For the isolated voluntary task (i.e., MVIC):   
 Hypothesis 3.2.a: SOL MCE would be significantly and negatively associated 
with SOL EMG. 





with SOL isometric torque. 
 Specific Aim 4: To investigate the associations between the MCE measure(s), as 
determined in Aim 2, and the neuromechanics of TA during walking and MVIC in people 
post-stroke. 
For the functional task (i.e., walking):  
 Hypothesis 4.1.a:  TA MCE would be significantly and negatively associated 
with TA EMG in the first half of swing phase. 
 Hypothesis 4.1.b:  TA MCE would be significantly and negatively associated 
with ankle angular velocity (AAV). 
For the isolated voluntary task (i.e., MVIC):  
 Hypothesis 4.2.a: TA MCE would be significantly and negatively associated with 
TA EMG. 
 Hypothesis 4.2.b: TA MCE would be significantly and negatively associated with 








REVIEW OF THE LITERATURE 
2.1 Introduction 
 After a stroke, two muscle groups in the lower limb that are impaired significantly 
are PF and DF. Since PF and DF play a significant role in various motor tasks, especially 
in upright activities (e.g., walking), their impairments due to stroke detrimentally 
influence the motor performance in these tasks. Though several rehabilitation strategies 
exist, none can fully restore either PF or DF function or the performance of the specific 
task. A possible reason might be the insufficient understanding of the underlying 
neurophysiological mechanisms of the motor control of these two muscle groups. The 
motor cortical input, which is one of the neural inputs to alpha motoneurons of the target 
muscle during a task, can be quantified using TMS in both healthy adults and individuals 
with neurological injury.  
  A potential approach is the investigation of the association between the motor 
cortical control and specific neuromechanics of PF and DF. The motor cortical control of 
PF and DF can be quantified using measures of MCE, while the task neuromechanics 
quantify indirectly the contributions of each muscle group during a specific task. To 
determine whether there are true associations between brain (i.e., MC) and motor 






 This chapter reviews the main characteristics of PF, in particular SOL, and DF, in 
particular TA, in terms of motor behavior, the basic principles and main measures of 
TMS related to SOL and TA, the primary effects of stroke on SOL and TA function, the 
principal measures that quantify indirectly the SOL and TA neuromechanics during 
walking and MVIC, and the importance of using MCE-neuromechanics associations for 
understanding the contributions of motor cortical output to SOL and TA during walking 
and MVIC. Lastly, certain existing gaps in the current literature are identified.  
 
2.2 Plantarflexors and Dorsiflexors 
2.2.1 Anatomical and Physiological Characteristics 
 The PF and DF are muscles located at the posterior and anterior compartment of 
the lower leg, respectively (Figure 2.1). The main function of the posterior muscles is to  





plantarflex the talocrural joint, whereas the main function of anterior muscle is to 
dorsiflex the talocrural joint (Schünke, Schulte, Ross, Schumacher, & Lamperti, 2006). 
The primary PF are GAS that has two heads, medial gastrocnemius (MG) and lateral 
gastrocnemius (LG), and SOL. The primary muscle of DF is TA.  
 MG and LG have an origin at the medial and lateral epicondyle of the femur, 
respectively, while both heads are inserted at the calcaneal tuberosity via the Achilles 
tendon (Schünke et al., 2006). Due to its origin and insertion characteristics, GAS is a 
biarticular muscle (i.e., crossing two joints: knee and talocrural at the ankle). On the other 
hand, SOL is a uniarticular muscle, it has an origin at the posterior surface of the head 
and neck of the fibula, it is attached to the soleal line of the tibia via the tendinous arch, 
and its insertion is the same as GAS (Schünke et al., 2006). The architectural properties 
differ for GAS and SOL. GAS, in particular the MG, is composed mainly of fast and 
relatively short fibers, whereas the SOL is composed only of slow and short fibers (R. L. 
Lieber & Friden, 2000). On the other hand, the physiological cross sectional area (PCSA) 
of the SOL is higher than MG (R. L. Lieber & Friden, 2000). PCSA and fiber length are 
proportional to maximum muscle force and excursion, respectively. Regardless of the 
few anatomical and physiological differences within PF, both GAS and SOL are 
antigravity muscles designed to generate high force with small excursion of the muscle, 
and they are innervated by the tibial nerve, which is derived from nerve roots of S1 and 
S2.  
  Like the SOL, TA is also a uniarticular muscle. TA originates from the two upper 
thirds of the lateral surface of the tibia, the crural interosseous membrane, and the highest 





medial cuneiform and the medial base of the first metatarsal (Schünke et al., 2006). 
Compared to MG and SOL, TA weighs less, has larger fibers, is composed primarily by 
slow twitch fibers, and has smaller PCSA (R.L. Lieber, 2010). A general conclusion is 
that TA is more functional for long muscle excursions and less important for force 
production (R. L. Lieber & Friden, 2000). It is innervated by the deep fibular nerve, 
which is derived from the nerve roots of L4 and L5 (Schünke et al., 2006).  
2.2.2 Muscle Activity during Walking  
 In intact human walking, PF and DF are active at different phases of the gait cycle 
(GC) (Figure 2.2 A), and thus they have different functional roles. PF are mainly active 
during the stance phase of gait (Figure 2.2 B), while DF are mainly active during early 
stance and throughout swing (Figure 2.2 C). 
Figure 2.2: Phase descriptions of the gait cycle, and muscle activity of Soleus and Tibialis Anterior 
during gait cycle. (A) Depiction of a typical right gait cycle, and muscle activity of (B) Soleus and (C) 





Just prior to heel strike, at the onset of the GC, only the GAS is activated (among PF 
muscles). As the leg rotates forward (5-40% of GC) PF contract mostly in isometric 
mode (mainly the muscle fascicle) (Cronin, Avela, Finni, & Peltonen, 2013; Panizzolo, 
Green, Lloyd, Maiorana, & Rubenson, 2013), while during the push-off phase (40-60% 
of GC), PF shorten to plantarflex the foot and produce a high impulse of energy. After toe 
off, GAS is slightly active due to its function as knee flexor, whereas SOL is silent. On 
the other hand, DF has a big burst of muscle activity at early stance to produce forces that 
isometrically (Chleboun, Busic, Graham, & Stuckey, 2007) control the lowering of the 
foot to the ground. After the forefoot touches the ground, DF is less active and has a 
minor role in pulling the leg forward over the foot. After the heel is off the ground, the 
muscle activity of DF begins to rise again due to DF lengthening, whereas after toe off, 
DF shorten and still increase muscle activity (Chleboun et al., 2007) to dorsiflex the foot 
in order to clear it during mid-swing (Winter, 1987).  
2.2.3 Corticomotoneuronal Connections  
The motoneurons of PF and DF have connections with their respective areas in 
the MC. Early work using TMS postulated that DF was more cortically controlled than 
PF for three reasons. First, it was suggested that DF had more CM connections than any 
other leg muscle (Brouwer & Ashby, 1992). Second, DF responses were less variable 
than SOL and MG responses (Brouwer & Qiao, 1995). Third, PF responses were weak, 
and other pathways (e.g., corticorubrospinal, corticoreticulospinal) might contribute to 
their control (J. Nielsen & Petersen, 1995). Contradicting the assumption that PF had 
fewer CM connections than DF, subsequent evidence showed that SOL has as many CM 





(Bawa et al., 2002). This discrepancy in the strength of CM connections might be due to 
the different functional role that each muscle group plays. The PF, as high force 
generating muscles (e.g., active during the stabilization and push off periods during the 
stance phase of walking), may have strong reliance on subcortical mechanisms, whereas 
the DF, as fine motor skill task muscles (e.g., foot clearance during the swing phase of 
walking), may rely more on cortical control. Regardless of these neurophysiological and 
functional differences between PF and DF, the MCE of SOL and TA, PF and DF muscles 
that we investigated in this project can be quantified using TMS (Figure 2.3). In this 
project, MCE is an umbrella term that reflects the excitatory and inhibitory characteristics 
of the neuromotor axis (motor cortical areas, crossed descending motor pathways, alpha 
motoneurons, and their corresponding muscles) when a stimulus via TMS is applied over 
the MC.  
Figure 2.3: Depiction of Soleus and Tibialis Anterior MCE assessment using TMS. Modified by 





2.3 Transcranial Magnetic Stimulation 
 2.3.1 Technical Principles 
TMS is a non-invasive brain stimulation technique that can quantify the 
corticospinal connectivity to muscles, as well as the intracortical and intercortical 
excitability. Briefly, TMS was the successor of  transcranial electric stimulation (TES), 
which was developed in the early 1980’s (Merton & Morton, 1980). A few years later, 
Antony Barker et al. successfully elicited an MEP in healthy adults by using a magnetic 
stimulator and a coil that was placed on the person’s contralateral MC (Barker, Jalinous, 
& Freeston, 1985). In contrast to TES, which can be uncomfortable and painful to the 
participant due to the high intensity required, TMS can elicit an MEP to a target muscle 
by applying a magnetic stimulation over the motor representation of that muscle. The 
main fundamental principle of TMS is the use of electromagnetic conduction. Simply, 
when an electric current passes through a metal (e.g., a stimulation coil) a magnetic field 
is produced, and subsequently this changing magnetic field elicits a flow of an electric 
current in the nearby environment (e.g., brain tissue) (Wasserman, Epstein, & Ziemann, 
2008). When a stimulating coil is applied over the MC, the pulse generated from that coil 
stimulates intracortical neurons that propagate a neural impulse from the MC to the target 
muscle on the contralateral side through the crossed corticospinal tract (CST)  
2.3.2 Stimulating PF and DF Motor Cortical Areas 
TMS testing of the PF and DF MCE involves a few minor limitations associated 
with the anatomical properties of the PF and DF motor cortical areas. First, the motor 
areas of PF and DF are located adjacent to the interhemispheric fissure at approximately 





2002) (Figure 2.4), while the axons of the corticospinal neurons are oriented 
perpendicular to the medial cortical surface. Second, the size of these areas is relatively 
small, in particular when they are compared with hand and facial muscles (Conti et al., 
2014) (Figure 2.4). Third, these areas are not clearly segregated (Saisanen et al., 2010) 
(Figure 2.5); therefore, accurate stimulation of the target motor cortical areas requires 
cautious selection of certain stimulation parameters (i.e., coil type, current direction, and 
optimal stimulation site). 
 2.3.3 Stimulation Parameters  
Use of the correct coil type for stimulating the PF and DF motor cortical areas is 
very important because different types of coil are capable of inducing different electric 
fields in the brain. Historically, the circular/round coil was the first to be used for testing 
PF and DF MCE. This type of coil has a diameter of 80-150 mm and 5-20 turns of wire 
(Wasserman et al., 2008) and is typically placed usually a few centimeters (e.g., 4 cm) 
anterior and lateral to vertex, the virtual intersection of the inter-aural and nasion-inion 
lines (Meyer, Britton, Kloten, Steinmetz, & Benecke, 1991). Subsequently, two types of 
figure-of-eight coil (i.e., two round coils together) were developed, flat and double cone, 
which typically are positioned either over the vertex or over 1-2 cm posterior. Terao et al. 
(1994) compared the effect of three coil types, large figure-of-eight with various angles, 
small figure-of-eight, and round coil, on the TA MCE. The large figure-of-eight coil with 
posterior current and round coil with lateral current induced the largest TA MEPs and 
used the lowest MT. A large figure-of-eight coil was more efficient than the round coil 





was active (Terao et al., 1994). 
Figure 2.4: Neuronavigated TMS-based DTI tractography of leg, arm, and face muscle CST. Adapted 
from Conti et al. (2014)  
Figure 2.5: Neuronavigated TMS mapping of leg muscles. Mapping of right leg muscles was carried out 





(orange); GC: gastrocnemius (pink); TA: tibialis anterior (yellow); SOL: soleus (light yellow); TFL: tensor 
fasciae latae (green). Adapted from Saisanen et al. (2010)   
Other differences between the round and figure-of-eight coils are the location, the 
area, and the amplitude of the electric field produced by the magnetic stimulation. In 
round coils, the maximum induced electric field is below the outer edge of the coil, and 
its area is diffuse (Cohen et al., 1990). In contrast, the maximum electric field induced by 
figure-of-eight coils is exactly below the junction of the two round coils, and its area is 
focal (Cohen et al., 1990; Toleikis, Sloan, & Ronai, 1991). These two characteristics of 
the figure-of-eight coils increase the user’s ability to identify the stimulated site by 
placing the center of the coil (intersection of the two round coils) over that site. Another 
advantage of this type of coil is that only the center of the coil is close to the stimulated 
site because the outer parts of the coil (flat) are farther from the brain tissue (Cohen et al., 
1990). Due to these characteristics, figure-of-eight coils are widely preferred and used for 
testing the MCE of the lower extremities.  
Several differences exist between the flat and double cone figure-of-eight coils. 
The main difference is that the flat coil has no angle between the two round coils, 
whereas the double cone coil has an angle (e.g., 100°). The outer diameter of the former 
is usually smaller (e.g., 70 mm) than that the latter (e.g., 120 mm). The flat figure-of-
eight coil can be pitched, yawed, and rolled, and the current can be manipulated in 
numerous directions; the maximal magnetic field strength is usually around 2 Tesla (T). 
On the other hand, a double cone coil can be pitched and rolled only because its 
angulation does not allow yaw, the current can be manipulated only in two directions, and 
the maximal magnetic field strength is usually less than 2 T. Both coils can induce mainly 





because of the indirect excitation of the CST via intracortical neurons (Maeda & Pascual-
Leone, 2003), resulting from transynaptic activation of the neurons in the leg motor areas.  
Yet  only the double cone coil can induce direct waves (D-waves) that result from direct 
activation of the CST neurons at high stimulus intensity (Terao et al., 2000). Despite 
these differences, the double cone coil is preferable to stimulate the leg motor area 
because it fits more securely on the head, and it has deeper stimulation strength than the 
flat figure-of-eight coil (Deng, Lisanby, & Peterchev, 2013, 2014; Lontis, Voigt, & 
Struijk, 2006; Terao et al., 1994).  
 The type of coil used dictates the optimal stimulation site of the PF and DF motor 
cortical areas that are typically located around the vertex. The optimal stimulation site is 
the coil location that elicits the largest response at the contralateral target muscle with the 
lowest intensity. When a round coil is used, the optimal site is usually a few centimeters 
lateral (contralateral to the target muscle) and anterior to vertex (Meyer et al., 1991). 
When figure-of-eight coils are used, the optimal site is usually closer to the vertex (e.g., 
1-2 cm lateral and posterior to vertex). Because of the close proximity between the PF 
and DF cortical areas, a common procedure is to determine the site that elicits the largest 
response in DF and then to use that site to test the MCE of both muscle groups. Although 
this procedure is often used and might be valid, two alternative approaches may 
determine more accurately the optimal sites of PF and DF.   
One approach to distinguish PF and DF MC is to examine the MCE (e.g., 
amplitude of MEP) of each muscle group on separate days (Geertsen, Zuur, & Nielsen, 
2010; Obata, Sekiguchi, Nakazawa, & Ohtsuki, 2009). The advantage of this approach is 





reduced; the disadvantage is that the participants must visit the lab twice. Furthermore, a 
common characteristic of the two approaches is that they rely on locating vertex (i.e., 
virtual intersection of the inter-aural and nasion-inion lines). Although these approaches 
are relatively simple, they do not consider the differences among individuals in the size, 
anatomy, and morphology of the brain, or the thickness of the skull (Wasserman et al., 
2008).    
 The second approach to differentiate PF and DF MC is to use the neuronavigation 
system with TMS (nTMS), which may solve the aforementioned issues. The nTMS is an 
image-guided TMS; either structural or functional MRI images can be used (Krings et al., 
2001; Ruohonen & Karhu, 2010; Sparing, Hesse, & Fink, 2010). The basic function of 
nTMS is to act as a positioning system to locate different anatomical landmarks in the 
brain. An optical camera, which acts as a position sensor, detects signals that are 
transmitted by reflective spheres placed on a stimulation coil, a pointer, and the 
stimulated head. A registration matrix obtained by identifying homologous anatomical 
landmarks on both images, which can be either the subject’s images or a representative 
set of images, is utilized to find the location of the coil from the real world to the image 
space. Then the coil can be displayed on the screen, and the target areas can be accurately 
stimulated. The main advantage of using nTMS is that it assures constant stimulation 
parameters within individuals across trials (Krings et al., 2001; Ruohonen & Karhu, 
2010; Sparing et al., 2010), and the primary disadvantage is its high cost (~$50,000-
250,000). In relation to testing the PF and DF MCE, nTMS might be a useful tool to 
eliminate the limitations of stimulating these areas. Several studies have used nTMS 





and DF (Forster, Limbart, Seifert, & Senft, 2014; Niskanen et al., 2010; Saisanen, 
Julkunen, et al., 2008; Saisanen et al., 2010; Thordstein, Saar, Pegenius, & Elam, 2013; 
Vaalto et al., 2013); those studies have found that nTMS has good reliability (TA only).   
 
2.4 PF and DF MCE 
 2.4.1 Measures  
The motor cortical control of the PF and DF can been quantified by several 
measures, and each reflects a different physiological property of the MCE. MT reflects 
the membrane-related neuronal excitability while MEP derived measures (i.e., the 
electrical potential recorded by a surface EMG (sEMG) placed over the belly of the target 
muscle in response to TMS stimulation of the MC) reflect the integrity and excitability of 
the whole CST (George & Belmaker, 2007). Center of gravity and map size, measures of 
cortical mapping, reflect the cortical representation of the target muscle. Recruitment 
curve (RC) derived measures likely represent the strength of the corticospinal projections 
(e.g., steeper curve requires low MT) (Chen, 2000). Another MCE measure is the silent 
period (SP), which can be measured on either the contralateral (cSP) or the ipsilateral 
target muscle (iSP). The cSP reflects the long-lasting motor cortical inhibition, which 
might be mediated via GABAb receptors, whereas the iSP reflects the functional integrity 
between the homologous motor areas (George & Belmaker, 2007). Lastly, measures of 
intracortical activity represent either corticocortical inhibitory mechanisms that are 
mediated by GABA receptors or corticocortical excitatory mechanisms that are mediated 
by glutamate receptors (Rossini & Rossi, 2007). For both muscle groups, MT, MEP, and 





MT can be determined either during muscle relaxation (i.e., rMT) or during slight tonic 
contraction of the target muscle (aMT). The MT of a muscle is defined as the lowest 
stimulation intensity required for inducing a distinguishable MEP on the target muscle 
(Groppa et al., 2012). Compared to the MT of distal hand muscles, the MT of distal leg 
muscles is greater (Forster et al., 2014; Lotze et al., 2003; Rossini et al., 2015; Saisanen, 
Julkunen, et al., 2008). In healthy adults, the PF MT (SOL) is usually higher than the DF 
MT, meaning that the current required to stimulate the PF cortical area is greater than DF 
(Needle, Palmer, Kesar, Binder-Macleod, & Swanik, 2013; Rossini et al., 1999; Rossini 
et al., 2015). This difference in MT between PF and DF may be caused by several 
potential factors. One factor is that the PF CM connections might be weaker than DF CM 
connections (i.e., similar number of peak responses but lower responses to different 
stimulus intensities) (Figure 2.6) (Bawa et al., 2002; Brouwer & Ashby, 1992). Other 
factor might be that the PF cortical areas may be smaller than DF (Figure 2.5) (Saisanen 





Figure 2.6. Comparisons of mean muscle activity responses of TA and SOL and responses of three 
concomitantly firing single motor units from TA and SOL. A and C: Thin lines with different symbols 
represent the EMG responses to different TMS stimulus intensities for each participant. Thick lines with 
large circles show the group means. The slope of the stimulus-response curve is higher for the TA (A) than 
for SOL (C). The same can be osberved in the mean stimulus-response curve. B and D: The top figure in 
each panel illutsrates the shapes of three concurrently recorded single motor units from TA (B) and SOL 
(D) while at the bottom of each panel the peristimulus time histograms, which show the discharge of each 
single motor unit of TA (B) and SOL (D), are illustrated. Modified from Bawa et al (2002) 
 MEP size parameters and latency are the other commonly used MCE measures. 
The assumption is that the MEP size parameters (amplitude: peak-to-peak; area: the 
integral of the rectified EMG between MEP onset and offset; duration: the time between 
MEP onset and offset) may reflect the number of the activated motoneurons (Wasserman 
et al., 2008). Among the three size parameters, amplitude is reported the most. The 
latency is defined as the time from the stimulus onset to the MEP onset and reflects the 
conduction time from MC to the target muscle. Latency may depend on two factors, the 
location of the muscle and the presence of a lesion in the neuromotor axis (i.e., MC, CST, 
alpha motoneuron pools, final common pathway, and muscle). Latency increases from 
proximal (quadriceps and hamstrings) to distal (PF and DF) muscles (Dimitrijevic et al., 
1992), while the PF and DF latency are similar since both muscle groups are located at 
the same body segment (Wochnik-Dyjas, Glazowski, & Niewiadomska, 1998). For this 
reason, MEP latency is usually normalized by the person’s height. After a stroke, the 
latency of the paretic DF increases, whereas the latency of the non-paretic DF is similar 
compared to healthy controls (Beaulieu et al., 2014; Cacchio et al., 2011). Conversely, 
the changes in the PF latency are unclear after stroke. A few studies have also 





2006) reported a task (rest vs. voluntary contraction vs. standing) effect on the MEP 
amplitude, latency, and area for TA and SOL in healthy adults. During rest, the amplitude 
and area of both muscles were smaller than active tasks (Soto et al., 2006). Compared to 
TA amplitude and area, SOL amplitude and area were smaller during rest yet larger 
during voluntary and standing tasks (Soto et al., 2006). This evidence indicates that 
comparisons between PF and DF MCE, in particular MEP derived measures, should 
occur within the same task.  
 Cortical mapping of the area for each target muscle is often used as a measure of 
MCE since each muscle has a unique representation within the cortex. The motor cortical 
representation (i.e., cortical mapping) is the number of motor cortical sites that elicit 
MEPs to a target muscle, and either the optimal stimulation site (i.e., hot spot or center of 
gravity) or its extent (i.e., map size) can characterize it. Only a few studies have mapped 
the motor cortical areas of PF (Saisanen et al., 2010) and DF and reported good test-retest 
reliability (Forster et al., 2014) and low variation when nTMS is used (Niskanen et al., 
2010). Furthermore, TMS and functional MRI (fMRI) can complement each other , and 
be equally reliable for mapping DF (Lotze et al., 2003). Since the stimulation site is vital 
for reliable TMS application, findings from these studies provide normative information 
about the exact location of both PF and DF.  
 RC (input-output or stimulus-response curve) has been commonly used to 
quantify the change in MEP size as a function of the stimulus intensity during resting 
(Devanne, Lavoie, & Capaday, 1997) and active tasks, such as voluntary contraction 
(Sandbrink, Syed, Fujii, Dalakas, & Floeter, 2000), standing (Obata et al., 2009), and 





output; % MSO) ranges from sub- to supra-threshold MT values with increments of 5%, 
while the defined number of stimulations (e.g., 5) is applied at each intensity. The 
common shape of the RC is sigmoidal, which is a result of the Boltzman equation (Press, 
Flannery, Teukolsky, & Vetterling, 1986).  The threshold (i.e., the x-intercept of the 
regression line flitted to the rising section of the RC), slope, and plateau level (MEPmax) 
(Devanne et al., 1997) are derived from RC and characterize the stimulus-response 
parameters of the CST as a whole. Obata et al. (Obata et al., 2009) investigated the input-
output relation of both PF (SOL) and DF (TA) during sitting and standing in 14 healthy 
adults. Despite similar background EMG, slope and plateau level were significantly 
greater during standing versus sitting, whereas threshold was similar between conditions 
for both muscles (Obata et al., 2009). During standing, the plateau value and threshold of 
SOL and TA were similar, while the TA maximum slope was greater than SOL (Obata et 
al., 2009). These findings demonstrate that use of RC derived measures also can decouple 
the motor cortical control between PF and DF during different tasks.  
 In contrast to the aforementioned MCE measures that characterize primarily 
excitatory mechanisms, certain measures of MCE also can quantify inhibitory 
mechanisms. One example is the SP, which is defined as the suppression of the EMG 
following MEP during tonic voluntary contraction. This phenomenon of EMG 
interruption can be observed when either the contralateral MC (cSP) or the ipsilateral MC 
(iSP) is stimulated. Nearly all studies that have investigated the SP of PF and DF have 
reported cSP. The first report on cSP was by Inghilleri et al. (1993). These authors argued 
that cortical inhibitory mechanisms might contribute to the latter part of hand muscle 





that cortical inputs might also contribute to the latter part of the SOL cSP. The TA cSP 
has been examined as well, mainly in studies that investigated the reliability and 
variability of TA MCE measures (Cacchio, Cimini, Alosi, Santilli, & Marrelli, 2009; 
Tallent et al., 2012; van Hedel, Murer, Dietz, & Curt, 2007). TA cSP is a reliable 
measure with low variability (Cacchio et al., 2009; Tallent et al., 2012). Though these 
studies provided normative data of TA cSP, it is not clear what the cSP implies in terms 
of function. In addition, it is not well understood whether there are differences between 
the cSP mechanisms of PF and DF or whether PF cSP is also a reliable measure with low 
variability. 
 It is important to distinguish iSP from the measures of inter-hemispheric 
inhibition. Though both measures reflect inhibitory effects, it has been suggested that 
they are mediated via different mechanisms (Chen, Yung, & Li, 2003). No study has 
investigated PF and DF iSP, yet one study recorded the iSP of a toe flexor muscle, 
abductor hallucis (AH) (Lo & Fook-Chong, 2004). Use of posterior-anterior and latero-
medial current directions induced by a figure-of-eight coil (70 mm diameter; 2.2 T) 
elicited the most AH iSPs, while age and leg side did not have any effect on iSP (Lo & 
Fook-Chong, 2004). iSP was recorded from the majority of the participants who all were 
neurologically healthy adults (age range: 20-80), 100% of the MSO was required (Lo & 
Fook-Chong, 2004). However, that high level of intensity might not be tolerable by every 
participant; therefore, the use of this measure may have some limitations. Thus, future 
studies should investigate whether iSP can be measured in PF and DF. If iSP of either PF 
or DF can be quantified, this metric might be used to determine the contribution of the 





Both the inhibitory and excitatory intracortical neuronal circuits that converge on 
the CST can influence MEP. Using a paired pulse TMS (ppTMS), subthreshold condition 
stimulus following by suprathreshold test stimulus with an inter-stimulus interval (ISI) 
less than 6 ms, Kujirai et al. reported a suppression in hand muscle MEP (1993). They 
suggested that this suppression might have cortical origin. A few years later, Stokic and 
colleagues utilized a similar approach to characterize the intracortical inhibition in DF 
motor areas (Stokic, McKay, Scott, Sherwood, & Dimitrijevic, 1997). They tested a wide 
range of ISIs (1-15 ms). The MEP of the relaxed TA was suppressed when ISI was less 
than 5 ms, whereas facilitated MEP was observed when the ISI was between 9-10 ms. 
This study was the first to show that both inhibitory and excitatory intracortical circuits in 
the leg motor areas can modulate the responses of the leg muscles. Since then, numerous 
studies have examined both intracortical inhibition, either short interval (SICI) or long 
interval, and facilitation (SICF) during different tasks (e.g., voluntary contraction, 
cycling) and postures (e.g., seated, standing) in various populations (healthy young and 
old adults, SCI, stroke, Parkinson disease) (Beaulieu et al., 2014; Mileva, Bowtell, & 
Kossev, 2009; Oliveri et al., 2012; Roy, Zewdie, & Gorassini, 2011; Soto et al., 2006; 
Stokic et al., 1997; Yamaguchi, Fujiwara, Liu, & Liu, 2012; Yang et al., 2013). The 
cumulative evidence from these studies indicates that using ppTMS over the leg motor 
area can elucidate the characteristics of the intracortical mechanisms during control of PF 
and DF in various tasks and populations. 
2.4.2  Effect of Posture during Testing  
The motor cortical control of PF and DF MCE is posture-dependent. In most 





fixed in a footrest with either relaxed or slightly contracted muscle. MEP is facilitated 
when the target muscle is voluntarily contracted, even slightly. However, only a few 
studies have examined the effect of posture (seated vs. lying vs. standing) on the SOL 
and TA MCE, and their results were inconclusive. This inconsistency might be due to 
several methodological differences among the studies. Ackermann et al. (1991) found 
that the PF (SOL) and DF (TA) MEP size was larger in standing than in sitting or lying 
supine. Similarly, Obata et al. (2009) found that maximum slope and plateau value of 
both SOL and TA RC were significantly larger during standing than in sitting. Despite 
similar findings, a main difference between the two studies was that the background 
EMG was not matched among tasks in the former study, whereas it was matched in the 
latter study. Conversely, two studies (Lavoie, Cody, & Capaday, 1995; Soto et al., 2006) 
showed no difference in SOL MEP size between standing and sitting. The main reason 
for this discrepancy was stimulus intensity, which was lower in Lavoie et al. (1995) 
(125% MT) and Soto et al. (2006) (120% MT) than the intensity used in Obata et al. 
(2009) (40-90% MSO). Additionally, SOL and TA responses were elicited from the same 
stimulus site in the former studies (Lavoie et al., 1995; Soto et al., 2006), whereas the 
optimal site of SOL was determined separately from TA in the study by Obata et al. 
(2009). Another study examined the effects of voluntary contractions (rest, dorsiflexion, 
and plantarflexion in lying supine) and postural tasks (standing on the soles, standing on 
the heels, and standing on the toes) on the SOL and TA MCE while using 100% MSO 
(Valls-Sole, Alvarez, & Tolosa, 1994). SOL MEPs were elicited 100% of the time during 
the active conditions but were elicited only 61% of the time during rest. SOL MEP 





heels and toes. On the other hand, TA MEP latency was shorter only during voluntary 
dorsiflexion and standing on the heels. Both SOL and TA MEP amplitudes were larger in 
all voluntary and standing conditions compared to rest (Valls-Sole et al., 1994). The 
findings from these studies indicate that posture may have an important effect on both PF 
and TA MCE; therefore, the task used during MCE testing should be thoughtfully 
selected. Among the different postures, sitting on a chair with fixed positions of the hip, 
knee, and ankle joints while the target muscle is slightly contracted might be the most 
feasible and reliable posture to use for testing PF and DF MCE across populations.  
2.4.3 During Walking 
Walking is a complex behavior resulting from integration of multiple structures 
and functions of the musculoskeletal and nervous systems. In humans, walking is 
controlled by three different subsystems of the nervous system (i.e., sensory receptors in 
the skin, muscles, and joints; the spinal cord; and the brain). The integration of these 
systems is responsible for the activation and modulation of motoneuron pools that 
innervate the active muscles during walking (J. B. Nielsen, 2003). All three subsystems 
are important during the GC, and the difference among them is their specific function 
during walking. For instance, the input from the supraspinal areas (e.g., MC, brain stem, 
cerebellum, visual cortex, etc.) (Figure 2.7) contribute to walking in several ways: 
triggering walking-related spinal systems, regulating walking speed, fine-tuning motor 
patterns in response to feedback from the moving limbs, and steering limb actions in 
response to visual input (Armstrong, 1988; Kandel, Schwartz, & Jessell, 2000). One of 
these supraspinal areas is the MC, the major motor cortical area responsible for the motor 





was derived from experiments in quadrupedal mammals (Drew, 1988, 1991; Drew, 
Andujar, Lajoie, & Yakovenko, 2008). These studies demonstrated that MC contributes 
significantly to gait modifications, especially when precise end-point control is required 
(e.g., paw placement and trajectory during stepping over obstacles) (Drew, 1988, 1991; 
Drew et al., 2008; Drew & Marigold, 2015). 
Figure 2.7. Schematic of the signal flows within and from supraspinal substrates. Adapted from 
Takakusaki (2013) 
 In humans, it has been postulated that the MC is a prerequisite for normal walking 
(J. B. Nielsen, 2003), yet the role of MC and CST during walking is not fully elucidated 
(Barthelemy, Grey, Nielsen, & Bouyer, 2011). The existing evidence has been derived 
from studies that used non-invasive techniques including TMS (Capaday et al., 1999; 
Schubert, Curt, Colombo, Berger, & Dietz, 1999; Schubert, Curt, Jensen, & Dietz, 1997), 
fMRI (Dobkin, Firestine, West, Saremi, & Woods, 2004), diffusion tensor imaging (Seo 





encephalography (Gwin, Gramann, Makeig, & Ferris, 2011; T. H. Petersen, Willerslev-
Olsen, Conway, & Nielsen, 2012), and near-infrared spectroscopy (Miyai et al., 2001). 
Among these techniques, the most evidence comes from studies that applied TMS over 
the PF and DF cortical areas during walking on a treadmill. Those TMS studies tested the 
effect of TMS on PF and DF muscle activity and reflexes during walking in healthy 
adults. 
 An obvious limitation of using TMS during dynamic actions, such as walking on 
a treadmill, is to keep the position of the TMS coil constant and, thus, maintain the 
stimulation site in spite of rhythmic body actions. All studies that have applied TMS 
during walking on a treadmill used the following methods to solve this issue. The coil 
was mounted to a helmet by using Velcro® tapes that fix the inside of the coil to the 
outer surface of a linen cap. The helmet was attached to a halo vest system. The coil 
cable was held by an elastic restraint that could be fixed either to the ceiling or to a body 





Figure 2.8. Schematic depiction of the experimental set-up of TMS application during treadmill 
walking. Adapted from Knikou et al. (2013) 
natural cadence and freely move the head without affecting the coil’s location. 
 The first study that stimulated the leg motor cortical areas in humans during 
walking was by Schubert et al. (1997), who examined the effect of cortical input by using 
TMS on PF (MG) and DF EMG during treadmill walking. Thirteen young healthy adults 
walked on the treadmill with an average walking speed of 4.27 km/h (1.19 m/s). The 
TMS coil was fixed with the approach described in the previous paragraph. Because the 
results showed constant MEPs across strides that indicated stable stimulation, subsequent 
studies adopted those techniques. TMS stimuli were applied at different moments during 
GC, which was divided into 16 periods. The main finding was that there was a 
modulation (i.e., changes relative to muscle activity during tonic voluntary muscle 
contraction) of TA and MG MEP amplitudes during walking. This modulation was 
predominant for TA MEP during pre-swing and swing phases in which TA is typically 
active, whereas the modulation was minor for MG MEP during mid-stance in which MG 
is mainly active. Between muscles, the response to TMS was greater in TA than MG. 
This was the first study to suggest a potential difference in the motor cortical control 
between PF (MG) and DF during walking in humans (Schubert et al., 1997). The same 
authors also found an effect of visual input on the motor cortical control of PF (MG) and 
DF during walking in humans (Schubert et al., 1999). Eleven healthy adults walked on 
the treadmill in two conditions: normal (walking without visual feedback of foot 
placement) and precision stepping (hit a colored spot on the treadmill). The main finding 
was that visual feedback of foot placement facilitated MG MEP and inhibited TA MEP 





The results from both studies indicate that the motor cortical control of PF and DF differ 
during walking and can be modulated by visual feedback.   
In addition to muscle responses, stimulation of the cortex can modulate the PF 
and DF reflexes during walking. In one study, 17 healthy adults walked on a treadmill 
while subthreshold TMS stimuli were applied over the leg motor area at different 
instances during the stance phase (N. Petersen, Christensen, & Nielsen, 1998). 
Recordings of the SOL H-reflex during stance showed a large short-latency facilitation 
due to TMS. Based on these results, the authors argued that SOL CM neurons are highly 
excitable during walking. In addition, they found no difference in the excitability of SOL 
CM cells between the stance phase of walking, tonic, and dynamic plantarflexion (N. 
Petersen et al., 1998). A subsequent study from the same lab examined the effect of TMS 
during stretch of the DF during walking (Christensen, Andersen, Sinkjaer, & Nielsen, 
2001). Seventeen healthy adults walked on a treadmill while DF was stretched by 
imposing a quick plantarflexion and suprathreshold TMS was applied. The researchers 
found that the combined response to stretch and TMS increased as the interval between 
the two stimuli increased (Christensen et al., 2001). This finding provided further 
evidence on the cortical control of DF during walking. Though the findings from both 
studies are crucial for understanding the neural control of PF and DF during walking, 
their results do not determine the actual activation of corticospinal cells of these two 
muscle groups during walking (J.B. Nielsen, 2002).  
 To clarify this issue, the same group conducted a study in which subthreshold 
TMS was applied during walking in 19 healthy adults while PF (SOL) and DF EMG 





heel contact) and DF EMG (700 ms after heel contact) was found, yet neither muscle was 
suppressed when TESn was applied. The authors suggested that this TMS-specific 
suppression of PF (SOL) and DF EMG was probably restricted to the cortical level. This 
study was one of the first to indicate that PF (SOL) and DF muscles receive cortical 
contributions during walking.  
Around the same time, another seminal study examined the extent to which CSTs 
are associated with PF (SOL) and DF spinal circuits during walking and tonic voluntary 
tasks (Capaday et al., 1999). The methodology of TMS application during walking was 
similar to the aforementioned studies. One of the main differences between this study and 
the others was the use of RC instead of reflexes or just MEPs. Utilization of the RC 
allowed the quantification of MEPs across several stimulation intensities, whereas the 
other studies used a single stimulation intensity. To compare the SOL and TA MCE 
between tasks, the prescribed level of SOL and TA EMG activities during the voluntary 
task were matched with their equivalent level of EMG activities during walking (e.g., 
SOL: early part of stance; TA: early part of swing). Twenty healthy adults participated in 
the study. The results showed that SOL MCE was less during walking (stance phase) than 
in MVIC, whereas the DF MCE was high and similar during walking (swing phase) and 
MVIC (Capaday et al., 1999). In addition to these findings, the results showed something 
that was not anticipated; TA MCE during the stance phase of walking was similar to SOL 
MCE during MVIC (Capaday et al., 1999). The authors suggested that during walking, 
the MC via the CM connections may strongly contribute to the control of TA during the 
swing phase and to a lesser extent during the stance phase, yet it has weak control over 





required for the control of both PF and DF. Similar to other studies, this study pointed out 
the extent to which SOL and TA are cortically controlled, and how this control differs for 
each muscle group between tasks (Figure 2.9).   
Figure 2.9. Schematic depiction of the strength of the linkage between the motor cortical areas and 
the muscle activities of SOL and TA during walking and MVIC. Modified from Capaday et al (1999). 
2.4.4 Reliability of PF and DF MCE Measures 
Consistent measurement of MCE requires the minimization of error (e.g., noise) 
to demonstrate that these metrics (e.g., MEP amplitude) reflect the actual MCE property 
(e.g., the number of the activated corticospinal motoneurons) measured. Though there is 
enough evidence to verify the investigation of PF and DF MCE using different MCE 
measures during multiple tasks, only a few studies have investigated the reliability for PF 
(SOL; one study) and for DF (three studies).   
The intra- and inter-session reliability of three SOL MCE measures were tested in 





fixed position (Lewis et al., 2014). During TMS stimulation, which was applied via 
double cone coil at 120% of aMT, participants contracted their SOL (electrode was 
placed at the medial site) at 10% of maximal voluntary contraction (MVC: voluntary 
contraction in which the maximal force of a muscle group is tested (Winter, 1991)). The 
MCE measures tested were the amplitude and area of the MEP and aMT, and reliability 
was quantified using the intraclass correlation coefficient (ICC). The results showed that 
amplitude and area had good (ICC>0.75) intra- and inter-session reliability when using as 
few as six MEP responses. In addition, aMT had high inter-session reliability. This is the 
only study that has examined the reliability of SOL MCE measures. Further studies 
should investigate the reliability of the other PF (i.e., LG and MG) MCE measures during 
resting and active conditions of the target muscle.   
 The reliability of several TA MCE measures was also found to be very good to 
excellent. Van Hedel et al. (2007) investigated the test-retest reliability (14.0 ± 11.4 days) 
of DF MCE measures (amplitude and latency of the MEP, and cSP) during static and 
dynamic tasks at different levels of MVC (10, 20, 40, and 60%). Twenty healthy adults 
lay in a supine position while biphasic TMS stimuli were applied via a figure-of-eight 
coil at 120% of aMT. Findings showed that the amplitude was the most reliable (ICC: 
0.77) during static condition at 40% MVC, the latency was reliable during static and 
dynamic conditions at both 40% and 60% MVC (0.74 < ICC < 0.81), and cSP was not 
reliable (van Hedel et al., 2007). Cacchio et al. (2009) investigated the intra- and inter- 
investigator, and test-retest reliability (within-session with a 1.5-h interval; between-
session with a 4-week interval) of TA MCE measures (rMT, three RC measures, latency, 





seated on a chair. For all three types of reliability the ICC of rMT, latency, and cSP was 
higher than 0.75; among the three measures, rMT always had the highest ICC. On the 
other hand, the RC measures had only moderate to good reliability; therefore, these 
measures should be used for quantifying the DF MCE with caution. Tallent et al. (2012) 
investigated the repeatability of TA MCE measures (rMT, amplitude of MEP, and cSP) 
during shortening and lengthening of TA at different levels of MVC (15, 25, 50, and 
80%) on three consecutive days. Experiments took place at the same time of the day. 
Twenty healthy adults were seated on a dynamometer while stimulations were applied via 
double cone coil. The ICC of rMT, amplitudes during shortening at 25% MVC, and cSP 
during shortening and lengthening were very good to excellent across 3 days. The 
cumulative evidence from these three studies indicates that a few TA MCE measures are 
very reliable especially during muscle contraction. None of these studies used nTMS, 
which may increase reliability, or investigated the reliability of SICI or SICF.  
In healthy adults, PF and DF are cortically controlled, and this control depends on 
several factors. Use of TMS can reliably measure the MCE of these muscle groups. After 
a stroke, however, these two muscle groups are impaired while there is a lesion in the 
brain. Therefore, stroke can alter the motor cortical control to PF and DF, but its 
ramifications during a motor task are not well understood.   
 
2.5 Stroke 
2.5.1 Categories  
 Stroke is a sudden neurologic deficit, either focal or global, due to occlusion 





blood circulation (Corbyn, 2014; Cuccurullo, 2004). To be classified as stroke, symptoms 
and signs of this deficit must last more than 24 hours; otherwise it is classified as a 
transient ischemic attack (TIA) or mini stroke (Aminoff, Greenberg, Simon, & 
Greenberg, 2005). Ischemic stroke accounts for 85% of all strokes, and it is classified 
either as thrombotic (~35%), embolic (~30%), or lacunar (~20%) (Cuccurullo, 2004). 
Hemorrhagic stroke is less prevalent, accounts only for 15% of all strokes, and can be 
caused by either intracerebral (hypertensive; ~10%) or subarachnoid (ruptured 
aneurysms; ~5%) hemorrhage (Cuccurullo, 2004).  
2.5.2 Epidemiology of Stroke  
In the U.S. in 2010, an estimated 6.8 million people, older than 20 years of age, 
had experienced a stroke. The prevalence rate of stroke is 2.8 %. Stroke is less prevalent 
in men than women, and it is most prevalent in African Americans, for both genders. 
Each year, nearly 795,000 people have a stroke, either new (610,000) or recurrent 
(185,000). The incidence is lower in men than women, and it is higher in whites than in 
African Americans. Stroke is the fourth leading cause of death, and a person dies from 
stroke every four minutes. The stroke death rate is the highest in the Southeastern states. 
Furthermore, stroke is a leading cause of chronic disability, and the combined direct and 
indirect costs of stroke in 2010 were $36.5 billion (Mozaffarian et al., 2015). The most 
common impairments after stroke are motor-related and include detrimental alterations in 
muscle strength, tone, and activation. One of the most common limitations is impaired 
walking.   





Typically, the main walking impairments after stroke are limited joint motion, 
altered muscle activity, and impaired force production, which contribute to the reduction 
of walking speed and the alteration of spatiotemporal measures (Olney & Richards, 
1996). These impairments are observed in all three lower extremity joints causing 
different gait patterns to emerge (Mulroy, Gronley, Weiss, Newsam, & Perry, 2003). The 
ROM, torque, and power of the ankle joint in the sagittal plane as well as PF and DF 
activity are smaller in the paretic side than in the non-paretic (Kim & Eng, 2004). The 
main impairment in the ankle sagittal motion is the reduced dorsiflexion motion during 
the swing phase, in particular during the mid-swing in which the foot clearance is a 
crucial gait event to advance the swing limb (Winter, 1992). The PF EMG is reduced 
during stance, while DF EMG is reduced during swing (Lamontagne, Malouin, Richards, 
& Dumas, 2002). The ankle plantarflexion torque is reduced during the push off phase; 
also decreased are the ankle power absorption during the first half of stance and the 
power generation during push off. Certain aforementioned ankle neuromechanics (muscle 
activity, joint kinematics, and kinetics) are positively correlated with gait speed. On the 
paretic side, only ankle power absorption and generation are associated with gait speed, 
whereas non-paretic ankle ROM, plantarflexion torque, and power absorption and 
generation are associated with gait speed (Kim & Eng, 2004). This evidence indicates 
that gait speed improvement is multifactorial, and it may have different contributions for 
each side’s neuromechanics.  
These impairments have an effect on the overall function of people post-stroke. 
Six months after stroke onset, 1 of 4 people require assistance with activities of daily 





Two-thirds of people after stroke may experience critical limitations in functional 
walking and may be at risk for additional declines in physical mobility and independent 
walking (Jorgensen, Nakayama, Raaschou, & Olsen, 1995; Pouwels et al., 2009; 
Weerdesteyn, de Niet, van Duijnhoven, & Geurts, 2008). Impaired locomotion restricts a 
person after stroke from both performing mobility activities (e.g., walking) and 
participating in vocational and avocational activities.  
2.5.4 PF and DF Rehabilitation 
Improving walking is one of the main goals in stroke rehabilitation (Bohannon, 
Andrews, & Smith, 1988) while numerous rehabilitation strategies have been developed 
to improve the functionality of walking and to promote participation in social activities in 
people post-stroke (Bowden, Embry, Perry, & Duncan, 2012).  
Among all the rehabilitation strategies, impairment-based and task-specific 
approaches are the two most common. The main principle of the impairment-based 
approach is that the focus of the rehabilitation should be on a specific impairment. For 
example, DF are weak after a stroke; therefore, rehabilitation should focus on 
strengthening this muscle group. On the other hand, a task-specific approach is used to 
improve a certain activity. Since walking after stroke is limited, people post-stroke should 
be trained during walking activities. Strength/power training is an example of an 
impairment-based rehabilitation approach, whereas treadmill training, either with or 
without a body weight support system, is an example of a task-specific approach. Yet, 
neither approach has been found to be capable of fully restoring walking after stroke 





Research in this area is limited for many reasons, two of which we will highlight 
here. First, there is insufficient understanding of the underlying neurophysiological 
mechanisms of the motor control of walking and how to apply specific rehabilitation 
techniques to engage these mechanisms. Second, it is not well understood what the 
relationships are between the neural control (e.g., motor cortical control) and 
neuromechanics (muscle activation, joint kinematics, and kinetics) of walking. Therefore, 
a potential area of study to understand the recovery mechanisms of walking after a stroke 
is to focus on a specific neural mechanism (i.e., motor cortical input) of the motor control 
of walking and then to examine the association between that mechanism and the 
neuromechanics of walking. Such a research focus is warranted for both PF and DF, since 
those two muscle groups play a significant role during walking. 
2.5.5 PF and DF MCE after Stroke 
Since stroke affects brain areas and potentially the descending pathways, TMS 
can be generally used to test the integrity of connectivity between MC and the target 
muscle after a stroke. One of the uses of TMS after stroke is to predict recovery. Several 
studies have showed that testing the DF MCE after stroke could predict recovery of 
mobility as measured by clinical evaluation tests (Arac, Sagduyu, Binai, & Ertekin, 1994; 
Hendricks, Pasman, van Limbeek, & Zwarts, 2003; Piron, Piccione, Tonin, & Dam, 
2005). Yet no study has examined whether PF MCE can be a strong predictor of mobility 
recovery after a stroke. Another use of TMS after stroke is to assess the effect of a 
rehabilitation strategy on the MCE of a certain muscle. For example, 4 weeks of treadmill 
training enhanced certain DF MCE measures in people with chronic stroke, whereas 





(Yen, Wang, Liao, Huang, & Yang, 2008). Furthermore, TMS can be used as a research 
tool to elucidate the residual motor cortical control (i.e., functional integrity of CST) of 
the target muscle. 
 Compared to the existing evidence on the motor cortical control of PF and DF in 
healthy adults, only a few studies have examined the PF and DF MCE after stroke, and in 
those studies, the greatest changes in PF and DF MCE occurred on the paretic side. 
Compared to DF MCE, there is minimal evidence regarding PF MCE. To elicit an MEP 
in PF (SOL), relatively greater stimulus intensity is required as compared to that in 
healthy controls (i.e., an increase in  aMT) (Lewis et al., 2014). For DF, latency increases 
and the amplitude and SICF decrease compared to healthy controls (Beaulieu et al., 
2014). Although these studies provided some evidence on changes in PF and DF MCE, 
further research should be conducted to elucidate clearly the changes in PF and DF MCE.  
 2.5.6 Reliability of PF and DF MCE Measures after Stroke 
 The reliability of measuring the PF and DF MCE has been minimally investigated 
in stroke. There is one study for each muscle group. Lewis et al. (2014) investigated the 
intra- and inter-session (7 days apart) reliability of PF (SOL) MCE measures (area and 
amplitude of MEP, and aMT) in 13 people with chronic stroke. TMS stimuli (120% of 
aMT) were applied via double cone coil while participants were seated on a chair with 
the test leg in a fixed position, and they contracted their SOL at 10% of MVC; only the 
paretic side was assessed. The intra-session reliability was excellent for the area and 
amplitude. This reliability increased as the MEP responses increased (from 4 to 10) and 
was similar for both methods used for calculating the MEP measures (average trace vs. 





but the inter-session reliability of aMT was good (ICC: 0.82). This evidence indicates 
that certain PF MCE measures are very reliable within a single session, but for assessing 
PF MCE between sessions, only aMT is highly reliable. However, not all PF MCE 
measures were tested, and testing occurred only during tonic contraction. Therefore, 
further studies should examine the reliability of other PF (MG) and MCE measures (e.g., 
latency, MEP duration, cSP, RC derived measures, SICI, SICF) during both resting and 
active muscle contraction in people post-stroke.   
 The test-retest reliability (4 weeks apart) of DF MCE measures (rMT, amplitude, 
and latency) was tested in 16 people post-stroke (Cacchio et al., 2011). Both paretic and 
non-paretic legs were assessed. TMS stimuli were applied via circular coil while 
participants were seated on a chair. For the paretic leg, the inter-session reliability was 
excellent for rMT (ICC: 0.90) and latency (ICC: 0.85), yet poor for the amplitude (ICC: 
0.38). In contrast, all measures on the non-paretic leg had excellent inter-session 
reliability. It is unclear whether these results would be different if figure-of-eight coils, 
either flat or double cone, were used in combination with nTMS. Similar to these 
findings, the inter-session reliability (7-10 days apart) of MCE measures of the 
quadriceps (vastus medialis and lateralis) was high on the paretic leg (rMT) and non-
paretic leg (rMT and amplitude) in 23 people with chronic stroke (Wheaton, Villagra, 
Hanley, Macko, & Forrester, 2009). 
 Based on the existing evidence, MT, either resting or active, might be the most 
reliable measure for quantifying both PF and DF MCE measures on the paretic side in 
people post-stroke, while latency might be also a reliable MCE measure for the paretic 





2.6 PF and DF Neuromechanics  
 Due to their respective locations in the lower leg and to their muscle properties, 
PF and DF have different functions during walking. One may argue that the use of 
clinical tests may not elucidate specifically and precisely the PF and DF contributions 
during a task. On the other hand, the function of PF and DF can be quantified using 
neuromechanical measures, either muscle activity, which is quantified using EMG, or 
body segment motions, which can be quantified by either kinematics or kinetics.  
 2.6.1 Electromyography 
 EMG characterizes the amplitude and the temporal characteristics of the electric 
signal associated with the muscle contraction during a motor task (Winter, 2009). EMG is 
quantified using either sEMG electrodes or fine wire electrodes. The former electrodes 
are easy to place and handle, but they measure the activity of surface muscles only. The 
latter type of electrodes is used when the electrical activity of deep and small muscles 
must be measured. The main limitation of fine wire electrodes is that they are invasively 
applied; this application is not simple and easy to handle, and it may cause discomfort to 
the participants. Since both PF and DF are relatively superficial muscles, their activity 
can be accurately quantified using sEMG electrodes.    
 Using EMG has a few strengths and drawbacks. The main strength of EMG is that 
it records the electrical activity from individual muscles; therefore, comparisons in 
muscle activity can be done between unilateral muscles and bilateral muscles. Another 
advantage is that EMG provides information about the timing and coordination of the 
muscle activity during a task (e.g., during intact gait the TA EMG profiles has two 





with hemiparesis whose bilateral EMG recordings elucidate the integrity of muscle 
activity in both paretic and non-paretic muscles. However, EMG has a few inherent 
weaknesses. EMG can be influenced by multiple factors (Farina, Merletti, & Enoka, 
2004). Physiological cross talk (i.e., sEMG detection from neighboring muscles) and 
external noise (e.g., power line noise) are a few of those factors, which can be eliminated 
by using the right methodology. Similarly, EMG can have high variability due to factors 
such as adipose tissue, oily skin, electrode placement, and artificial movement of the 
electrode during the task. Of course, the experimenter can control nearly all these 
preceding factors. Furthermore, EMG does not provide direct information about the type 
of muscle contraction (e.g., eccentric vs. concentric). For example, TA is active during 
early stance and swing phase of GC, yet the type of contraction of the TA is not the same 
during these phases (Chleboun et al., 2007). By combining EMG with ultrasound and 
kinematic recordings, muscle contraction can be determined during specific subtasks of a 
motor task (e.g., walking). Lastly, EMG is not a direct measure of motion, which can be 
fully characterized using both kinematics and kinetics.  
2.6.2 Kinematics 
 Kinematics describe bodies in motion using the linear and angular positions and 
their temporal derivatives (i.e., velocity and acceleration), without regard to the motion’s 
cause (forces at work) (Robertson, 2004). The kinematics of dynamic tasks can be 
quantified either in two dimensions (planar) or in three dimensions (spatial). Via modern 
motion capture systems, three dimensional body kinematics can be characterized from the 
data collected from spatial kinematics (position) of reflective markers (passive markers), 





the participant. Then the three dimensional joint angles (sagittal, frontal, transverse) can 
be calculated offline using several methods,  most commonly the Cardan/Euler approach; 
and subsequently, both joint linear and angular velocities and accelerations are quantified 
(Robertson, 2004). During walking, joint ROM and joint angular velocities are usually 
used to quantify joint kinematics, especially in the sagittal plane, which characterize joint 
flexion and extension. At the case of the ankle joint, which consists of two joints 
(talocrural and subtalar), the sagittal ankle kinematics reported in gait studies quantify the 
motion at the talocrural joint, which GAS/SOL plantarflexes and TA dorsiflexes. In 
addition to motion capture systems, simple goniometers can be used to measure the active 
joint moved voluntarily by the participant or passive joint moved by the examiner 
without assistance from the participant in order to determine joint ROM (i.e., the arc of 
joint motion) in static conditions (Norkin & White, 2003).   
 Although the kinematic analyses of certain joints during specific tasks can answer 
questions related to the speed of motion and the ROM, kinematics do not describe 
directly the forces that cause the motion; however, kinetics do. Nevertheless, kinematics 
can be used as one of the inputs in inverse dynamics modeling to estimate the joint 
torques and powers of a linked system.   
2.6.3 Kinetics    
 Kinetics describe the forces that cause a motion in a rigid body and their resultant 
energetics. The three laws of motion can explain the relationship between the forces and 
the motion (1st: Law of inertia; 2nd: Law of acceleration; 3rd: Law of action-reaction). The 





torque); the motion is caused either by intrinsic musculoskeletal forces or forces present 
in the interaction with the surroundings (e.g., ground reaction forces; GRFs).  
 Intrinsic musculoskeletal forces include the joint reaction forces and muscle 
forces (Enoka, 2008). Muscle forces can be measured in vivo using buckle transducers 
that are implanted invasively. Although few studies have measured these forces (e.g., 
force exerted at Achilles’ tendon) in humans (Komi, Fukashiro, & Jarvinen, 1992), direct 
force measurement is limited due to the invasiveness of the technique. However, the net 
force, the sum of all these forces, can be indirectly calculated with the inverse dynamics 
approach. Three sets of data are used as inputs in the inverse dynamics: body segment 
kinematics (position, velocity, acceleration), anthropometric measures (mass and mass 
distribution of body segments), and external forces (e.g., GRFs) (Winter, 2009). Two of 
the main outputs of this modeling are joint torques and powers. Joint torque is the net 
result of all forces (e.g., from muscles and ligaments.) acting internally upon that joint, 
while joint power is the product of joint torque and angular velocity and quantifies the 
rate of energy change (Winter, 1991). To calculate joint torques and powers during 
walking, kinematics collected via motion capture system, anthropometric measures, and 
GRFs measured by force plates are required. During an isolated task, joint torques and 
powers, if the task is isokinetic or isotonic, are calculated using just a dynamometer. 
Lastly, both joint torques and powers can be used when the level of interest is at the joint.       
 In addition to intrinsic musculoskeletal forces, external forces can cause a motion. 
Such external forces are the GRFs, which are examples of the 3rd law of motion that 
states that “when one object (e.g., human body) applies a force to another object (e.g., 





(Robertson, 2004). GRFs have three components to the force vector, vertical (GRFV), 
anterior-posterior (GRFAP), and medio-lateral (GRFML). Each component (i.e., the 
algebraic summation of the mass-acceleration products of all body segments during foot 
contact (Winter, 1991)) represents the reaction of the support surface on which the task is 
performed (e.g., treadmill’s surface) to body motions (e.g., walking) that exert forces 
through the feet to the ground (Enoka, 2008). GRFs are present only during the stance 
phase of GC in which the foot is in contact with the ground; therefore, GRFs can be used 
to quantify kinetics only in stance. All three components of GRFs during walking can be 
measured by force plates that are located underneath the walking surface. Modern 
instrumented treadmills (e.g., split-belt) can measure the GRFs exerted on each leg. 
Among the three GRF components, the GRFV and GRFAP are the largest and most 
commonly used during walking. During stance, the GRFV has a typical bimodal profile 
(two modes representing peak vertical forces at heel strike/weight acceptance and toe 
off/late stance), whereas the GRFAP has negative and positive phases. In GRFAP, the 
negative phase in the first half of stance demonstrates a net braking of the whole body, 
while the positive phase in the second half of the stance demonstrates the forward 
acceleration of the body, which is the force that moves the body anteriorly over the 
ground. Although GRFs are limited to stance phase only, they provide great information 
about the whole body’s kinetics during stance and can be used to calculate the joint 
torques with inverse dynamic calculations. 
 Both kinematic and kinetic data during a task should be acquired because they 
provide a comprehensive description of the motion during that task. Otherwise, 





kinematics to describe the motion of the leg joints during walking omits the significant 
contributions of GRF during the stance, yet this kinematic analysis occurs throughout the 
GC. Conversely, capturing only kinetic data during gait can quantify causes of motion 
mainly during stance because joint torques and powers during swing are low (especially 
at the ankle joint) compared to stance. Therefore, if the goal is to capture fully the motion 
of certain joints during a task, both kinematic and kinetic data should be collected. A 
limitation of this approach is the high cost of acquiring the tools that collect this data; 
however, currently nearly all motion analysis laboratories obtain all the required tools for 
collecting both kinematic and kinetic data.   
2.6.4 Quantification of PF and DF Function 
 All aforementioned neuromechanical measures indirectly describe the body 
motion during a task. However, not all measures represent the specific contribution of a 
certain muscle during a motor task. In both walking and isolated tasks, certain 
neuromechanical measures can be used to quantify indirectly the function of a specific 
muscle.       
 Plantarflexors: During walking, PF have three functions. First, PF stabilize and 
control the ankle joint as the lower leg rotates forward during the early part of single leg 
stance (Winter, 1991) while they contract isometrically (Cronin et al., 2013; Panizzolo et 
al., 2013). Second, PF move the body’s center of mass (COM) forward by major energy 
generation during the single leg stance (push-off phase; ~40-60% of GC in healthy 
controls) (Neptune, Kautz, & Zajac, 2001; Winter, 1983) while contracting 
concentrically. Third, PF contribute to swing initiation during the pre-swing phase of GC 





their contributions in these three functions differ. SOL may contribute more than GAS to 
ankle stabilization throughout single leg stance (Neptune et al., 2001), whereas GAS (i.e., 
MG) may be the strongest contributor during push-off (Gottschall & Kram, 2003; 
Neptune et al., 2001) and pre-swing (Neptune et al., 2001). Among all three functions of 
PF, the second function might be the most crucial. Therefore, EMG and GRFs can 
quantify this function of PF because during the push-off phase in stance, PF, both SOL 
and GAS, are concentrically active, and the positive phase of GRFAP occurs. 
Since in push-off, PF shorten and contribute to a PI (the time integral of the 
positive GRFAP), any impairment to PF will have an impact on both muscle activity and 
PI. After stroke, the push-off phase of stance is limited due to impairments in PF whose 
muscle activity decreases compared to healthy controls (Knutsson & Richards, 1979; Peat 
et al., 1976). The PI reflects the forward acceleration of the body. In an intact system, PI 
results from a large ankle power burst, which occurs while PF are active during the push 
off phase of stance, and from the angle of the trail leg (i.e., the angle between a line from 
the pelvis COM to the foot COM and vertical) during the second half of the single leg 
stance and the second double limb support (Peterson, Cheng, Kautz, & Neptune, 2010). 
After stroke, in which one side is more affected than the other, the PI generated from 
each leg has been found to be asymmetrical (Bowden, Balasubramanian, Neptune, & 
Kautz, 2006; Sousa, Silva, Santos, Sousa, & Tavares, 2013), and it can be influenced by 
joint torques other than ankle joint torque (Peterson et al., 2010). One of the advantages 
of using PI is that only force plates are required to calculate directly PI, whereas ankle 





multiple sets of different data. Therefore, PI may provide a quantitative measure of the 
coordinated output from PF either in healthy controls or people post-stroke.  
 Dorsiflexors: During walking, DF have two distinct functions. First, just prior to 
and just after heel contact, DF are isometrically active (largest DF burst during GC) 
(Chleboun et al., 2007) in order to lower the foot to the ground and to avoid slapping the 
foot. Second, DF is concentrically active immediately after toe off to clear the foot 
sufficiently during mid-swing. Between the two functions, the second holds more 
significance, especially in people post-stroke. The main goal in swing is to move the 
unloaded limb from behind the body to the front of the body with minimum foot lift and 
to optimize energetic efficiency. In normal walking, the minimum toe clearance has been 
reported to be less than 20 mm with low variability (Moosabhoy & Gard, 2006; Winter, 
1992), and it occurs typically at about mid-swing (Moosabhoy & Gard, 2006), which is 
preceded by DF EMG burst at the time point when the ankle joint is dorsiflexing with 
peak AAV (Winter, 1991).  
Toe clearance in swing is partly controlled by DF. This function of DF is 
considered to be cortically driven because of the strong CM connections. In addition, in 
contrast to stance in which the leg is in contact with the ground, the swing limb is not 
affected by the environmental surroundings. Therefore, this precise motor task (clear the 
foot with minimum lift) may rely on input from supraspinal centers (e.g., MC) (Capaday 
et al., 1999; Schubert et al., 1997). This cortical reliance of the DF during swing may 
explain the decreased dorsiflexion ROM (drop foot) during swing in people post-stroke. 
Further evidence for the cortical control of DF is that the PF and DF isometric strength 





incomplete SCI, ankle motor skill quantified by the root mean square error during a 
visuomotor ankle torque-tracking task is deteriorated in people post-stroke (van Hedel, 
Wirth, & Curt, 2010). Since toe clearance is a type of fine motor skill, this evidence may 
explain why people post-stroke are usually unable to clear the foot during swing without 
using compensatory patterns generated in other joints.     
Toe clearance is an important kinematic measure that describes quantitatively the 
ability of the swing limb to be advanced and positioned forward by clearing the floor. In 
two studies, toe clearance (toe elevation) was employed to quantify foot drop in people 
with incomplete SCI; the authors suggested that toe elevation during swing is more valid 
and reliable than angular changes (Barthelemy et al., 2013; Barthelemy et al., 2010). 
Nevertheless, toe clearance may not fully quantify the function of DF during swing. A 
reason may be that the angular changes in other joints, both ipsilateral and contralateral, 
can contribute to toe clearance as well (Winter, 1992). For example, activating DF 
immediately after toe off achieves toe clearance in healthy adults, yet in people post-
stroke, whose DF are impaired, toe clearance can be accomplished by either increasing 
the knee and hip flexion during swing or through circumduction ( greater than normal 
frontal thigh ROM during mid-swing (Kerrigan, Frates, Rogan, & Riley, 2000)). 
Therefore, improving toe clearance after stroke does not necessarily imply improvement 
in DF function. 
 Other measures than toe clearance should be used to quantify the contribution of 
DF during swing. Reliance on DF EMG has the same limitations that have been 
discussed in a previous section. In contrast to stance phase, in which the foot is in contact 





power in swing are minimum. Thus, the ankle motion during swing is primarily 
quantified by the ankle kinematics, joint ankle angle and angular velocity. Between the 
two, ankle joint angular velocity might be the most appropriate to characterize the 
contributions of DF during swing (the peak AAV when the ankle joint is dorsiflexing 
during the first half of swing); because the ankle joint torque is so low in swing, the AAV 
during swing can be used as a surrogate of mechanical power, which is the product of 
joint torque and joint angular velocity. Therefore, ankle joint power during swing 
primarily represents the AAV.   
 Compared to research on ankle joint angle, few studies have used ankle joint 
angular velocity to quantify local kinematics at the ankle during walking. Granata et al. 
(2000) investigated whether joint angular velocities were influenced by muscle-tendon 
lengthening in children with spastic diplegia (cerebral palsy). They reported that joint 
angular velocity was a better discriminator than joint angle for gait patterns between 
clinical and normal populations (Granata et al., 2000). Similarly, another study showed 
no differences in ankle excursions (i.e., the difference between the maximum dorsiflexion 
and plantarflexion during gait) between healthy individuals and people with incomplete 
SCI whereas ankle joint angular velocity during the second double limb support differed 
between groups (Krawetz & Nance, 1996). Findings from these studies indicated that 
using joint angular velocities might help to discriminate gait changes between healthy 
people and neurologically impaired people more accurately than the typically reported 
joint angles. Granata et al. (2000) proposed two potential reasons for the superiority of 
joint angular velocity to discriminate gait patterns. First, joint angular velocities may 





angles, which are prone to bias errors (e.g., incorrect marker placement and calibration 
procedures), joint angular velocities are not influenced by those bias errors because they 
characterize the relative change in joint angles.  
Regardless of the measure used to quantify PF or DF during walking, we should 
bear in mind that joint kinematics and kinetics can be influenced by other factors (e.g., 
walking speed). Conversely, during MVIC, which is a closed chain task, PF and DF 
neuromechanics may be less influenced by external factors. Therefore, measuring both 
muscle activity and torques during MVIC may accurately quantify the contributions of 
each muscle group. 
 
2.7 Associations between PF and DF MCE and Motor Behavior 
Associations between the motor cortical input to a leg muscle and motor behavior 
of that muscle during a motor task have been found in both healthy controls and 
neurologically disabled individuals. In nine people with chronic stroke, Jayaram et al. 
(2012) investigated the relationship between an MCE measure of the vastus lateralis 
(knee extensor) and two commonly used clinical measures, Fugl-Meyer lower extremity 
(FM-LE) score and walking speed. The authors used the functional connectivity ratio to 
assess the corticospinal connectivity from each MC to both the paretic and non-paretic 
vastus lateralis muscles. This functional connectivity measure represented the ratio 
between the slope of ipsilateral and contralateral RC. Values of the functional 
connectivity ratio less than 1 indicated predominant contralateral connectivity (normal 
state). Results showed negative relationships between the functional connectivity ratio 





reliance from the ipsilateral MC was associated with lower FM-LE score and slower 
walking speed. This study was the first to show that the functional integrity of the 
bilateral CST that innervates a leg muscle was associated with clinical measures in 
people post-stroke. Despite the clinical importance of this study, its results should be 
interpreted with caution. Walking speed is a global measure that can be influenced by 
multiple factors. Therefore, the significant relationship between the cortical control of the 
vastus lateralis and walking speed does not explicitly explain the contributions of the 
motor cortical input to vastus lateralis during walking after stroke. In addition, a recent 
study that applied TMS during treadmill walking in 13 healthy adults showed that the 
vastus lateralis was less cortically driven than ankle muscles, suggesting weak motor 
cortical contributions to the vastus lateralis during walking (Iglesias, Lourenco, & 
Marchand-Pauvert, 2012).  
For a better understanding of how a certain muscle is cortically controlled during 
a task, the association should be between the MCE of that muscle and a specific 
neuromechanical measure that quantifies its function during a specific task. Few studies 
utilized that approach. Barthelemy et al. (2010) tested whether there was a relationship 
between the TA MCE and foot drop in people with chronic SCI. As a measure of foot 
drop and function of TA, Barthelemy and colleagues used toe elevation; the largest 
distance between the marker placed on the 5th metatarsophalangeal joint and the ground 
during swing. Their results showed a negative relationship between MEP latency and toe 
elevation and a positive relationship between MEP amplitude and toe elevation. The 
findings suggested that adequate toe elevation during the swing phase requires sound TA 





measures (amplitude and latency of MEP) were associated with clinical measures such as 
walking speed, the 6 minute walking test (6MWT), and Timed Up and Go (TUG). The 
results demonstrated no relationship between any TA MCE measure and clinical tests, yet 
toe elevation was strongly associated with all clinical tests. In contrast to Jayaram et al. 
(2012), the two studies by Barthelemy et al. (2013; 2010) showed that both amplitude and 
latency of TA MEP were associated with the toe elevation, a kinematic measure that 
indirectly quantifies the function of TA during swing, but not with any clinical tests. 
Therefore, this evidence strengthens the argument that to investigate the motor cortical 
control of a muscle during a task, a neuromechanical measure that quantifies the function 
of that muscle should be used in the association instead of a clinical measure. 
The existence of this type of association between MCE of either PF or DF and a 
neuromechanical measure in people post-stroke is limited. A recent study (Beaulieu et al., 
2014) examined whether the impairment of voluntary dorsiflexion motion was associated 
with the functional integrity of CST in 18 people with chronic stroke. The DF MCE 
measures used were the aMT, latency, amplitude, cSP, SICI, and SICF. Ankle 
dorsiflexion was quantified using the neuromechanical measures of active dorsiflexion 
ROM, MVICn, and TA EMG in both tasks (i.e., ROM and isometric muscle strength). 
The rresults demonstrated only two significant relationships among all the relationships 
examined between the DF MCE measures and the neuromechanical measures (six TMS 
measures x four clinical measures: 24). The amplitude of DF MEP was positively 
associated with DF ROM and strength during MVIC.  
The cumulative evidence from these studies supports the notion that investigating 





understanding of the motor cortical control of DF during different tasks in people post-
stroke. Such potential associations have not been widely investigated in stroke or for PF. 
The only existing evidence is for DF during MVIC, whereas none exists during walking.  
  
2.8 Remaining Gaps 
 The measures used in these associations must be fully understood for the 
associations to be scientifically and clinically important. Among the measures used in 
these associations, the PF and DF MCE measures are the least well understood, 
especially in people post-stroke. First, the reliability of the PF and DF MCE measures has 
not been adequately investigated either in neurologically intact adults or in people post-
stroke. Within the last decade, only a few studies have tested the reliability of certain 
MCE measures in healthy controls. These studies focused primarily on TA (Cacchio et 
al., 2009; Tallent et al., 2012; van Hedel et al., 2007); only one study investigated a few 
MCE measures of SOL (Lewis et al., 2014). In people post-stroke, only two studies have 
reported good reliability of certain PF (only for SOL) (Lewis et al., 2014) and DF 
(Cacchio et al., 2011) MCE measures, even though all possible MCE measures have been 
used in stroke studies that have investigated the motor cortical control of PF and DF. 
 Although the findings from these studies are important, several gaps in knowledge 
regarding reliability still exist. First, both physiological (state of muscle contraction 
during stimulation) and methodological (type of coil, use of nTMS) factors that may 
influence the reliability of PF and DF MCE measures have not been thoroughly 
investigated. Secondly, the reliability has not been established for all potential measures 
that quantify the MCE of SOL and TA. In addition to lack of certain knowledge about 





used to examine comparisons across persons. The MCE measure used in the brain and leg 
motor behavior associations in people post-stroke must detect the differences between an 
intact and lesioned CNS (i.e., stroke). In addition, it may be inaccurate to assume that the 
measure used to characterize the best PF MCE is the same for DF MCE. These brain and 
leg motor behavior associations in people post-stroke can be useful only after the 
characterization of MCE measures for each muscle. 
 Investigating the associations between MCE and the neuromechanics of PF and 
DF during functional and isolated tasks in stroke has the potential to elucidate the extent 
to which deficits in post-stroke motor cortical contributions to PF and DF are related with 
muscle-specific neuromechanics and whether these relationships are task-specific. This 
evidence may provide vital information about how PF and DF are cortically controlled 
after a brain lesion. Moreover, this evidence may influence rehabilitation strategies to 
help people post-stroke optimally gain full functional recovery. In healthy adults, MC 
may contribute less to the control of PF than DF, but MC’s input is still necessary and 
depends on the nature of the task. For example, PF and DF MCE are task-specific in 
healthy people and similar during MVIC but different during walking (Capaday et al., 
1999). Following a stroke, the motor cortical input to PF and DF changes, yet how this 
motor cortical control changes remains unclear. Moreover, studies have yet to examine 
whether motor cortical control differs between PF and DF depending on the mechanical 
demands of the task (e.g., a walking vs. an isolated task). Unfortunately, such potential 
associations have not been well investigated in people post-stroke. No study has 





people post-stroke, either during walking or during MVIC. The only existing evidence is 



















RESEARCH DESIGN AND METHODS 
3.1 Specific Aims and Hypotheses  
 The overall objectives of this project were to investigate the extent to which 1) the 
SOL and TA were cortically driven in people post-stroke (paretic leg) and in healthy 
controls (dominant leg) and 2) deficits in post stroke motor cortical control were 
associated with the neuromechanics of the paretic SOL and TA during walking (i.e., a 
functional task) and MVIC (i.e., voluntary isolated task) (Figure 3.1). Prior to any 
correlational analysis, we systematically investigated which MCE measure, among 8, for 
each muscle was the most reliable and detected the differences in variances and means 
between an intact CNS (healthy controls) and lesioned CNS (people post-stroke) (Aims 1 
and 2 in Figure 3.1). Then we investigated the associations between the MCE and ankle 
neuromechanics (i.e., muscle activation, joint kinematics, and kinetics) for the paretic 
SOL and TA during walking and MVIC tasks in people post-stroke (Aims 3 and 4 in 
Figure 3.1). Eight MCE measures were quantified while the target muscle was relaxed, 
either SOL (Figure 3.1 A) or TA (Figure 3.1 B), on the paretic side in people post-stroke 
and the dominant side in healthy controls during the resting condition (rMT, MEP 
amplitude, MEP latency, and normalized MEP latency) and slightly contracted during the 
active condition (MEP amplitude, MEP latency, normalized MEP latency, and cSP).
  
The neuromechanical measures of the paretic SOL were the EMG and PI in single leg 
stance (SLS1 & SLS2) and second double limb support (DLS2) during walking as well as 
EMG and torque during MVIC (Figure 3.1 C). The neuromechanical measures of the 
paretic TA were the EMG and AAV during the first half of the swing (50% Swing1) 
during walking and EMG and torque during MVIC (Figure 3.1 D). 
Specific aims for this dissertation were as follows: 
Aims 1 and 2: 
 The overall goal of Aims 1 and 2 was to quantify eight MCE measures of SOL 
and TA in people post-stroke and in healthy controls. The quantification of each measure 
occurred in three steps. The first step was to investigate the intra-rater test-retest 
reliability in both groups. Only measures that were reliable in both groups were used in 
the next step. The second step was to examine the inter-group difference in variance for 
the measures that passed the first step. The third step was to examine the inter-group 
difference in mean for the measures that passed the second step. We employed those 
three steps for the following reasons. A main goal was to avoid running multiple 
correlations using SOL and TA MCE measures that had not been quantified to the 
populations of interest in our study. Furthermore, instead of examining only the reliability 
of each measure, we sought to identify the measure that could best distinguish damage to 
CNS. To determine this distinction, we investigated the inter-group differences for both 
variance and means. We expected low between-subject variance within a group with 
healthy CNS, as the integrity of the neuromotor axis is the same among the healthy 
participants. Conversely, within a group with damaged CNS, due to the different level of 





the integrity of the neuromotor axis is not the same among stroke participants. 
Furthermore, the group mean of a MCE measure in healthy adults should differ from the 
group mean of the same measure in stroke participants. Consequently, significant inter-
group differences in both variance and mean would indicate the distinction between 
damaged and healthy CNS. In Aims 3 and 4, therefore, we used only the MCE measures 
of SOL and TA that were reliable in both groups and that differed in variance and mean 
between groups.  
 The evidence for the quantification of the SOL and TA MCE is limited for both 
groups, especially for SOL. Although SOL MCE may differ from TA MCE, we expected 
that the measurement characteristics of SOL MCE would be similar to TA MCE. 
Therefore, the hypotheses of these two aims were based mainly on the TA MCE studies, 
which demonstrated good reliability for rMT, latencies, and cSP (Cacchio et al., 2009; 
Cacchio et al., 2011; Forster et al., 2014; Meaney, Collett, Dawes, Howells, & Izadi, 
2015; Tallent et al., 2012; van Hedel et al., 2007). Furthermore, these three particular 
measures typically increase after a stroke (Kobayashi & Pascual-Leone, 2003).   
 Specific Aim 1: To determine which of the eight SOL MCE measures was 
reliable both in healthy controls and in people post-stroke yet differed in both variance 
and mean between groups (Figure 3.1 A). 
When SOL was at resting state (Figure 3.2 A-I): 
 Hypothesis 1.1.a: SOL rMT, latency, and normalized latency of SOL would be 
the most reliable in both groups  
 Hypothesis 1.1.b: SOL rMT would be significantly higher and more variable in 





 Hypothesis 1.1.c: SOL latency would be significantly longer and more variable in 
people post-stroke than in healthy controls. 
 Hypothesis 1.1.d: SOL normalized latency would be significantly longer and 
more variable in people post-stroke than in healthy controls. 
When SOL was at active state (Figure 3.2 A-II): 
 Hypothesis 1.2.a: SOL latency, normalized latency, and cSP would be the most 
reliable in both groups. 
 Hypothesis 1.2.b: SOL latency would be significantly longer and more variable in 
people post-stroke than in healthy controls. 
 Hypothesis 1.2.c: SOL normalized latency would be significantly longer and more 
variable in people post-stroke than in healthy controls. 
 Hypothesis 1.2.d: SOL cSP would be significantly longer and more variable in 
people post-stroke than in healthy controls. 
 Specific Aim 2: To determine which of the eight TA MCE measures were 
reliable both in healthy controls and in people post-stroke yet differed in both variance 
and mean between groups (Figure 3.1 B). 
When TA was at resting state (Figure 3.1 B-I): 
 Hypothesis 2.1.a: TA rMT, latency, and normalized latency of SOL would be the 
most reliable in both groups.  
 Hypothesis 2.1.b: TA rMT would be significantly higher and more variable in 
people post-stroke than in healthy controls.  
 Hypothesis 2.1.c: TA latency would be significantly longer and more variable in 





 Hypothesis 2.1.d: TA normalized latency would be significantly longer and more 
variable in people post-stroke than in healthy controls. 
When TA was at active state (Figure 3.2 B-II): 
 Hypothesis 2.2.a: TA latency, normalized latency, and cSP would be the most 
reliable in both groups. 
 Hypothesis 2.2.b: TA latency would be significantly longer and more variable in 
people post-stroke than in healthy controls. 
 Hypothesis 2.2.c: TA normalized latency would be significantly longer and more 
variable in people post-stroke than in healthy controls. 
 Hypothesis 2.2.d: TA cSP would be significantly longer and more variable in 
people post-stroke than in healthy controls. 
Aims 3 and 4: 
 The overall goal of Aims 3 and 4 was to investigate the associations between the 
descending drive, quantified by MCE measures determined in the two previous aims, and 
the specific ankle neuromechanics of the paretic SOL and TA during walking and MVIC 
in people post-stroke. Instead of using clinical measures that can be influenced by 
multiple factors, we chose to use specific neuromechanical measures that quantify 
indirectly the function of each muscle during specific phases of walking and during 
MVIC. These neuromechanical measures included both the muscle activity and the ankle 
mechanics (i.e., kinematics and kinetics) of the paretic SOL and TA.  
 In healthy adults, Capaday et al. (1999) demonstrated that the contributions of the 
descending drive to SOL and TA depended on the nature of the task. Specifically, SOL 





the TA MCE was the same during the swing phase of walking as in dorsiflexion MVIC. 
Since stroke detrimentally affects the integrity of the neuromotor axis in people post-
stroke, the contributions of the descending drive to each muscle should be weaker than in 
healthy controls. However, the pattern of contributions to the paretic SOL and TA should 
be similar in both tasks as described in Capaday et al. (1999). Additionally, because 
stroke increases the MCE measures (as we hypothesized to pass all three criteria in Aims 
1 and 2), and stroke decreases the neuromechanical measures used to quantify paretic 
SOL and TA during walking and MVIC, we expected to find negative associations 
between the MCE measures and the neuromechanics of the paretic SOL and TA.         
 Specific Aim 3: To investigate the associations between the MCE measures 
determined in Aim 1 and the neuromechanics of the paretic SOL during walking and 
MVIC in people post-stroke (Figure 3.1 C). 
For the functional task (i.e., walking):  
 Hypothesis 3.1.a:  SOL MCE would not be significantly associated with SOL 
EMG in stance phase (Figure 3.2 C-I). 
 Hypothesis 3.1.b:  SOL MCE would not be significantly associated with PI 
(Figure 3.2 C-II). 
For the isolated voluntary task (i.e., MVIC):   
 Hypothesis 3.2.a: SOL MCE would be significantly and negatively associated 
with SOL EMG (Figure 3.2 C-III). 
 Hypothesis 3.2.b: SOL MCE would be significantly and negatively associated 
with SOL isometric torque (Figure 3.2 C-IV). 





determined in Aim 2, and the neuromechanics of TA during walking and MVIC in people 
post-stroke (Figure 3.1 D). 
For the functional task (i.e., walking):  
 Hypothesis 4.1.a:  TA MCE would be significantly and negatively associated 
with TA EMG in the first half of swing phase (Figure 3.2 D-I). 
 Hypothesis 4.1.b:  TA MCE would be significantly and negatively associated 
with AAV (Figure 3.2 D-II). 
For the isolated voluntary task (i.e., MVIC):  
 Hypothesis 4.2.a: TA MCE would be significantly and negatively associated with 
TA EMG (Figure 3.2 D-III). 
 Hypothesis 4.2.b: TA MCE would be significantly and negatively associated with 
TA isometric torque (Figure 3.2 D-IV). 





Figure 3.2: Outline of the hypotheses 
3.2 Study Design 
 This study was cross-sectional. All experimental procedures took place in the 
Functional Neurostimulation Laboratory (FNL; testing MCE), Locomotion Energetics 
and Assessment Laboratory (LEA; testing walking neuromechanics), and the Locomotor 
Rehabilitation Laboratory (LRL; testing MVIC neuromechanics). All labs are located in 
the College of Health Professions research building (CHP-C) at the Medical University of 
South Carolina (MUSC), Charleston, SC.  
 
3.3 Participants 
 Fifteen people with chronic stroke were recruited within a period of 6.5 months 
(2/11/2015 - 8/24/15). People post-stroke were included in the study if they met the 





or subcortical lesion and either an ischemic or hemorrhagic type of stroke; 4) residual 
paresis in the lower extremity (FM-LE motor score <34) preservation of minimal DF and 
PF contraction (at least 2 of 5 on a manual muscle test); 5) able to walk 1 minute on a 
treadmill with minimum speed of 0.2 m/s; 6) passive ROM of 5° of plantarflexion; 7) 
provision of informed consent; and 8) no cognitive impairments that made it difficult to  
follow the instructions about experimental procedures. Individuals were excluded from 
the study if they 1) had a history of seizures or used medications that could lower seizure 
thresholds; 2) had a history of brain injury or preexisting neurological disorder; 3) had a 
pacemaker or intracranial metallic implants (Rossi, Hallett, Rossini, Pascual-Leone, & 
Safety of, 2009); or 4) had severe arthritis or orthopedic problems that limit passive 
ROM.  
 Twenty five neurologically intact controls were recruited within a period of 3.5 
months (12/1/2014 - 3/15/2015) and were free from any neurophysiological or 
musculoskeletal ailments. 
 
3.4 Experimental Procedures 
 People post-stroke and healthy controls attended two data collection sessions 
(Stroke: 8 ± 2 days apart; Healthy: 7 ± 2 days apart). Before the first experimental 
session, a MRI session occurred either on a separate day or on the same day. That session 
lasted 31 and 26 minutes, respectively, for people post-stroke and for healthy controls. 
For the people post-stroke, the experimental procedures lasted approximately 3 and 4 
hours for the first and second sessions, respectively. For the healthy controls, the 





3.4 present each of the overall experimental procedures carried out in healthy controls 
and stroke participants, respectively. 
Figure 3.3: Flowchart of the experimental procedures used in healthy controls 





 The first time that all participants came to the setting and prior to any testing (i.e., 
MRI), we informed them orally about the experimental procedures and potential risks, 
then asked them to read and sign written informed consents approved by the MUSC 
Institutional Review Board and adhering to the Declaration of Helsinki. To ensure 
participants’ safety and qualification for MRI and TMS testing, we administered MRI 
(Shellock & Spinazzi, 2008) and TMS (Rossi, Hallett, Rossini, & Pascual-Leone, 2011) 
safety-screening questionnaires (Appendices). Then we collected anthropometric (e.g., 
height, body mass) and demographic (e.g., age, gender) data. For people post-stroke, we 
also collected information about their mobility capacity and present comorbidities, and 
one of three licensed physical therapists with multiple years of clinical experience 
administered a single clinical test (FM-LE).  
 The FM-LE scale was used to assess the sensorimotor function of the lower 
extremity in people post-stroke, and it consisted of 17 items (Fugl-Meyer, Jaasko, 
Leyman, Olsson, & Steglind, 1975). Each item was scored on a 0 to 2 scale; a total score 
of 34 points was possible (Appendices).  
 At the two subsequent data collection sessions, the MCE testing occurred in both 
groups. At the second data collection session, the walking and MVIC neuromechanics, 
which were measured only in people post-stroke, were always tested after MCE to avoid 
any interference with MCE testing (e.g., fatigue of descending pathways due to the 
neuromechanics testing). The order of the two neuromechanical tests was randomized; 
they were administered consecutively, with a short break between tests. There was a 30-
minute break between the cessation of the MCE testing and beginning of the 





 3.4.1 Structural MRI and TMS Frameless Stereotaxy Neuronavigation 
System  
 To ensure accurate and precise positioning of the coil throughout the MCE testing 
and across sessions, we used a BrainsightTM (v2.2) TMS Frameless Stereotaxy 
Neuronavigation System (Rogue Research Inc.; Montreal, Quebec, Canada), into which 
each participant’s structural MRI was imported. We asked people post-stroke and healthy 
controls, who did not have the anatomical images of their brain taken in a previous study, 
to attend a MRI session. In addition to structural MRI (both groups: localizer and 
MPRAGE), several other MRI protocols (stroke group: flair, DKI, ep2d resting state; 
healthy group: flair, DKI) were carried out for secondary analyses which were part of 
other studies. During scanning, participants were in a supine position with a cushion 
placed under their knees to ensure a comfortable posture; they wore earplugs to attenuate 
the loud noise of the scanner and were asked to keep still (Figure 3.3 A & 3.4 A). For the 
structural MRI of each participant, high-resolution T-1 weighted anatomical brain images 
were acquired (TR=1900 ms, TE= 2.26 ms, voxel dimensions 1.0 x 1.0 x 1.0 mm, 192 
slices (1 mm thickness), full brain and cerebellar coverage) using a Siemens 3T TIM trio 
scanner (Siemens, Erlangen, Germany) with a thirty-two-channel head coil (Siemens, 
Erlangen, Germany). MRI testing occurred in the Center of Biomedical Imaging located 
at the Medical University of South Carolina.  
 Shortly after the end of the MRI session, we uploaded each participant’s images 
(i.e., DICOM files) into Brainsight and several steps were undertaken prior to the 
experiment (Figure 3.3 B & 3.4 B). The first step was to co-register manually each 





commissures, so the individual’s MRI could be mapped using a widely used stereotaxic 
coordinate system, the Montreal Neurological Institute (MNI) atlas. The origin of the 
MNI atlas was the anterior commissure (0, 0, 0); therefore, any spot in the brain had x 
(mediolateral), y (anteroposterior), and z (vertical) coordinates in relation to the origin. 
Then we reconstructed the 3D skin and curvilinear brain models. We used the 3D skin 
model to identify four anatomical landmarks, which we used to calculate the participant 
to image registration. These anatomical landmarks were the tip of the nose, bridge of the 
nose (i.e., nasion), and supratragic notch of the right and left ear. We used the 3D 
curvilinear brain model to identify manually the leg motor area on which a rectangular 15 
mm (4 columns in the mediolateral axis) x 40 mm (9 rows in the anteroposterior) grid 
(total of 36-points) was overlaid at each hemisphere (Figure 3.5).  
Figure 3.5: Bilateral 36-spot grid superimposed over the leg motor areas of a representative brain 
The space between points was 5 mm; using 5 mm was found to determine the hot spot 





Fuhr, Hallett, & Cohen, 1992). Rather than using a scalp based target approach in which 
any error in orientation can alter the stimulation site, we used a cortex based approach in 
which error in orientation has a negligible effect on the stimulation site (Comeau, 2014). 
For this reason, we positioned the centered row of the grid at the center and below the 
surface of the leg motor cortical area where CST that innervate leg motor pools originate 
(Conti et al., 2014). For consistency across participants, the same person created all 
Brainsight files.  
 3.4.2 SOL and TA MCE  
 MCE was assessed twice in both groups, and each data collection occurred at the 
approximately the same time of the day (e.g., morning). In healthy controls, SOL and TA 
MCE were assessed bilaterally at both visits (Figure 3.3 C & D). In people post-stroke, 
SOL and TA MCE were assessed bilaterally at the first visit, whereas the MCE of the 
paretic SOL and TA were only assessed at the second visit (Figure 3.4 C & D). Other 
than this minor difference, all MCE procedures were the same for both groups (Figure 
3.6). We strongly suggested to all participants to avoid consuming caffeine or alcohol for 
at least 3 hours prior to experimental procedures.| 
 After EMG placement and testing (Figure 3.6 Step 1; see below for further 
explanation), participants sat comfortably in a reclined position (~95° from horizontal) 
with both arms and shanks supported by armrests and limb-support pads, respectively 
(Figure 3.6 Step 2). To ensure consistent feet placement across participants, both feet 
were secured in walking boots that allowed the ankle ROM to be adjusted from 30° 
dorsiflexion to 45° plantarflexion in 7.5° increments. The angles at the hip, knee, and 





respectively. Both hip and knee angles were slightly adjusted in case the participant 
reported discomfort with the current posture. When there was a need to keep the head still 
during TMS application, we used a forehead rest arm that was attached on the chair and 
positioned opposite to the site where the coil was placed. Throughout the experiment, we 
instructed participants to keep still. 
Figure 3.6: Flowchart of the experimental procedures carried out for MCE testing 
 After EMG placement and the participant’s setup on the chair, we determined the 
MVIC of the SOL and TA bilaterally using EMG (Figure 3.6 Step 3). For each motion, 
participants were instructed to maximally contract the target muscle (e.g., SOL) 4 times 
(~5 seconds contractions seperated by 60 seconds of break) while they were seated at the 
posture described above. After each contraction, the maximum contraction, which was 
quantified using EMG, was calculated immediately using Spike v7.15 (Cambridge 
Electronic Design; Cambridge, UK) by taking the average within a 100 ms window 





0.165 sec) EMG. We used the same method to calculate simultaneously the joint torque 
and EMG during the voluntary isolated task (MVIC); see section 3.6.3 for further 
explanation. The highest value of the four was used to calculate the 15% MVIC, which 
was used during the active TMS conditions. We chose that level of MVIC because it has 
been commonly used in previous studies which examined TA MCE in people post-stroke 
(Beaulieu et al., 2014; Beaulieu, Masse-Alarie, Brouwer, & Schneider, 2015). During 
pilot testing, futhermore, we found that level to be achievable by people post-stroke and 
adequate to yield cSP during pilot testing. 
 Following the MVIC protocol, we prepared the neuronavigation system. First, a 
headband with reflective markers was placed on the participant’s head. After creating a 
new TMS session on the participant’s Brainsight file, the target grid for stimulation was 
selected. Our next step was to verify the proper position of the motion capture camera, 
Polaris Vicra System (Northen Digital Inc.; Waterloo, Ontario, Canada) by placing the 
headband tracker, the pointer, and the coil tracker on its capture volume space. Then we 
performed the participant-image registration by placing the tip of the pointer on 4 
anatomical landmaks: nasion (Figure 3.6 Step 4-A), the tip of the nose (Figure 3.6 Step 4-
B), and the supratragic notch of the right and left ear (Figure 3.6 Step 4-C). Once all 
anatomical landmarks were sampled, we verified whether registration occurred accurately 
by placing the tip of the pointer on random spots over the participant’s skull. If the 
distance from the tip of the pointer to the reconstructed skin was less than 5 mm, we 
procceeded to TMS experiment; otherwise, participant-image registration was repeated 
until the desired values were obtained.    





across hemispheres. For all experiments, the same TMS user applied a single pulse 
stimuli on the optimal site (i.e., hot spot; see next paragraph for further details) of the 
target muscle using a BiStim module magnetic stimulator (The Magstim Company 
Limited; Whitland, UK). The stimulator was set at the standard mode; the power of the 
second unit was set at 0%, while ISI was greater than 0 sec (i.e., 10 sec). We used a 
double cone coil (part number: 9902AP; 120 mm outer and 90 mm inner diamater of each 
winding with an 100° angle between windings; maximal output of 1.4T; weight ~ 2 kg; 
average inductance 17.85 µH) that induced a posteroanterior intracranial current. The 
stimulated pulse was monophasic current waveform with rise and duration time of 100μs 
and 1ms, respectively. The TMS user controlled the coil manually, and its position in 
relation to the desired stimulated spot was corrected when it was necessary prior to each 
stimulus using the neuronavigation system. Throughout MCE testing, the ISI was 
controlled manually by the TMS user and ranged randomly from 5-10 s to avoid stimulus 
anticipation and to minimize the carry-over effects of the previous pulse to the 
subsequent one (Awiszus, 2003). In both conditions, we instructed participants to keep 
their legs still and fully relaxed between stimuli.  
 To ensure that the hot spot of the SOL and TA was systematically stimulated in 
both hemispheres and across participants, we placed and used the neuronavigated 36-spot 
grid over each hemisphere (Figure 3.6 Step 5-I). Prior to the hot spot grid protocol, a 
suprathreshold intensity was determined by applying a single stimulus over the centered 
spot next to the medial fissure (Figure 3.6 Step 5-A). We chose to use that single spot in 
that step to achieve consistency between days and across participants, and because that 





from neurophysiological studies (Alkadhi et al., 2002; Conti et al., 2014). We started 
always at 30% MSO and gradually increased the TMS intensity by 5% increments, until 
the intensity that elicited MEP with peak-to-peak amplitudes was greater than 50 µV in 
all contralateral target muscles in 3 consecutive stimuli. Both raw waveforms with total 
duration 500 ms (100 and 400 ms pre- and post-TMS, respectively) and peak-to-peak 
amplitudes (25-125 ms post TMS) of all muscles were displayed and determined 
immediately after each stimulus using Signal v5.11 (Cambridge Electronic Design; 
Cambridge, UK). We used the intensity determined in the previous step for the hot spot 
hunting for two reasons. First, that intensity was most likely above SOL and TA rMT 
since MEPs were elicited at least in both muscles in 3 consecutive stimuli. Second, it has 
been suggested a slighty supratheshold intensity should be used for mapping procedures 
when target muscle is in the resting state (Krings et al., 1997; Saisanen et al., 2010), 
although in the present study a single stimulus was applied over each point of the 36-spot 
grid (Figure 3.6 Step 5-B) compared to 3-5 stimuli per spot used typically in mapping 
studies (Malcolm et al., 2006; Wassermann, McShane, Hallett, & Cohen, 1992). During 
hot spot hunting, which was done in both days, the stimulation order was always the 
same (i.e., start at the top spot in the most rightward column and move downwards) 
(Figure 3.5). After we completed the hot spot protocol, the amplitude values of each spot 
for all muscles were tranferred and sorted from high to low in a Excel spreadsheet. The 
hot spot of contralateral SOL and TA was defined as the spot in the grid that a single 
stimulus applied over that spot elicited the largest response (Rossini et al., 2015) as 
quantified by the peak-to-peak amplitude (µV) on the contralateral SOL and TA, 





both SOL and TA (e.g., 0-2 cm posterior and 1-2 cm lateral to the vertex when either 
figure-of-eight or double cone coil was used), we found that SOL and TA hot spots 
differed within each hemipshere in the majority of cases. Thus, each hot spot, which was 
the scalp position over the virtual spot at the neuronavigated grid (Figure 3.6 Step 5-C), 
was used to determine the rMT of each muscle and to apply 10 stimuli at 120% rMT of 
each muscle in two muscle state conditions. The first condition was the resting state, in 
which the target muscle was fully relaxed; whereas during the second condition, the 
active state, the target muscle was slightly contracted at 15% MVIC. For the remaining 
procedures the MCE testing was fixed; we always started the MCE testing on the right 
TA and SOL (Stroke: Day 1; Healthy: Days 1 & 2). At the second visit, when only the 
MCE of the paretic muscles was assessed in people post-stroke, TA was tested before 
SOL. 
 rMT is a fundamental parameter for TMS protocols, both assessment and 
treatment, and it can be used either as a measured outcome or to test MCE using a 
suprathreshold intensity to apply a specific number of stimuli (e.g., 10) in order to elicit 
MEPs. To determine rMT, there are few established methods (Farzan, 2014). The most 
widely used and recommended by the International Federation for Clinical 
Neurophysiology is the relative frequency method (Groppa et al., 2012), which is based 
on the following Rossini-Rothwell criterion (Rossini et al., 1994; Rothwell et al., 1999): 
the MEP response to half of N stimuli, usually 10, must be greater than 50 µV. In the 
present study, nevertheless, we used an adaptive threshold-hunting method over the 
relative frequency method because the former is more efficient (i.e., fewer stimuli are 





Patterson, Pevcic, Windnagel, & Thickbroom, 2013). There are two types of adaptive 
threshold-hunting: the simple adaptive parameter estimation by sequential testing (SA-
PEST) and the maximum likelihood PEST (ML-PEST) (Awiszus & Borckardt, 2011). 
Between the two, we selected the SA-PEST because it determines more accurately rMT 
than the ML-PEST, even though the latter can determine rMT quicker (Borckardt, Nahas, 
Koola, & George, 2006). The first intensity used in rMT hunting was always set at 45% 
MSO, while the initial step size was set at 6% MSO. For example, if the first stimulus at 
45% MSO induced a MEP with amplitude greater than 50 µV on the contralateral target 
muscle, the next intensity was set at 39% MSO. Conversely, if amplitude was less than 
50 µV on the contralateral target muscle, the next intensity was set at 51% MSO. We ran 
twice the rMT protocol for each target muscle and then calculated the average of the two 
(Figure 3.6 Step 5-II). For both resting and active conditions, we used a suprathreshold 
intensity, 120 % of the averaged rMT. We chose that intensity because it is the most 
commonly used and is high enough to elicit MEP at the target muscle. We did not 
calculate the aMT of the target muscles because there is not well established 
methodology for that measure. Besides, aMT was found to be correlated with and lower 
than rMT (~ 82%) (Ngomo, Leonard, Moffet, & Mercier, 2012). Therefore, even when 
using a suprathreshold intensity of rMT, the intensity is high enough that MEP can be 
elicited. The resting condition was always administered prior to active condition.     
 During the resting condition, we asked participants to stay still and relax the target 
muscles bilaterally, especially the contralateral muscles, while a single pulse TMS at 
120% rMT and over the hot spot of the target muscle was applied 10 times (Figure 3.6 





real time visual feedback displaying on a computer screen. In case any  contralateral 
target muscles were  active before or after TMS. we applied a single pulse again. The 
goal was to get 10 waveforms of each contralateral target muscle at rest.   
 During the active condition, we asked participants to contract the target muscle at 
15% MVIC while a single pulse TMS at 120% rMT was applied over the hot spot of the 
target muscle 10 times  (Figure 3.6 Step 6-II). When SOL was the target muscle, we 
instructed participants to push slightly down against the boot on their contralateral leg, 
match the moving line with the horizontal cursor, and sustain that contraction at that level 
for few seconds. When TA was the target muscle, we instructed participants to pull 
slightly up against the bootstraps on their contralateral leg, match the moving line with 
the horizontal cursor, and sustain that contraction at that level for few seconds. The 
moving line was the rectified and low-pass filtered (RMS amplitude of 0.165 sec) EMG 
of the target muscle, whereas the cursor was set at 15 % MVIC of the target muscle prior 
to the onset of the active condition. Participants were instructed to maintain contraction at 
least 1 sec after TMS and to relax between stimuli. As in resting condition, the muscle 
activity of all muscles was monitored by a real time visual feedback displaying on a 
computer screen.   
 3.4.3 SOL and TA Neuromechanics during Walking 
 In addition to EMG electrodes that were already attached on the participants, we 
positioned bilaterally 36 active LED markers on the pelvis, knee joint, shank, ankle joint, 
and foot using a lower extremity specific configuration. Then participants wore a safety 
harness (Robertson Mountaineering; Henderson, NY, USA), which was worn across the 





of loss of balance. The harness off-loaded no body weight. 
 After setup, participants stood on the center of the treadmill for 5 sec to capture a 
static trial, from which a static model of each participant was reconstructed and used for 
the inverse dynamic analysis. During walking assessment, people post-stroke walked on a 
dual-belt treadmill instrumented with 2 independent 6-degree of freedom force platforms 
(Bertec Corporation; Columbus, OH, USA; treadmill dimensions: 206 x 139 x 39 cm; 
size of each belt: 175 x 30 cm; walking surface: 175 x 62 cm) under one walking speed 
condition, self-selected walking speed (SSWS), and grade, 0 degrees (Figure 3.4 E). 
During SSWS, we instructed participants to “Walk at your normal usual walking pace.” 
During walking assessment, a licensed physical therapist was always present to guard 
closely the participants as they walked on a treadmill; however, no form of manual 
support was provided during the actual data collection. Since participants had to walk 
without an assistive or orthotic device before we begun testing, they were allowed to 
practice treadmill walking until they felt comfortable walking without assistive and 
orthotic devices. During this practice time, the physical therapist offered any physical 
support the subject may have needed. After each participant reported comfort walking on 
the treadmill without any assistance, SSWS was determined by setting the treadmill 
speed initially at 0.2 m/s. Treadmill speed was gradually increased by 0.05 m/s 
increments until the participant reported that the current speed was his/her SSWS. Once 
SSWS was determined, participants walked for three 1-minute trials. Between trials, 
participants rested for at least 1 minute or until they were ready to resume. In addition, 
participants were allowed to sit any time they felt there was a need.  





 During MVIC, people post-stroke sat comfortably with similar posture as during 
MCE testing on a Biodex Multi-Joint System Pro dynamometer (Biodex Medical 
Systems, Shirley, NY, USA) with their test leg fixed to a limb-support pad and a 
footplate (Figure 3.4 F). The shank was parallel to the floor, and the foot was firmly 
secured by placing the calcaneus in the metal heel cup mounted on the footplate, with 
plastic straps fastened across the toes and the dorsum of the foot. The back of the chair 
was set at 85° from horizontal, while the dynamometer axis of rotation was aligned with 
the lateral malleolus of the ankle (i.e., ankle joint axis of rotation). To ensure proximal 
stabilization of the participants during contractions, a waist strap, thigh strap, and two 
crossover shoulder straps were used.  
 After performing a single practice trial for each motion to ensure that participants 
understood the procedures, all participants performed three successive MVIC of PF and 
DF with the non-paretic leg. We repeated the same procedures with the paretic leg. 
During each contraction, we instructed participants to sit with their arms folded across 
their chest and to “gradually push down on” (SOL) or “gradually pull up on” (TA) the 
footplate “as hard” as they could and “hold it for few seconds.” Additionally, during each 
contraction, participants received a verbal encouragement from the experimenter to 
ensure maximal effort and visual feedback displayed on a screen for their torque output. 
Each contraction lasted approximately 5 seconds (i.e., rapid contraction and maintenance 
of 100% MVIC); there was a 60 seconds rest between contractions.  
3.5  Data Collection 
 3.5.1 Muscle Activity 





sEMG electrodes and hardware, yet the software used to acquire EMG data at each lab 
differed. We used pre-amplified (x20) single double differential MA-411 (Motion Lab 
Systems; Baton Rouge, LN, USA) sEMG electrodes (body size of 38 mm x 19 mm x 8 
mm, two 12 mm discs of medical grade stainless steel, a 13 x 3 mm bar of medical grade 
stainless steel separating the two discs, and inter-electrode distance of 17 mm). The anti-
alias filter and gain were preset at 1000 Hertz (Hz) and 2000, respectively, on MA-300 
Back-Pack Unit (Motion Lab Systems; Baton Rouge, LN, USA). During MCE testing, 
the muscle activity signal was sampled at 5000 Hz using CED Micro 1401-3 data 
acquisition unit (Cambridge Electronic Design; Cambridge, UK). Online data acquisition 
was achieved using both Spike2 v7.12 (EMG electrode placement and signal quality 
testing, MVIC protocol, active condition) and Signal v5.11 (rMT protocol and resting 
condition) software. During walking and MVIC, muscle activity signal was sampled at 
2000 Hz. However, it was acquired using LabVIEW (National Instruments; Austin, TX, 
USA) and WinDaq v3.30 (DATAQ Instruments, Inc.; Akron, OH, USA) during walking 
and MVIC, respectively. We saved EMG data automatically after each trial as coded data 
files on a password-protected computer at each lab for offline analysis. 
 The preparation and placement of sEMG always occurred prior to MCE testing at 
FNL using published guidelines (Cram & Criswell, 2011; Hermens & Klug, 1999) with 
the participants in the standing position. First, to improve the electrode-skin contact, the 
areas over which the electrodes would be placed were shaved and lightly exfoliated with 
alcohol swaps to remove any dead skin cells and oils from the skin surface. Then, eight 
sEMG electrodes were attached over TA, SOL, LG, and MG bilaterally. For the TA 





Then we placed the TA sEMG electrode at 1/3 of the line between the tip of the fibula 
and the tip of the medial malleolus (Cram & Criswell, 2011). For the SOL, LG, and MG 
placement, participants were also in upright position while raising their heels. We placed 
the SOL sEMG electrode at 2/3 of the line between the lateral femoral condyle to the 
lateral malleolus (Cram & Criswell, 2011). We placed the LG and MG sEMG electrodes 
at the most prominent aspect of the muscle belly 2 cm laterally and medially from the 
midline, respectively (Cram & Criswell, 2011). A reusable stainless steel ground 
reference passive electrode with a diameter of 30 mm (Natus Medical Incorporated; San 
Carlos, CA, USA) was placed on the patella. We applied electrolyte gel (SIGNALGEL®, 
Natus Medical Incorporated; San Carlos, CA, USA) on the metal surface of the ground 
electrode to optimize the conductive path between that surface and skin (Kamen & 
Gabriel, 2010). We attached all sEMG electrodes and the reference electrode on the skin 
using surgical tape.  
 After electrodes fixation and prior to experimental procedures, we first tested the 
electrodes placement (e.g., for clear visually detectable EMG burst) and then the quality 
of the signal (e.g., for baseline noise). To test the placement of the electrodes, we asked 
participants to either plantarflex or dorsiflex their ankle in an upright posture while the 
raw EMG signal of all muscles tested was displayed on a computer screen. All 
participants from both groups were capable of performing those tasks, yet a few people 
post-stroke required some assistance with standing balance while performing those ankle 
motions. If an electrode was misplaced, we removed and replaced it until there was a 
clear visually detectable EMG burst. To test the signal quality, we discharged the 





the chair in resting state. The expectation was that the baseline signal at each EMG 
channel should be close to zero since TMS pulse was applied on air and not at the 
participant’s head. If there was no baseline noise (e.g., 60 Hz power line hum), the peak-
to-peak amplitude was less than 50 µV. If baseline noise occurred at a channel, we 
removed the corresponding electrode and repeated the skin preparation procedures. If the 
noise was still present (i.e., peak-to-peak amplitude > 50 µV), we adjusted the reference 
electrode’s position and replaced the electrolyte gel. After we determined that the 
electrodes’ position and signal quality were satisfactory, we secured the electrodes using 
underwrap. Periodically throughout the experimental procedures, we checked electrodes’ 
position and signal quality.  
 3.5.2 Ankle Joint Kinematics and Kinetics during Walking 
 Twelve motion capture system cameras (PhaseSpace Inc.; San Leandro, CA, 
USA) tracked the 36 active LEDs during a static trial and walking trials, in which pelvis, 
shank and foot segments were defined bilaterally using a lower extremity specific 
configuration. Before any testing, the capture volume space surrounding the treadmill 
was calibrated using a calibration wand; calibration lasted less than 5 minutes. GRF was 
measured bilaterally by force plates, which were built-in underneath each treadmill belt. 
To optimize capture of steady state data on the treadmill, participants walked for 10-30 
seconds prior to the 30 seconds of data collection (~ 1 min per trial). The coordinates of 
active LED markers, GRF, and EMG of four muscles were collected bilaterally during 
each trial. Coordinates data were sampled at 120 Hz, while the GRF data were sampled at 
2000 Hz. Both sets of data were acquired using LabVIEW (National Instruments; Austin, 





files on a password-protected computer for offline analysis.  
 3.5.2 Ankle Joint Kinetics during MVIC 
 Peak torques and EMG of the SOL and TA were simultaneously collected during 
each trial. Like EMG, torque data were sampled at 2000 Hz, acquired using DI-720-USB 
(DATAQ Instruments, Inc.; Akron, OH, USA), and collected using WinDaq/Pro v3.30 
(DATAQ Instruments, Inc.; Akron, OH, USA). Both types of signal were saved 
automatically after each trial as coded data files on a password-protected computer for 
offline analysis.  
 
3.6 Data Analyses 
 All offline data analyses were carried out using a customized script written in 
Matlab v8.1 (Mathworks, Inc.; Natick, MA, USA).   
 3.6.1 SOL and TA MCE 
 For all measures but rMT, we calculated the value of each measure from each 
MEP sweep (total duration of 500 ms: 100 ms pre-TMS and 400 ms) for all muscles and 
then averaged these 10 values to get a single value (i.e., mean). A recent study 
demonstrated this approach to be more reliable than using the value calculated from the 
average MEP sweep in people post-stroke (Lewis et al., 2014). The EMG signal of each 
muscle collected during MCE testing was corrected for the gain amplification, and the 
units were converted from Volts to mV.    
 Resting Condition: rMT, amplitude, latency, and normalized latency were 
calculated to quantify SOL and TA MCE while the target muscle was relaxed. rMT was 





directly from the output display on the master unit of the stimulator pair. Amplitude (mV) 
was calculated from the raw EMG and defined as the largest difference between positive 
and negative peaks (i.e., peak-to-peak) of the MEP (Figure 3.7 A). Latency was 
calculated from the rectified EMG (Figure 3.7 B). Latency (ms) was defined as the time 
between TMS onset and MEP onset, which was defined as the time when a rectified 
EMG trace first crossed a predetermined threshold, pre-stimulus  mean EMG  (over a 100 
ms period)  plus 3 standard deviation (SD) (Cacchio et al., 2011). In addition to raw 
latency, we normalized latency relative to each participant’s height ([latency (ms) / height 
(cm)] ∗ 100) because latency was found to be correlated with participant’s height 
(Livingston, Friedlander, Gibson, & Melvin, 2013).  
 Active Condition: Amplitude, latency, normalized latency, and cSP were 
calculated to quantify SOL and TA MCE while the target muscle was slightly contracted 
at 15% MVIC. As in resting condition, amplitude (mV) was calculated from the raw 
EMG and defined as the largest difference between positive and negative peaks (i.e., 
peak-to-peak) of the MEP (Figure 3.7 C), and latency (ms) was calculated from the 
rectified EMG and defined as the time between TMS onset and MEP onset (Figure 3.7 
D). Yet MEP onset in active state was calculated differently than in resting. For the 
calculation of the MEP onset and offset, and for EMG resumption, which was used for 
cSP calculation (see below), we adopted an automated approach published previously 
(Damron, Dearth, Hoffman, & Clark, 2008; Daskalakis et al., 2003). Additionally, we 
slightly modified this automated method to ensure that the MEP onset and offset were 
accurately calculated across muscles and participants. First, we found the time points that 





stimulus mean EMG  (over a 100 ms period). Then we found the peaks that were at least 
greater than the mean of the pre-stimulus EMG plus three SD and between those two 
time points. Then we searched from the first peak to 50 data points before that peak for 
the time that the rectified EMG trace first crossed the threshold of the mean pre-stimulus 
EMG; we defined that time as the MEP onset. Similarly, we searched from the last peak 
to 200 data points after that peak for the time that the rectified EMG trace last crossed the 
threshold of the mean pre-stimulus EMG; we defined that time as the MEP offset. As in 
resting, the normalized latency relative to each participant’s height ([latency (ms) / height 
(cm)] ∗ 100) was calculated. Lastly, cSP (ms) was also calculated from the rectified EMG 
(Figure 3.7 D). In the present study, we calculated the absolute cSP (i.e., exclusion of 
MEP): the time between MEP offset and the resumption of baseline EMG (Saisanen, 
Pirinen, et al., 2008). EMG resumption was the time that the rectified EMG trace last 
crossed the 25% of the mean pre-stimulus EMG (Damron et al., 2008).  





 3.6.2 SOL and TA Neuromechanics during Walking 
 All measures collected during gait were divided into strides (i.e., starting at foot 
contact of one leg and ending with the next foot contact of the same leg). Additionally, all 
those gait measures except GRFAP were linearly interpolated to 100 points (i.e., GC was 
normalized to stride period and presented in %). In order to do this, specific gait events, 
bilateral heel strikes and toe offs, were determined using an automated method, which 
used GRFV (Zeni, Richards, & Higginson, 2008). GRFV was filtered with a low-pass 20 
Hz cut-off frequency using a fourth order, zero phase lag Butterworth filter (Gottschall & 
Kram, 2003) and was resampled at 120 Hz. After digital filtering, any potential offsets 
were corrected, and body weight (N) was calculated using bilateral GRFV, which were 
then normalized by the body weight and multiplied by 100. A threshold of 20 N divided 
by the body weight (N) multiplied by 100 was used to determine the threshold crossings 
in GRFV trace. Each crossing at this preset threshold denoted bilateral heel strike and toe 





Figure 3.8: Outline of the analysis used to detect gait events 
 The first step for EMG analysis was to divide the EMG of each muscle by the 
gain (i.e., 2000) and then multiply by 1000 to convert the units from Volts to mV. Then 
EMG data were band-pass filtered (20-500 Hz) and band-stop filtered (156-158 Hz – to 
remove a 157 Hz power line hum which was detected using a spectrum analysis) using a 
third order zero phase lag Butterworth filter, rectified, smoothed (50 Hz filter), divided 
into strides, and averaged across strides. Then the average EMG of each muscle was 
calculated in specific gait phases based on when each muscle was typically active: single 
leg stance and second double limb support for SOL (Figure 3.9 A) and first half of swing 
for TA (Figure 3.9 B). Lastly, these EMG values (mV) were averaged across trials.  
 GRFAP was filtered with low-pass 20 Hz cut-off frequency using a fourth order, 
zero phase lag Butterworth filter (Gottschall & Kram, 2003), normalized by the body 
weight (N), multiplied by 100, and divided into strides. In order to calculate accurately 
the positive area under the curve during the SLS and DLS2, we searched first for the 
maximum positive peak between 30 data points after the initial heel strike and next heel 
strike. We selected 30 data points as a mark for two reasons. First, the period of the 
GRFAP that we were interested in occurred approximately 0.25 sec after the initial heel 
strike, and secondly to avoid miscalculating the fast spike of propulsion happening 
immediately after heel strike. After finding the positive peak, we found the times that last 
crossed the zero line left and right from the positive peak. Next, the area under the 
positive curve between those two time points was calculated (i.e., PI; % BW.sec) for each 
stride and averaged across strides and trials (Figure 3.9 C). 
 The first step for AAV analysis was to resample the coordinates of active LED 





differentiation of the time-based ankle joint sagittal angle (i.e., Euler angle that was 
calculated using rotational matrices). All aforementioned steps were carried out using a 
custom written script in LabVIEW, the only data analysis steps that used a software other 
than Matlab. After transferring AAV data to a Matlab workspace, we divided AAV into 
strides. The peak AAV (rad/sec) during the first half of swing was calculated for each 
stride and averaged across strides and trials (Figure 3.9 D).  
Figure 3.9: Outline of the analysis of the SOL and TA walking neuromechanics 
3.6.3 SOL and TA Neuromechanics during MVIC 
 For both SOL and TA, the isometric torque was first low-pass filtered (10 Hz) 
using a third order zero lag Butterworth filter and then calculated by averaging the torque 
within a 100 ms window centered around the max torque of each trial (Figure 3.10 A). A 
500 ms window (i.e., ± 250 ms from max) has been reported to be used for simultaneous 
torque and EMG analysis in healthy adults (Soylu & Arpinar-Avsar, 2010). However, in 





the peak occurred immediately after the contraction onset, a case that was observed in 
pilot testing. Therefore, the 200 ms window was selected after getting consistent results 
in the analysis of pilot data. Then torque (N·m) was subsequently averaged across the 
three trials. 
 Similar to walking EMG analysis, the EMG of each muscle was first divided by 
the gain (i.e., 2000) and then multiplied by 1000 to convert the units from Volts to mV. 
The EMG data was band-pass (20-500 Hz) and band-stop filtered (59-61 Hz – to remove 
a 60 Hz power line hum which was detected using a spectrum analysis) using a third 
order zero phase lag Butterworth filter, rectified, smoothed (50 Hz filter), and averaged 
over the same time window as torque (Figure 3.10 B). Then it (mV) was subsequently 
averaged across the three trials.  






3.7 Statistical Analyses 
 For this project, we focused our statistical analyses on the paretic SOL and TA in 
people post-stroke and on the right (i.e., dominant) SOL and TA in healthy controls, 
although we collected SOL and TA data from both legs and from LG and MG bilaterally. 
We will run secondary analyses for extra data collected. In addition to the mean and SD, 
we reported the coefficient of variation (CV), which is independent of units and is a 
measure of relative variation (Portney & Watkins, 2009). Therefore, three descriptive 
statistics (mean ± SD, CV) were reported for all data used in those analyses. The inter-
group differences in age, height, weight, and test-retest period were tested. Normality of 
all data was tested using the Shapiro-Wilk test because it has more power to find 
differences than the Kolmogorov-Smirnov test (Field, 2009). We conducted statistical 
analyses using IBM SPSS Statistics for Windows v23 (IBM Corp, Armonk, NY, USA). 
Figure 3.11 presents the overall statistical analyses carried out in each aim.  





 3.7.1 Aims 1 and 2 
 These aims were exploratory and had two goals. The first goal was to characterize 
the MCE measure (s) of SOL and TA that had low methodological error (i.e., reliable) 
both in people post-stroke and in healthy controls. The second goal was to identify 
stroke-related impairments to the CNS (i.e., detect true differences between people post-
stroke and healthy controls) testing the variances and means between the two groups. To 
achieve these goals, we ran three statistical procedures/steps that were the same for both 
aims. The level of significance was set at p < 0.05, and the test of significance was one-
tailed. 
 First, we examined the test-retest reliability of all SOL and TA MCE measures 
using the coefficient of variation of method error (CVME) instead of using ICC, which is 
the most widely used reliability metric. ICC is the ratio of the between-subject variance 
to the total variance (sum of the between-subject and between-day variance), is a relative 
measure of reliability, has no units, and ranges from 0 to 1, with a value closer to 1 
reflecting greater reliability (Weir, 2005). However, it has one main pitfall. When 
samples are homogeneous, ICC of the target measure is low, but low ICC does not 
necessarily mean the measure is unreliable. Therefore, pure reliance on ICC may lead to 
incorrect conclusions. For this reason, we did not use ICC as the reliability metric. 
Nevertheless, we calculated and reported ICC with lower and upper 95% confidence 
interval (CI) so we could conduct post-hoc comparisons with the present limited 
evidence. Briefly, we calculated ICC using the 2-way random model with absolute 
agreement type and average measures form. ICC values above 0.75 indicated good 





insensitive to the lack of variation in the samples and (2) CVME is independent of ICC 
(Portney & Watkins, 2009). To calculate CVME, we first calculated the method error, 
which is the ratio of the SD of the test-retest score differences to √2 (Portney & Watkins, 
2009). Then CVME was calculated using the following equation: (2ME / (Mean of Day 1 
+ Mean of Day 2))*100 (Portney & Watkins, 2009). The advantage of using CVME 
instead of ME is that CVME is expressed as a percentage and has no units as ICC. A 
measure with CVME equal or less than 15 was considered a reliable measure (Stokes, 
1985). For steps 2 and 3, we used measures whose CVME was lower than 15. If no 
measure met that requirement, we chose the measure with the lowest CVME. Based on the 
previous literature, we expected that at least one measure for each muscle would have 
low CVME (≤ 15).   
 The second step was to examine whether the between-subject variability differed 
for each group. Because the MCE measures used in these procedures would have good 
reliability determined in the previous step, we expected that the within-subject variability 
would be low in both groups. Low between-subject variability in healthy controls would 
result from random factors (i.e., unsystematic variation). Conversely, between-subject 
variability in stroke would be high because the differences in stroke characteristics had 
different (and larger) effects on the MCE in each stroke patient. Thus, the difference in 
variability between the two groups would most likely be due to the CNS lesion. 
Therefore, the second procedure tested whether the variance (i.e., SD2) of a MCE 
measure collected in day 2 differed between people post-stroke and healthy controls 
using Levene’s test. If the results of Levene’s test were significant (p ≤ 0.05), this finding 





the third procedure was carried out for that MCE measure. 
 The third step examined whether the means (day 2) of the two groups differed. A 
recent study reported that the MEP amplitude and latency of the paretic TA decreased 
and increased, respectively, compared to the dominant side of the healthy controls 
(Beaulieu et al., 2014). These changes in MCE after a stroke also reflected the lesioned 
CNS. We tested the normality of each distribution to ensure that we had selected the right 
test, either parametric or non-parametric, to examine the differences in mean between the 
groups. We used an independent t-test when the data were normally distributed; 
otherwise, we used the Mann–Whitney U test. If the group means were significantly 
different (p ≤ 0.05), the MCE measure of either the paretic SOL or paretic TA was used 
in Aim 3 and 4, respectively. 
 In summary, the MCE measure(s) used in Aims 3 and 4 had to demonstrate the 
following: 1) good reliability, CVME ≤ 15, in both groups, 2) significantly higher variance 
in people post-stroke versus in healthy controls (Levene’s test), and 3) a significant 
difference in means between people post-stroke and healthy controls (independent t-test 
or Mann–Whitney U test) (Figure 3.11 A & B).     
 3.7.2 Aims 3 and 4 
 The MCE measure(s) determined by Aims 1 and 2 were used in the statistical 
analyses for Aims 3 and 4, respectively. Because we assessed eight MCE measures each 
for Aims 1 and 2, there was a possibility for more than one MCE measure to qualify for 
use in the correlational analyses of Aims 3 and 4. However, due to the small sample size, 
a maximum of two MCE measures that passed all three statistical steps in Aims 1 and 2 





performed for each muscle was eight; otherwise, a minimum of four associations per 
muscle would need to occur. Since we performed multiple associations for each aim 
(minimum four and maximum eight), we corrected the level of significance using a 
Bonferroni adjustment. In case of four associations, the level of significance was adjusted 
to 0.012, whereas in case of eight associations, the level of significance was adjusted to 
0.006. The test of significance was two-tailed.   
 To test the relationships between MCE (day 2) and neuromechanics for each 
muscle group, we performed correlations between the MCE and walking neuromechanics 
and between MCE and MVIC neuromechanics (Figure 3.11 C & D). The strength and 
direction of each correlation was determined using correlation coefficients. The selection 
of the correlation coefficient, either parametric or non-parametric, was determined by 
testing the normality of each distribution. If both distributions were normally distributed, 
we used Pearson’s correlation coefficient (r); otherwise, we used Spearman’s correlation 
coefficient (rs). Correlation coefficients less than 0.5, greater than 0.5 and less than 0.75, 
and greater than 0.75 indicated a poor, good, or excellent relationship, respectively 
(Portney & Watkins, 2009). 
 Aim 3: For this aim, we examined the relationships between paretic SOL MCE 
and paretic SOL neuromechanics during walking and MVIC. At least four associations 
were tested (Figure 3.11 C).  During walking, we tested the relationships between SOL 
MCE measure(s) and SOL EMG, and SOL MCE measure(s) and PI. During MVIC, we 
tested the relationships between SOL MCE measure(s) and SOL EMG, and SOL MCE 
measure(s) and SOL torque. 





paretic TA neuromechanics during walking and MVIC. At least four associations were 
tested (Figure 3.11 D). During walking, we tested the relationships between TA MCE 
measure(s) and TA EMG, and TA MCE measure(s) and AAV. During MVIC, we tested 
the relationships between TA MCE measure(s) and TA EMG, and TA MCE measure(s) 

















4.1 Group Characteristics 
 Healthy: Of the 25 participants, one female, and one male withdrew from the 
study due to TMS discomfort, one male’s data could not be used due to insufficient MRI 
quality, and one male could not attend the second session. Therefore, all data presented 
here are from 21 healthy controls (8F/13M, 42 ± 11 years, 174 ± 12 cm, 75 ± 17 kg). 
 Stroke: Of the 15 participants, one female withdrew from the study due to TMS 
discomfort. Therefore, all data presented here are from 14 stroke participants (6F/8M, 62 
± 13 years, 173 ± 12 cm, 83 ± 22 kg). Lesion related characteristics (type, subtype, and 
location) were characterized by a stroke neurologist using each participant’s MRI. Table 
4.1 presents the individual and group demographical, clinical, and experimental 
characteristics of 14 stroke participants. 
 People post-stroke (N = 14) were significantly older than the healthy adults (N = 
21) were (p = 0.000; Figure 4.1 A), whereas there were no significant differences 
between groups for height (p = 0.855; Figure 4.1 B), weight (p = 0.561; Figure 4.1 C), 
and test-retest period (p = 0.907; Figure 4.1 D). All participants in both groups were 
right-leg dominant. We determined leg dominance by simply asking participants the 
question: “Which leg would you use the most if you had to kick a soccer ball three 
times?” 
  
Table 4.1: Demographical, clinical, and experimental characteristics of stroke participants 





 4.2 Aim 1: Quantification of the Soleus MCE Measures in Stroke and Healthy 
 Table 4.2 includes the test-retest normative data of eight SOL MCE measures 
collected in both groups on day 1 and 2.  
 4.2.1 Resting Motor Threshold: Responses and Number of Stimulations  
 Healthy: On day 1, we could not measure the SOL rMT in two participants. In 
both participants, MEPs on the right SOL were inconsistently elicited using intensities 
greater than 85% MSO, so we stopped rMT hunting. On day 2, we could measure the 
SOL rMT in one of the two participants whose SOL rMT could not be determined on day 
1; however, we were unable to measure the SOL rMT in the second participant. In 
summary, we measured the rMT of the right SOL from 19 participants on day 1 and 20 
participants on day 2, and fewer than 15 stimulations were required on average to 
calculate rMT of the right SOL on both days (Day 1: 13 ± 5, 41; Day 2: 15 ± 6, 41). 
 Stroke: On day 1, we were unable to measure the SOL rMT in five participants. In 
four participants, we were unable to elicit a MEP on the paretic SOL even with intensities 
greater than 90% MSO. The fifth participant could not tolerate intensities greater than 
70% MSO. On day 2, we again could not measure SOL rMT in those same four 
participants, but we could measure the SOL rMT of the fifth participant who could not 
tolerate intensities greater that 70% MSO on day 1. In summary, we measured the rMT of 
the paretic SOL from 9 participants on day 1 and 10 participants on day 2, and on both 
days fewer than 25 stimulations on average were required to calculate rMT of the paretic 
SOL (Day 1: 15 ± 5, 30; Day 2: 22 ± 10, 46). 
 4.2.2 Testing Reliability 





MCE measures in both groups. For these analyses, we used data collected from 19 
healthy adults and 9 stroke participants on both days. 
 Healthy: All measures but amplitude had CVME less than 15 during resting 
condition (Figure 4.2 A) while only raw and normalized latency had CVME less than 15 
during the active condition (Figure 4.2 B). During the resting condition, all measures but 
normalized latency had ICC greater than 0.75 (Figure 4.2 C), while only amplitude and 
raw latency had ICC greater than 0.75 in the active condition (Figure 4.2 D).  
 Stroke: As in the healthy group, for all measures but amplitude, CVME was less 
than 15 during the resting condition (Figure 4.2 A), and only for raw and normalized 
latency CVME was less than 15 during the active condition (Figure 4.2 B). Of the eight 
measures, only rMT, amplitude, raw latency during resting (Figure 4.2 C) and cSP during 
active (Figure 4.2 D) had ICC greater than 0.75.    
 Only the following measures with CVME less than 15 in both groups were used in 
the next step: rMT, raw and normalized latency during resting, and raw and normalized 
latency during active.     
 4.2.3 Testing Group Variances 
 For the variance analyses, we used data collected with the five aforementioned 
measures from 20 healthy adults and 10 stroke participants on day 2. 
 The variances of all measures except raw latency in resting were equal between 
stroke participants and healthy adults (rMT: F(1,28) = 0.657, p = 0.425; resting normalized 
latency: F(1,28) = 0.194, p = 0.663; active raw latency: F(1,28) =1.846, p = 0.185; active 
normalized latency: F(1,28) = 1.164, p = 0.290) (Figure 4.3 A, C - E). Conversely, the 





stroke participants (35.9) than in healthy adults (16.6) (Figure 4.3 B). Therefore, we used 
only the resting raw latency to test whether the group means differed.  
 4.2.4 Testing Group Means 
 The resting raw latency in both groups was normally distributed (Stroke: W(10) = 
0.854, p = 0.064; Healthy: W(20) = 0.983, p = 0.967); therefore, an independent t-test was 
used. The resting latency was significantly longer (t(1,28) = 2.135, p = 0.026) longer in 
stroke participants (42.0 ± 6.0 ms) than in healthy controls (37.6 ± 4.1 ms) (Figure 4.4). 
 In Aim 3, therefore, only the resting raw latency was used in the correlational 
analyses for walking and MVIC neuromechanics of the paretic SOL.  
Table 4.2: Test-retest normative data, mean ± SD (CV), of eight SOL MCE measures in Healthy 
(right SOL) and Stroke (paretic SOL)  
Measures
Statistics Day 1 Day 2 Day 1 Day 2 Day 1 Day 2 Day 1 Day 2
N 19 20 19 20 19 20 19 20
  Mean ± SD      
(CV) 
52 ± 11 
(11)






37.5 ± 4.4  
(12)
37.6 ± 4.1 
(11)
22 ± 2      
(9)
22 ± 2        
(9)
N 9 10 9 10 9 10 9 10
  Mean ± SD      
(CV) 
51 ± 9   
(18)






42.6 ± 3.8 
(9)
42.0 ± 6.0 
(14)
24 ± 1     
(4)
24 ± 3   
(12)
Measures
Statistics Day 1 Day 2 Day 1 Day 2 Day 1 Day 2 Day 1 Day 2
N 19 20 19 20 19 20 19 20






35.0 ± 4.7  
(13)
33.8 ± 3.3  
(10)
20 ± 2        
(10)






N 9 10 9 10 9 10 9 10






37.1 ± 4.2 
(11)
36.6 ± 4.5  
(12)
22 ± 2     
(9)












Silent Period              
(ms)                       
Motor Threshold         
(% MSO)  
MEP Amplitude       
(mV)  
MEP Latency           
(ms)                  
MEP Normalized 







MEP Amplitude       
(mV)  
MEP Latency           
(ms)                  
MEP Normalized 





Table 4.3: Test-retest reliability, CVME and ICC (95% CI), of eight SOL MCE measures in Healthy 









Days 1 2 1 2 1 2 1 2
Mean ± SD (CV)  52 ± 11      
(22)






37.5 ± 4.4    
(12)
37.3 ± 4.1   
(11)
 22 ± 2        
(9)




Day 1 2 1 2 1 2 1 2
Mean ± SD (CV) 51 ± 9    
(18)






42.6  ± 3.8  
(9)
42.5 ± 6.1 
(14)
24 ± 1      
(4)





Days 1 2 1 2 1 2 1 2




35.0 ± 4.7 
(13)
33.5 ± 3.1   
(9)
20 ± 2        
(10)








Day 1 2 1 2 1 2 1 2




 37.1 ± 4.2 
(11)
36.6 ± 4.8 
(13)
22 ± 2      
(9)
21 ± 3    
(14)








26 7 7 17
0.93 (0.82 - 0.97) 0.78 (0.42 - 0.92) 0.51 (-0.19 - 0.81) 0.72 (0.03 - 0.90)
Stroke 
(N=9)
31 9 9 19
0.55 (-1.46 - 0.90) 0.63 (-0.89 - 92) 0.6 (-0.95 - 0.91) 0.83 (0.31 - 0.96)
0.79 (0.44 - 0.92) 0.71 (0.22 - 0.89)
Soleus - Active (15% MVIC)
MEP Amplitude          
(mV)  
MEP Latency              
(ms)                  
MEP Normalized Latency 
((ms/cm)*100)     
Silent Period                
(ms)                       
0.97 (0.87 - 0.99) 0.87 (0.39 - 0.97) 0.8 (0.01 - 0.96) 0.45 (-2.2 - 0.88)
Healthy 
(N=19)
9 26 7 7
0.93 (0.81 - 0.97)
Stroke 
(N=9)
4 31 7 7
0.86 (0.64 - 0.95)
Soleus - Resting
Motor Threshold            
(% MSO)  
MEP Amplitude          
(mV)  
MEP Latency               
(ms)                  
MEP Normalized Latency 





Figure 4. 2: Test-retest reliability, CVME and ICC, of eight SOL MCE measures in Healthy (right 
SOL) and Stroke (paretic SOL) 






Figure 4.4: Inter-group differences in mean for the resting raw latency of SOL  
4.3 Aim 2: Quantification of the Tibialis Anterior MCE Measures in Stroke and 
Healthy 
 Table 4.4 includes the test-retest normative data of eight TA MCE measures 
collected in both groups on day 1 and 2. 
 4.3.1 Resting Motor Threshold: Responses and Number of Stimulations  
 Healthy: On both days, we measured the rMT of the right TA in all participants 
(N = 21), and on average fewer than 15 stimulations were required to calculate the right 
TA rMT (Day 1: 14 ± 6, 40; Day 2: 13 ± 4, 33). 
 Stroke: On day 1, we measured the paretic TA rMT in all participants. In two 
participants, the paretic TA rMT was higher than 83% MSO (86 & 90% MSO), making 
120% intensity greater than 100% MSO. As a result, data collected from those two 
participants were not included in the reliability analyses. On day 2, TA rMT was 





not elicited even using 100% MSO. In summary, TA rMT was measured from 14 
participants on day 1 and 13 participants on day 2, while fewer than 20 stimulations were 
required on average to calculate paretic TA rMT on both days (Day 1: 16 ± 7, 44; Day 2: 
14 ± 3, 24). 
 4.3.2 Testing Reliability 
 Table 4.5 includes the test-retest reliability metrics, CVME and ICC, for eight TA 
MCE measures collected in both groups. For those analyses, we used data that were 
collected from 21 healthy adults and 12 stroke participants on both days.  
 Healthy: All measures except amplitude had CVME less than 15 during the resting 
condition (Figure 4.5 A) while only raw and normalized latency had CVME less than 15 
during the active condition (Figure 4.5 B). All measures in both conditions except active 
normalized latency had ICC greater than 0.75 (Figure 4.5 C & D).  
 Stroke: In both resting and active conditions, all measures except resting and 
active amplitude had CVME less than 15 (Figure 4.5 A & B), while all measures had ICC 
greater than 0.75 (Figure 4.5 C & D).    
 Only the following measures with CVME less than 15 in both groups were used in 
the next step: rMT, raw and normalized latency during resting, and raw and normalized 
latency during active.        
 4.3.3 Testing Group Variances 
 For those analyses, we used data from the five aforementioned measures collected 
from 21 healthy adults and 13 stroke participants on day 2. 
 Of five TA MCE measures, the variances of three measures differed significantly 





for rMT (F(1,32) = 0.479, p = 0.494; Figure 4.6 A) and active raw latency (F(1,32) = 1.393, p 
= 0.247; Figure 4.6 D). The variance of resting raw latency was significantly higher 
(F(1,32) = 8.999, p = 0.005; Figure 4.6 B) in the stroke group (55.9) than in the healthy 
group (13.6). Additionally, the variance of resting normalized latency was significantly 
higher (F(1,32) = 18.6, p = 0.000; Figure 4.6 C) in the stroke group (13.2) than in the 
healthy group (1.7). Similarly, the variance of active normalized latency was significantly 
higher (F(1,32) =5.6, p = 0.024; Figure 4.6 E) in the stroke group (4.2) than in the healthy 
group (1.4). Therefore, resting raw latency and resting and active normalized latency 
were used to test whether the group means differed.       
 4.3.4 Testing Group Means 
 In both groups, the distributions of the resting raw latency (Stroke: W(13) = 0.921, 
p = 0.259; Healthy: W(21) = 0.983, p = 0.960) and resting normalized latency (Stroke: 
W(13) = 0.887, p = 0.089; Healthy: W(21) = 0.953, p = 0.396) were normally distributed. 
The distribution of the active normalized latency was normally distributed in stroke (W(13) 
= 0.892, p = 0.103) but not in healthy adults (W(21) = 0.883, p = 0.017). Consequently, we 
used an independent t-test for the resting raw and normalized latency and Mann–
Whitney U test for the active normalized latency. 
  The means of all three measures were different between groups. The resting raw 
latency was significantly (t(1,32) =3.013, p = 0.004) longer in stroke participants (41.2 ± 
7.5 ms) than in healthy controls (34.5 ± 3.7 ms) (Figure 4.7 A). Furthermore, the resting 
normalized latency was significantly (t(1,32) =3.976, p = 0.000) longer in stroke (24 ± 4 
ms) than in healthy controls (20 ± 1 ms) (Figure 4.7 B). Similarly, the active normalized 





(19 ± 1 ms) (Figure 4.7 C). 
 Although three measures passed all three criteria, we could use only two measures 
in the correlational analyses. In Aim 4, therefore, the resting raw latency and the active 
normalized latency were used in the correlational analyses for walking and MVIC 
neuromechanics of the paretic TA.    
Table 4.4: Test-retest normative data, mean ± SD (CV), of eight TA MCE measures in Healthy (right 





Statistics Day 1 Day 2 Day 1 Day 2 Day 1 Day 2 Day 1 Day 2
N 21 21 21 21 21 21 21 21
  Mean ± SD      
(CV) 
47 ± 11 
(23)






33.9 ± 3.1 
(9)
34.5 ± 3.7 
(11)
19 ± 1     
(5)
20 ± 1       
(5)
N 14 13 12 13 12 13 12 13
  Mean ± SD     
(CV) 
57 ± 16 
(28)






39.6 ± 6.4 
(16)
41.2 ± 7.5 
(18)
23 ± 3   
(13)
24 ± 4   
(17)
Measures
Statistics Day 1 Day 2 Day 1 Day 2 Day 1 Day 2 Day 1 Day 2
N 21 21 21 21 21 21 21 21






32.1 ± 3.0    
(9)
32.6 ± 3.2  
(10)
19 ± 1      
(5)






N 12 13 12 13 12 13 12 13






36.6 ± 5.3 
(14)
36.8 ± 4.6  
(12)
21 ± 2   
(10)














Tibialis Anterior - Active (15% MVIC)
Groups
MEP Amplitude       
(mV)  
MEP Latency           
(ms)                  
MEP Normalized 
Latency ((ms/cm)*100)     
Silent Period              
(ms)                       
Tibialis Anterior - Resting
Groups
Motor Threshold          
(% MSO)  
MEP Amplitude       
(mV)  
MEP Latency           
(ms)                  
MEP Normalized 





Table 4.5: Test-retest reliability, CVME and ICC (95% CI), of eight TA MCE measures in Healthy (right 








Days 1 2 1 2 1 2 1 2
Mean ± SD (CV) 47 ± 11       
(23)






 33.9 ± 3.1 
(9)
34.5 ± 3.7   
(11)
19 ± 1        
(5)




Day 1 2 1 2 1 2 1 2
Mean ± SD (CV) 52 ± 11 
(21)




 0.338 ± 
0.226 (67)
 39.6 ± 6.4 
(16)
40.4 ± 7.1   
(18)
 22.9 ± 2.7 
(12)





Days 1 2 1 2 1 2 1 2
Mean ± SD (CV) 1.790 ± 
0.675 (38)
1.640 ±  
0.694 (42)
32.1 ± 3.0 
(9)
32.6 ± 3.2 
(10)
19 ± 1        
(5)








Day 1 2 1 2 1 2 1 2




 36.6 ± 5.3 
(15)
36.3 ± 4.5   
(12)
21 ± 2     
(10)








Tibialis Anterior - Resting
Motor Threshold           
(% MSO)  
MEP Amplitude          
(mV)  
MEP Latency               
(ms)                  
MEP Normalized Latency 
((ms/cm)*100)     
0.86 (0.52 - 0.96)
Healthy 
(N=21)
11 40 3 4
0.89 (0.73 - 0.96)
Stroke 
(N=12)
6 31 6 6
0.84 (0.61 - 0.93)
Stroke 
(N=12)
22 3 3 14
0.86 (0.49 - 0.96) 0.97 (0.90 - 0.99) 0.93 (0.74 - 0.98) 0.88 (0.58 - 0.97)
Healthy 
(N=21)
21 3 4 20
0.83 (0.58 - 0.93) 0.93 (0.84 - 0.97) 0.70 (0.24 - 0.88) 0.81 (0.53 - 0.92)
0.93 (0.84 - 0.97) 0.76 (0.42 - 0.90)
Tibialis Anterior - Active (15% MVIC)
MEP Amplitude          
(mV)  
MEP Latency              
(ms)                  
MEP Normalized Latency 
((ms/cm)*100)     
Silent Period                
(ms)                       





Figure 4. 5: Test-retest reliability, CVME and ICC, of eight TA MCE measures in Healthy (right TA) 
and Stroke (paretic TA) 
 






Figure 4.7: Inter-group differences in mean for three TA MCE measures  
 
4.4 Aim 3: Associations Between MCE Measures and Neuromechanics of the 
Paretic Soleus 
 For this aim, we used data from the 10 stroke participants who had detectable 
MEP in the paretic SOL on day 2. Since four correlations were carried out, we considered 
a correlation significant only if its p was less than 0.012.  
 Prior to correlational analyses, we tested the normality of distributions for the 
paretic SOL neuromechanical measures collected during walking and MVIC. The 
distributions of the walking EMG (W(10) = 0.928, p = 0.430), PI (W(10) = 0.954, p = 0.711) 
and MVIC torque (W(10) = 0.955, p = 0.726) were normally distributed, whereas the 
MVIC EMG (W(10) = 0.802, p = 0.015) was not. During walking, the descriptive data of 
the paretic SOL EMG and PI were 0.028 ± 0.017 mV (60) and 1.36 ± 0.64 % BW.sec 





torque were 0.053 ± 0.058 mV (109) and 18.5 ± 9.1 N.m (49), respectively.    
 Walking: Resting raw latency was not significantly associated with either 
neuromechanical measure. Specifically, the resting raw latency of the paretic SOL had 
good positive and non-significant association with the paretic SOL EMG (r = 0.713, p = 
0.021; Figure 4.8 A), and it had poor negative and non-significant association with the 
paretic SOL PI (r = -0.127, p = 0.728; Figure 4.8 B).  
 MVIC:  Resting raw latency was not significantly associated with either 
neuromechanical measure. Specifically, the resting raw latency of the paretic SOL had 
good positive and non-significant association with the paretic SOL EMG (rs = 0.576, p = 
0.082; Figure 4.8 C), while it had poor positive and non-significant association with the 
paretic SOL torque (r = 0.341, p = 0.335; Figure 4.8 D).  
Figure 4.8: Associations between resting raw latency and neuromechanics during walking and MVIC 





 In summary, resting raw latency of the paretic SOL was not significantly 
associated with any neuromechanical measure of the paretic SOL during walking and 
MVIC. Despite the absence of significance in any of the four associations, the association 
between resting raw latency and walking EMG was positive and strong (r = 0.713), 
therefore as latency increased the EMG increased (Figure 4.8 A). For that specific 
association, the p was less than 0.05, yet higher than the corrected value of 0.012.    
 
4.5 Aim 4: Associations Between MCE Measures and Neuromechanics of the 
Paretic Tibialis Anterior 
 For this aim, we used the data from the 13 stroke participants who had detectable 
MEP in the paretic TA on day 2. Because eight correlations were carried out, we 
considered a correlation significant only if its p was less than 0.006. 
 Prior to correlational analyses, we tested the normality of distributions for paretic 
TA neuromechanical measures collected during walking and MVIC. The distributions of 
the walking EMG (W(13) = 0.929, p = 0.335) and MVIC torque (W(13) = 0.935, p = 0.394) 
were normally distributed, but the AAV (W(13) = 0.853, p = 0.031) and MVIC EMG (W(13) 
= 0.836, p = 0.019) were not. During walking, the descriptive data of the paretic TA 
EMG and AAV were 0.071 ± 0.041 mV (58) and 0.90 ± 0.67 rad/sec (74), respectively. 
During MVIC, the descriptive data of the paretic TA EMG and torque were 0.137 ± 
0.080 mV (58) and 11.1 ± 5.5 N.m (50), respectively.    
 Walking: Resting raw latency and active normalized latency were associated only 
with the angular velocity of the paretic ankle. The resting raw latency of the paretic TA 





= 0.184; Figure 4.9 A) and excellent negative and significant association with the paretic 
TA AAV (rs = -0.929, p = 0.000; Figure 4.9 B). Similarly, the active normalized latency 
of the paretic TA had poor positive and non-significant association with the paretic TA 
EMG (r = 0.393, p = 0.184; Figure 4.10 A) but good negative and significant association 
with the paretic TA AAV (rs = -0.728, p = 0.005; Figure 4.10 B). 
 MVIC: Resting raw latency and active normalized latency were not associated 
with either neuromechanical measure. The resting raw latency of the paretic TA had poor 
negative and non-significant association with both paretic TA EMG (rs = -0.308, p = 
0.306; Figure 4.9 C) and with paretic ankle dorsiflexion torque (r = -0.128, p = 0.678; 
Figure 4.9 D). Similarly, the active normalized latency of the paretic TA had poor 
negative and non-significant association with paretic TA EMG (rs = -0.206, p = 0.499; 
Figure 4.10 C) and good negative and non-significant association with paretic ankle 





Figure 4.9: Associations between resting raw latency and neuromechanics during walking and MVIC 
of the paretic TA 
Figure 4.10: Associations between active normalized latency and neuromechanics during walking 
and MVIC of the paretic TA 
 In summary, both latencies of the paretic TA were significantly associated only 
with the angular velocity of the paretic ankle during walking. Notably, both associations 
(Figure 4.9 B & Figure 4.10 B) were strongly negative, therefore as the latency of the 










5.1 Overall Findings 
 Despite the common use of nearly all available measures to quantify SOL and TA 
MCE in healthy and clinical populations, evidence has been sparse regarding which MCE 
measure of the two muscles is reliable and, thus, preferable for detecting true differences 
between neurologically intact and impaired CNS. Additionally, the relationships between 
the descending drive and the neuromechanical measures of SOL and TA can elucidate the 
cortical contributions to these muscles during a motor task, yet there is limited evidence 
about this kind of relationship, especially in stroke. Therefore, in the present project, we 
first quantified the MCE of SOL and TA in healthy and stroke participants, and second, 
we investigated the associations between MCE and neuromechanical measures during 
walking and MVIC for the paretic SOL and the paretic TA in people post-stroke. For the 
quantification of SOL and TA MCE, we employed a relatively different methodological 
approach compared to previous studies with similar research goals. In addition to testing 
reliability, which was determined using CVME with ICC also reported, we subsequently 
investigated which measures differed between groups in both variance and means. We 
included variance in this analysis because we reasoned that a variance of a reliable MCE 
measure would be low in a healthy control and high in a stroke participant.
  
For the brain-behavior relationships, we used the MCE measures that met all three pre-
defined requirements for reliability, variance, and mean, and as well as certain 
neuromechanical measures that quantified indirectly the biomechanical functions of the 
paretic SOL and TA during walking and MVIC in stroke participants.   
 Several findings occurred. First, not all MCE measures of SOL and TA were 
reliable in both groups, whereas only latencies had good reliability and differed in 
variance and mean between the two groups. Specifically, resting raw latency of the 
paretic SOL, resting raw latency of the paretic TA, and both resting and active 
normalized latencies of the paretic TA met all three pre-defined requirements. In the 
associations, therefore, one SOL and two TA MCE measures were used; thus, a total of 
four and eight correlations were run for the paretic SOL and TA, respectively. Second, 
the resting raw latency of the paretic SOL was not significantly associated with any 
neuromechanical measure in both walking and MVIC; however, there was a strong 
positive association between the resting raw latency of the paretic SOL and the EMG of 
the paretic SOL during the stance phase of walking. Third, both the resting raw latency 
and active normalized latency of the paretic TA were significantly and negatively 
associated only with the AAV during the swing phase of walking; the remaining 
associations were relatively weak and non-significant. In the following sections, we 
discuss in depth the meaning and importance of the findings, the clinical implications, the 
methodological considerations, and the future directions for each aim. 
 
5.2 Aim 1: Quantification of the Soleus Motor Cortical Excitability in Stroke and 





 For this aim, we characterized eight MCE measures of the paretic SOL in stroke 
participants and right SOL in healthy controls. The evidence on the reliability of SOL 
MCE in both healthy and stroke participants is limited to a single study (Lewis et al., 
2014). Therefore, our hypotheses were exploratory and based on the few prior studies 
that had examined TA MCE reliability in various populations (Cacchio et al., 2009; 
Cacchio et al., 2011; Meaney et al., 2015; Tallent et al., 2012; van Hedel et al., 2007). All 
those studies determined reliability using ICC; in contrast, we quantified reliability using 
CVME. We hypothesized that only certain measures would be reliable in both groups and 
their variances and means would differ between groups. Results partially supported our 
hypotheses. As we hypothesized, rMT, raw and normalized latency were reliable during 
resting in both groups whereas only raw and normalized latency were reliable during 
active condition in both groups. Among those five measures, only the variance and mean 
of the resting raw latency differed between groups. Therefore, only resting raw latency of 
the paretic SOL had a low measurement error and, thus, detected the differences between 
a neurologically intact versus a neurologically impaired CNS.   
 As anticipated, of the six measures that were hypothesized to be reliable, all 
measures were except cSP; however, the resting and active amplitude of SOL were not 
reliable. To the best of our knowledge, this is the first attempt to examine systematically 
and thoroughly the reliability of SOL MCE in healthy adults and people post-stroke while 
the SOL was in either resting or active state. While SOL was at complete rest, all 
measures but amplitude could be quantified reliably in both groups; thus, they had low 
measurement error. Similarly, during active, only the raw and normalized latency had 





measures, we cannot directly compare our findings with results from previous research. 
To the best of our knowledge, the work by Lewis et al. (2014) is the only study that 
allows a relative comparison of results. In that prior study, the authors investigated the 
test-retest reliability of three MCE measures of SOL (aMT, MEP amplitude, and MEP 
area) in both healthy adults (randomly assigned side) and stroke participants (paretic side) 
while SOL was slightly contracted with a target force level at 10% MVIC. Although the 
prior research measured SOL aMT and not rMT as our study did, SOL aMT was reliable 
in both groups using both ICC (Healthy: 0.92; Stoke 0.82) and typical percentage error 
(TPE; Healthy: 5; Stroke: 8). They calculated TPE in a similar way we calculated CVME. 
Interestingly, our results showed that CVME was lower and ICC was higher in people 
post-stroke than in healthy adults while Lewis et al. (2014) found the opposite. This 
discrepancy might be due to certain differences in methodology (rMT versus aMT; use of 
neuronavigation versus no use of neuronavigation). Despite this difference, in general the 
previous finding about SOL aMT was in agreement with our results on SOL rMT. 
Findings from both studies indicate that SOL MT can be reliably measured in both 
healthy adults and stroke participants regardless of the state of contraction of the SOL. 
 In addition to rMT, our results indicated that both raw and normalized latencies 
were reliable in both groups while SOL was either relaxed or contracted. No other study 
has examined the reliability of these SOL MCE measures in either group; therefore, 
comparisons with previous literature are limited. Interestingly, only the ICC of the resting 
raw latency in both groups and the active raw latency in healthy adults indicated good 
reliability. However, as we discussed in section 3.7.1, the ICC may misinterpret the 





for the SOL latency measures whose ICC was less than 0.75. For example, the ICC of the 
active raw latency of the paretic SOL was 0.63, yet the group CV in both days was less 
than 15 (Day 1: 11; Day 2: 13), indicating low between-subject variability. That was the 
reason we chose using CVME, which is insensitive to variability in the samples and is 
independent of ICC, as the main reliability metric. Including SOL rMT, SOL latencies 
had a CVME much lower than 15%. Therefore, in addition to SOL rMT, the raw and 
normalized latencies in both conditions can be reliably measured in both healthy adults 
and stroke participants.    
 Despite the wide use of MEP amplitude to quantify SOL MCE, neither resting nor 
active amplitude was a reliable measure. Both measures had CVME higher than 15; hence, 
they had low reliability. On the other hand, only active amplitude in stroke had ICC less 
than 0.75. Again, if ICC was used as a reliability metric, resting amplitude in stroke and 
healthy and active amplitude in healthy would be considered reliable measures. However, 
that was the case due to high variability within each sample. Lewis et al. (2014) reported 
low ICC and high TPE for active amplitude of the paretic SOL but high ICC and TPE for 
active amplitude of SOL in healthy. Similar to our results, they found that SOL amplitude 
in both groups had high TPE, hence high measurement error. Combining the findings 
from both studies, one would postulate that SOL amplitude is not a good reliable measure 
to quantify SOL MCE despite the fact that the majority of studies use and report MEP 
amplitude as a major metric to investigate SOL MCE.  
 Though our hypothesis about SOL cSP was exploratory, we postulated that SOL 
cSP would be a reliable measure in both groups. That postulation was based on the 





2009; Tallent et al., 2012; van Hedel et al., 2007). Based on CVME, SOL cSP did not have 
good reliability in either group whereas the ICC of SOL cSP was higher than 0.75 in 
stroke and lower than 0.75 in healthy. As this is the first study to investigate this measure 
for SOL in both healthy and stroke, we cannot make sound comparisons with previous 
studies. One reason that SOL cSP was not reliable in either group might be the fact that 
we calculated the maximum isometric SOL EMG instead of using force. Tallent et al. 
(2012) reported recently that TA cSP is an excellent reliable measure in healthy controls 
when TA was contracted at a certain level of maximum target force, either during 
concentric (ICC: 0.94) or eccentric (ICC: 0.96) contraction. Due to the lack of evidence 
on SOL cSP, we cannot ensure that this can be applied to the SOL cSP. Future studies 
should use similar approaches as Tallent et al. (2012) to determine whether SOL cSP can 
be reliably measured when it is contracted, either concentrically or eccentrically. To the 
best of our knowledge, our study was the first to measure SOL cSP, either in healthy or 
stroke. 
 Among the five measures with good reliability, only raw resting latency of SOL 
detected differences between groups. Specifically, raw resting latency of SOL had higher 
variance and mean in stroke than in healthy. In order to define a reliable measure, we 
asked whether a reliable measure could detect true differences between a neurologically 
intact and an impaired population. Rather than focusing only on group differences in 
mean, we also looked at the between group difference in variance. No group differences 
in variances implied that the variability of each group was due to factors other than the 
integrity level of CNS. As the methodology was the same across participants and between 





activation state) (Rubens & Zanto, 2012). Surprisingly, the variance of the resting 
normalized latency was not different between groups though the variance of the resting 
raw latency was. As normalized latency was the raw latency divided by the height, the 
fact that there was no significant difference in variance might be due to the height 
difference between groups. However, there was no significant difference in height 
between the groups. These findings indicate that although multiple SOL MCE measures 
were reliable in both groups, the detection of true differences between the two groups 
was limited only to resting raw latency. Therefore, studies that examine the SOL MCE in 
just healthy adults may use any of the five measures that our results demonstrated to be 
reliable using CVME. On the other hand, if the goal of a study is to quantify the MCE of 
the paretic SOL after stroke, we suggest that resting raw latency might be the only 
measure that should be used to ensure reliability and distinction with an intact CNS.          
 
5.3 Aim 2: Quantification of the Tibialis Anterior MCE Measures in Stroke and 
Healthy 
 Similar to Aim 1, we characterized eight MCE measures of the paretic TA in 
stroke and right TA in healthy. In contrast to the limited evidence of SOL MCE reliability 
studies, some evidence on the reliability of certain TA MCE measures exists in healthy 
(Cacchio et al., 2009; Forster et al., 2014; Tallent et al., 2012; van Hedel et al., 2007), 
stroke (Cacchio et al., 2011), SCI (van Hedel et al., 2007), and Multiple Sclerosis 
(Meaney et al., 2015). Therefore, this aim’s hypotheses were based on the cumulative 
evidence reported in those studies. As for SOL, we hypothesized that only certain TA 





differ between groups. Results partially supported the hypotheses. During resting, rMT, 
raw and normalized latency had good reliability in both groups whereas during active 
only raw and normalized latency had good reliability in both groups. Of the five 
measures, the variance and mean of resting raw and normalized latency and active 
normalized latency differed between groups. Therefore, three of these five TA MCE 
measures had low measurement error and detected differences between a neurologically 
intact and impaired CNS.   
 While TA was relaxed, all measures but amplitude had good reliability in both 
groups. Interestingly, both CVME and ICC indicated good reliability for rMT, resting raw 
and normalized latency. Other studies have also demonstrated good reliability for TA 
rMT in healthy participants (Cacchio et al., 2009; Forster et al., 2014; Tallent et al., 
2012), stroke participants (Cacchio et al., 2011) and people with Multiple Sclerosis 
(Meaney et al., 2015). Although all of those studies relied solely on ICC to determine 
reliability, their results are in agreement with ours. Therefore, rMT is a reliable measure 
to quantify TA MCE, either in people with or without neurological impairment. No study 
has investigated whether resting latency of TA is reliable in either healthy or stroke 
populations. As for SOL latencies during resting condition, resting raw and normalized 
latency of TA also had good reliability, indicating that these measures, which reflect the 
conductivity of the signal from MC to the muscle, can also be measured consistently 
across days.   
 Although TA was slightly contracted, only raw and resting latency had good 
reliability in both groups. The CVME of active raw and normalized latency was very low 





same measures were very high except for the ICC of normalized latency in healthy, 
whose ICC was 0.70. This is another example that sole reliance on ICC may misinterpret 
the consistency of measuring a metric. No other study has reported the ICC of the active 
normalized latency of TA in any population; therefore, we cannot make comparisons 
about the reliability values of this measure. However, one study that examined the 
reliability of the active raw latency of TA among other measures in 16 stroke participants 
and 16 age-matched healthy controls did report high ICC bilaterally in both groups 
(Cacchio et al., 2011). Another study also reported good ICC of active raw latency in 
both healthy and people with SCI, especially when TA was contracted in high 
percentages of maximum torque effort (van Hedel et al., 2007). Although neither study 
calculated any reliability metric similar to CVME, their results, in conjunction with our 
findings, indicate that both active raw and normalized latency of TA can be reliably 
measured with consistent low measurement error in both healthy and stroke.  
 Regardless of the contraction state of TA and the integrity level of CNS, MEP 
amplitude had low reliability using CVME but good reliability using ICC. The CVME 
ranged between 31-40 in both groups for the resting amplitude whereas it was 21 in 
healthy and 22 in stroke for the active amplitude. Because we chose a cutoff value of 15 
to distinguish a reliable measure from a non-reliable measure, amplitude might not be a 
consistent measure of TA MCE for either group. Conversely, the ICC for resting and 
active amplitude ranged from 0.82 to 0.87 in both groups. Similar to our results, other 
studies reported high ICC for TA amplitude. van Hedel et al. (2007) reported good 
reliability of TA amplitude in both healthy adults (ICC = 0.77) and people with SCI (ICC 





torque. Additionally, a more recent study demonstrated that the amplitude of the resting 
TA could be also reliably (ICC = 0.92) measured in people with Multiple Sclerosis 
(Meaney et al., 2015). Cacchio et al. (2011) reported similar ICCs for TA active 
amplitudes measured bilaterally in healthy and on the non-paretic side in stroke. 
However, the ICC of the TA active amplitude measured on the paretic side was 0.38, 
indicating poor reliability (Cacchio et al., 2011). The differences that our study and the 
latter study had in methodology, such as type of coil, use of neuronavigation, time 
between sessions, and MVIC level, may explain the disagreement between the studies 
about the reliability of the paretic TA active amplitude. Furthermore, the fact that 
cumulative evidence indicates that TA amplitude can be consistently measured due to 
high ICC may lead to wrong assumptions about TA MCE. As the variabilities of TA 
amplitudes reported here and elsewhere were high, one would expect that ICC would be 
high as well. As we discussed previously, this is the main drawback of using ICC to 
quantify reliability. As we chose CVME as the metric to determine reliability, measuring 
and reporting amplitude, either resting or active, to quantify TA MCE should be done 
with caution in both healthy and stroke participants.      
 The TA cSP could be reliably measured in stroke but not in healthy. For the 
paretic TA, CVME and ICC were 14 and 0.88, respectively. If only ICC was used to 
determine reliability, one could argue that the high ICC of paretic TA cSP could be due 
to high variability. However, because of low CVME, that might not be the case. Therefore, 
these findings indicate that TA cSP can be consistently measured in stroke participants. 
Thus far, no other study has examined the reliability of paretic TA cSP in this patient 





Hedel et al., 2007) reported poor reliability for TA cSP while the second study (Cacchio 
et al., 2009) reported good reliability with ICC higher than 0.75. The former study 
calculated the absolute cSP (i.e., period between MEP offset and EMG resumption), as 
we did in this study while the latter calculated the relative cSP (i.e., period between MEP 
onset and EMG resumption). In our study, CVME and ICC of the right TA cSP was 20 and 
0.79, respectively; therefore, this measure in healthy did not have good reliability based 
on the criterion (CVME <15) that we used in the present study. The inconsistencies of 
results across the three studies might be due to methodological differences. First, neither 
of the previous studies used a neuronavigation system, which can improve accuracy and 
precision of the stimulation site within and between sessions (Krings et al., 2001; 
Ruohonen & Karhu, 2010; Sparing et al., 2010). Second, neither of the previous studies 
used a double cone coil, which is considered to have an adequate stimulation depth 
appropriate to stimulate cortical representations of leg muscles (Deng et al., 2013, 2014; 
Lontis et al., 2006; Terao et al., 1994). Third, it was not clear in the methods section of 
the previous studies whether the TA cSP was calculated manually or automatically. In 
our study, we used published automated algorithms, which could assist in the consistent 
calculation of cSP across participants. Regardless of those differences across studies, 
caution should be taken when using cSP to quantify the inhibitory mechanisms of TA’s 
neuromotor axis, especially in healthy controls.  
 Despite the fact that some TA MCE measures were reliable, only few of those 
detected differences between groups. As for SOL MCE, the variance and the mean of the 
resting raw latency were higher in stroke than in healthy. Additionally, the variance and 





healthy. These results indicate that TA latencies, especially after taking into account each 
participant’s height, might be a good MCE measure that can quantify accurately the TA 
MCE in people post-stroke. Of course, all five measures that were found to be reliable 
might be used to quantify TA MCE in healthy controls. Therefore, our findings can 
provide some guidance concerning which measure should be used to quantify TA MCE 
in either healthy or stroke participants; a final decision should be thoroughly made based 
on the research question asked and the kind of population investigated. Researchers 
should bear in mind that our results are limited only to healthy and stroke participants.  
 
5.4 Aims 1 and 2: Clinical Applications, Methodological Considerations, and 
Future Work 
 The findings of the present study may provide novel information on the 
measurement characteristics of certain SOL and TA MCE measures that clinical studies 
may utilize in the future. In recent years, non-invasive brain stimulation techniques have 
been employed in neurorehabilitation science, as either an assessment or intervention tool 
(Liew, Santarnecchi, Buch, & Cohen, 2014). However, the number of studies that have 
investigated the MCE of upper extremity muscles (in the thousands) is much larger than 
the number of studies that have investigated the MCE of the lower extremity (less than 
500). Additionally, the characteristics of the upper extremity muscles MCE measures 
have been quantified more extensively than lower extremity MCE. Thus, despite the fact 
that there is no sound evidence on the measurement characteristics of the SOL and TA, 
studies continue to use nearly all available MCE measures to quantify SOL and TA MCE 





measures, only the rMT and the resting and active latencies of SOL and TA can be 
reliably measured in both stroke and healthy participants. As those five MCE measures 
were reliable for both muscles and groups, one could argue that the measurement 
consistency of the ankle musculature MCE is independent of muscle and damage in CNS, 
and, as a result, the inter-muscle and inter-group differences can be investigated. 
Furthermore, studies that investigate the cortical plastic changes either in SOL or TA due 
to an intervention (e.g., behavioral, neurophysiological) should carefully choose the MCE 
measures to quantify these changes. According to our findings, rMT or latencies might be 
the most appropriate measures to use to assess these changes in neuromotor axis without 
the caution of high measurement error. Hence, the observed changes in SOL or TA MCE 
would be most likely due to the true effect of the intervention. Additionally, if a goal of a 
study is to assess globally the MCE of either SOL or TA, any MCE measure of the five, 
either rMT or latency, can be used. For example, a potential study may choose to use 
only the rMT to quantify SOL and TA MCE; as a result, the total number of stimuli 
applied over participants’ brains will be small and the total assessment period will be 
short. Furthermore, our results provide normative data of eight MCE measures of SOL 
and TA in both healthy adults and stroke participants; similar studies in the future can use 
the present findings either for comparisons or as a guide in intervention studies. In 
summary, findings from the present study can be used in both scientific and clinical 
studies to either assess cross-sectional or longitudinal SOL and TA MCE in either healthy 
adults or people post-stroke.  
 We acknowledge a few methodological considerations that were present in these 





= 14) which was similar to the sample size of the stroke groups used in Lewis et al. 
(2014) study (N = 13) and Cacchio et al. (2011) (N = 16). As we could not get responses 
on the paretic SOL and TA from all participants in both days, the sample size used to 
determine reliability of SOL (N = 9) and TA (N = 12) MCE measures decreased. Also, 
for the between group comparisons for measures collected in day 2, the sample size of the 
paretic SOL (N = 10) and TA (N = 13) were smaller than the sample size of the right 
SOL (N = 20) and TA (N = 21). Interestingly, the number of people that we could not get 
responses from was greater for SOL than in TA; this pattern was more apparent in the 
stroke group. This finding may add to the existing notion that higher stimulus is required 
to elicit a response to SOL than in TA (Bawa et al., 2002). Importantly, no detectable 
MEP does not necessarily imply absent MCE for that target muscle. If a coil with higher 
maximum output (e.g., figure-of-eight coil with maximum magnetic field of 2T) was 
used than the one we used in the present study (i.e., double cone coil with a maximum 
magnetic field of 1.4T), we could potentially get responses from all stroke participants.  
 Another methodological consideration was the significant difference in age 
between our groups while both Lewis et al. (2014) and Cacchio et al. (2011) recruited 
age-matched healthy controls. We did try to recruit age-matched healthy controls, yet it 
was not feasible. We do acknowledge that age has generally a significant effect on the 
MCE of the lower extremity muscles; in general, compared to young adults, older people 
have higher rMT, smaller amplitudes, and longer latencies. These changes might be due 
to multiple factors, such as reduction of the overall brain volume, nerve fiber 
degeneration, muscle atrophy, and increase of subcutaneous fat tissue (Budui, Rossi, & 





affect a different component of the neuromotor axis. Reduction of brain volume results in 
increase of the skull to cortex distance; therefore, the coil to cortex distance increases as 
well. Because of these increases, higher intensities are required since as the coil to cortex 
distance increases, the TMS intensity increases (Danner et al., 2012; McConnell et al., 
2001). Degeneration of nerve fiber may contribute to increases in latency, which reflects 
the conductivity of the descending pathways. Muscle atrophy and increase of the 
subcutaneous fat tissue may contribute to the reduced detection of the muscle activity 
measured by sEMG; thus, amplitudes are smaller in the elderly. Nevertheless, the 
summative evidence from these studies is that age does not have a significant effect in all 
MCE measures of leg muscles (Baudry, Collignon, & Duchateau, 2015; Rossini, Desiato, 
& Caramia, 1992; Saisanen, Julkunen, et al., 2008; Stevens-Lapsley, Thomas, 
Hedgecock, & Kluger, 2013; Tobimatsu, Sun, Fukui, & Kato, 1998). However, the MCE 
measure that was found to be significantly higher always in the elderly was the latency; 
this finding was for multiple ankle muscles: SOL (Baudry et al., 2015), TA (Eisen & 
Shtybel, 1990; Saisanen, Julkunen, et al., 2008), and AH (Tobimatsu et al., 1998). In the 
present study, we found that latencies collected in both muscle state conditions and for 
both muscles were significantly higher in stroke participants than in healthy. 
Consequently, both damage in CNS and aging might affect those inter-group differences 
in latencies; there was no height or weight difference between groups. However, the 
significant inter-group differences in variances might decouple the effect of damage in 
CNS and aging on latencies; therefore, latency may still distinguish a damage in CNS 
regardless of the factor of age. Nevertheless, as age has an effect on certain MCE 





objectives as ours should definitely recruit controls whose age is matched with the 
experimental or clinical group.         
 In addition to age, numerous factors can influence the effect of TMS over the 
neuromotor axis. These factors are either physiological or methodological and are present 
in both healthy and stroke participants (Cortes, Black-Schaffer, & Edwards, 2012; 
Ridding & Ziemann, 2010; Rubens & Zanto, 2012; Wassermann, 2002). The level of 
control is less for the physiological factors than the methodological ones. In the present 
study, we tried to control those physiological factors over which we had some control, 
such as no consumption of alcohol and caffeine at least three hours prior to experiment, 
level of arousal, height, weight, and gender. Similarly, we employed a methodology that 
was tight and consistent across participants and days. The same sEMG electrodes were 
used for the same muscles between days and across participants; the same person placed 
sEMG in all experiments using standardized protocol for the sEMG placement and 
testing. Furthermore, we used the simple adaptive PEST, an automated method, to 
determine rMT, which was tested twice for each muscle. Then we used the average of 
two to calculate the 120% intensity used during the resting and active conditions. 
Furthermore, use of the neuronavigation with each participant’s structural MRI increased 
both the accuracy and precision of stimulating the hot spot, which was determined for 
each target muscle. In contrast to other studies, we detected the hot spot of each muscle in 
a 36-points grid (see Figure 3.5) using a suprathreshold intensity. From repeated 
measures of pilot experiments in our lab, we found that the hot spot of each muscle is not 
exactly the same, even with a 30 minute break between each hot spot hunting process. 





inter-session hot spot differed for each muscle in both hemispheres and groups. Certainly, 
future studies should investigate similar approaches to detect hot spot using mathematical 
models. Establishment of a precise method for searching for the hot spot of the target 
muscle may reduce a portion of the methodological error that is inherent in TMS.               
 One further methodological consideration was that we did not examine the 
reliability of RC derived measures, measures that quantify intracortical mechanisms, or 
measures that characterize the motor representations of SOL and TA in either group. 
Therefore, the application of our results is limited only to the measures tested in the 
present study. Furthermore, our results are limited to only the two muscles and groups 
that we investigated here.  
 Two subjects remain to elucidate the cortical control of SOL and TA:  the 
intracortical networks and the motor representations of SOL and TA. A few studies have 
reported intracortical measures (i.e., SICI and SICF) of SOL and TA in both healthy and 
clinical populations (Beaulieu et al., 2014; Liepert, Hassa, Tuscher, & Schmidt, 2011; 
Liepert & Neveling, 2009; Oliveri et al., 2012; Roy, Norton, & Gorassini, 2007). 
However, no study examined whether these measures are reliable in either group and 
detect true differences between the target groups. Future studies may use similar 
approaches used in aims 1 and 2 to determine SOL and TA intracortical measures that 
have good reliability and detect truly existing differences between healthy and clinical 
populations. Elucidation of this subject may hold clinical significance, especially in 
stroke participants. It has been suggested that MCE measures, similar to the ones used in 
this study, might be more appropriate to quantify corticospinal integrity within the first 





(Di Pino et al., 2014). The underlying hypothesis is that the motor recovery of a certain 
muscle may rely on the remaining CST in the early phase after stroke while that reliance 
might be shifted to cortical networks in later stages of stroke (Di Pino et al., 2014). 
Therefore, since the majority of stroke studies recruit stroke participants in the chronic 
phase, it would be worth quantifying the measurement characteristics of intracortical 
measures of SOL and TA in both healthy and stroke participants. 
 Motor mapping of SOL and TA is the second subject that future work should 
focus on. Compared to the number of studies that examined the motor cortical area of TA 
(Forster et al., 2014; Niskanen et al., 2010; Thordstein et al., 2013; Vaalto et al., 2013), 
only one study reported the motor cortical area of SOL from a single patient with focal 
cortical dysplasia (Saisanen et al., 2010). A common characteristic that all these studies 
share is the use of the same nTMS system (Eximia, Nexstim Ltd.; Helsinki, Finland). 
However, this system is extremely expensive, and it is usually found in hospitals. Future 
work should systematically investigate and establish normative data of cortical mapping 
measures for SOL and TA in healthy controls using user-friendly neuronavigation 
systems that are more available to researchers. This will establish which motor mapping 
measures should be used to specifically quantify the motor representations of SOL and 
TA. Then, clinical studies can use these metrics to characterize plastic changes at the 
cortical areas of each muscle after an intervention.          
 
5.5 Aim 3: Associations Between MCE Measures and Neuromechanics of the 
Paretic Soleus 





measure, resting raw latency, and the neuromechanics of the paretic SOL during walking 
and MVIC. We hypothesized that paretic SOL MCE (in this case, it was quantified using 
resting raw latency) would not be associated with either walking neuromechanical 
measure of paretic SOL whereas it would be negatively associated with both MVIC 
neuromechanical measures. Results partially supported our hypotheses. As we 
anticipated, there was no significant association between the resting raw latency and 
neuromechanics of the paretic SOL during walking, but, in contrast to our hypotheses, the 
resting raw latency of the paretic SOL was not significantly associated with either 
neuromechanical measure of the paretic SOL during MVIC. 
 During walking, resting raw latency of the paretic SOL increases were strongly 
associated with increases in EMG of the paretic SOL, yet the association was not 
statistically significant. Evidence from studies that applied TMS during walking in 
healthy controls supports the notion that the activity of SOL is also generated by motor 
cortical signals, particularly during the stance in which SOL is active ((Knikou, Hajela, & 
Mummidisetty, 2013; N. Petersen et al., 1998; N. T. Petersen et al., 2001). The cortical 
contribution to SOL in those studies was quantified calculating MEP amplitude of SOL. 
In contrast to those studies, Capaday et al. (1999) reported a weak linkage between the 
descending drive from MC to SOL and SOL EMG during stance in healthy controls; they 
quantified descending drive using RC derived measures. Although there were differences 
in methodology and results between those studies, descending drive from MC does 
contribute to SOL activity during the stance phase of walking; this evidence comes 
mainly from healthy controls. In the case of SOL, those cortical contributions might not 





distinction is difficult to be made (J.B. Nielsen, 2002). Additionally, SOL has weak CM 
connections (Bawa et al., 2002) while other pathways (e.g., corticorubrospinal, 
corticoreticulospinal) might contribute to its activation (J. Nielsen & Petersen, 1995). 
Due to those particular characteristics of the SOL MCE and the fact that stroke affects 
multiple descending pathways, including CST, we postulated that the contributions of the 
descending drive to the SOL EMG during stance would be weak (i.e., non-significant 
association); hence other parts of the CNS might be responsible for the activation of 
SOL. As we hypothesized, the association was not statistical significant after correcting 
for multiple comparisons, but the association was strong and positive. In other words, the 
more impaired the descending drive to paretic SOL was, the higher the activation of the 
paretic SOL was during stance. A potential explanation for this unanticipated finding 
could be that stroke participants with a greater level of impairment in SOL MCE activate 
their paretic SOL at high levels just to accomplish the task during the stance phase. As 
stroke alters SOL MCE (i.e., resting raw latency), increase in the activation of paretic 
SOL might be due to the increased contributions from either sensory receptors (e.g., force 
receptors) or spinal networks. Whether this is true cannot be addressed by the current 
study. Moreover, the results from this specific association cannot be definitive because of 
the small sample size (N = 10) and the low p (0.021). If the size of the sample had been 
larger, there might have been statistically significant association. Future studies should 
test this assumption.           
 As we anticipated, resting raw latency of the paretic SOL was not significantly 
associated with PI. We chose PI as one of the walking neuromechanical measures of SOL 





along with LG and MG. Our results suggest that the capacity to accelerate the COM 
forward after stroke is not associated with the integrity of SOL MCE. After stroke, a 
positive association exists between paretic SOL EMG and PI in stroke participants 
(Turns, Neptune, & Kautz, 2007). However, PI is not exclusively dependent on the 
activation of SOL, along with LG and MG. Other factors, including ankle moment and 
power and the trailing limb, contribute to PI in both healthy adults and stroke participants 
(Hsiao, Knarr, Higginson, & Binder-Macleod, 2015a, 2015b; Peterson et al., 2010). 
Therefore, stroke participants can still generate adequate PI to accelerate forward the 
COM using several biomechanical patterns regardless of the level of integrity of the 
descending drive to the paretic SOL.   
 As in walking, the resting raw latency of the paretic SOL increased when the 
activation of the paretic SOL during MVIC increased; yet association was non-
significant. Capaday et al. (1999) reported a strong linkage between the descending drive 
to SOL and activation of SOL during MVIC in healthy adults; therefore, we postulated 
that as the MEP latency of the paretic SOL would be increased due to stroke, the 
activation level of SOL during MVIC would be decreased. Contrary to our hypotheses, 
the association was non-significant and positive, but it was still strong. Results suggest 
that the activation of paretic SOL during MVIC may increase due to the impaired 
conductivity of the descending drive to the paretic SOL. A potential explanation for this 
unanticipated finding might be that the increase in activation of the paretic SOL during 
MVIC might be due to increased neuromotor output from the SOL motor pools. Paretic 
SOL motor pools may be activated by other descending pathways (e.g., 





delayed signal from the MC to the paretic SOL via CST. Although this postulation may 
be true, because this association was strong but non-significant, no definitive inferences 
can be made.  
 In contrast to our hypothesis, we found no associations between resting raw 
latency and paretic plantarflexion torque production during MVIC. In contrast to walking 
in which the leg is in contact with the ground during the stance phase and factors other 
than SOL EMG may affect PI, during MVIC the leg is fixated to a footplate. This results 
in the torque production being mainly affected by the activation of the responsible muscle 
whose contraction is most likely generated by a descending and spinal drive and, to a 
lesser extent, by the feedback from sensory receptors. Nevertheless, results indicate that 
impaired conductivity of the descending drive to the resting paretic SOL was not 
associated with the paretic plantarflexion torque production during MVIC.   
 
5.6 Aim 4: Associations Between MCE Measures and Neuromechanics of the 
Paretic Tibialis Anterior 
 For this aim, we examined the associations between two MCE measures of the 
paretic TA, resting raw latency and active normalized latency, and the neuromechanics of 
the paretic TA during walking and MVIC. We hypothesized that paretic TA MCE would 
be negatively and significantly associated with both walking and MVIC neuromechanical 
measures. Results partially supported our hypotheses. Both the resting raw latency and 
active normalized latency of the paretic TA were significantly, strongly, and negatively 
associated with only the peak AVV during the swing phase of walking. Conversely, the 





 During walking, activation of paretic TA was not significantly associated with 
either resting raw latency or active normalized latency, both associations were weak and 
positive. It is generally accepted that activation of TA during walking, especially in 
swing phase, relies heavily on descending drives from the MC (T. H. Petersen et al., 
2012). Therefore, when the descending drive to TA increases, the activation of TA also 
increases. Conversely, if the descending drive to TA is impaired due to a lesion at the 
brain level of the neuromotor axis, TA activation should be decreased as well. In the past, 
studies that attempted to elucidate the descending drive to TA during walking employed 
associations with either kinematic measures or clinical measures (Barthelemy et al., 
2013; Barthelemy et al., 2015; Barthelemy et al., 2010); therefore, there is no evidence 
about the relationship between the descending drive to TA and the activation of TA in 
stroke participants. In disagreement with our hypotheses, results indicated that neither TA 
latencies were significantly associated with the activation of the paretic TA while the 
associations were positive rather negative.  
 During walking, the AAV decreased as both resting raw latency and active 
normalized latency of paretic TA increased. The significant, negative, and strong 
associations between latency and AAV were one of the most robust results in our study. 
As previously discussed, one of the TA’s primary functions during walking is to clear the 
foot sufficiently during early and mid-swing. For this reason, previous studies examined 
the relationship between the descending drive to TA and toe clearance during mid-swing, 
in both healthy individuals and people with SCI. Similar to our results, they demonstrated 
a significant and negative association between the latency of the most impaired TA and 





that delayed TA latency might indicate impaired toe clearance, which may either cause 
the emergence of compensatory walking patterns or increase the risk of potential falling 
due to foot scuffing. For reasons that have been explained in section 2.6.4, here we chose 
AAV to quantify kinematically the function of TA during early to mid-swing. As in the 
two aforementioned studies, findings from the present study suggest that delayed TA 
latency, either resting or active, can also indicate an impaired biomechanical pattern of 
the ankle during early to mid-swing.    
 During MVIC, activation of the paretic TA was not significantly associated with 
either MCE measure of the paretic TA. We expected that the more impaired the 
descending drive to TA was, the less the activation of the paretic TA would be during 
paretic dorsiflexion isometric torque. The non-significant associations for either latency 
might imply that impaired conductivity may not be a good indicator of TA activation 
during MVIC. Our findings are in agreement with Beaulieu et al. (2014). In that study, no 
significant associations between six MCE measures of the paretic TA, including 
normalized latency, and MVIC EMG were found. Findings from both studies suggest that 
TA MCE cannot indicate the activation of the paretic TA during MVIC. 
 Paretic dorsiflexion torque was not significantly associated with either latency of 
the paretic TA, yet both associations were negative as we predicted. As in walking, 
delayed latency of the paretic TA indicated less production of the paretic ankle 
dorsiflexion torque. However, only active normalized latency was strongly associated 
with the reduction of torque. This might have occurred because during active conditions 
motoneurons are excitable similar to MVIC whereas during resting motoneurons are 





between MCE and isometric strength of the paretic TA. Yet, that MCE measure was 
MEP amplitude. In their study, amplitude of the paretic TA increased as the strength of 
the paretic TA increased. Therefore, the cumulative evidence from both studies suggests 
that the MEP amplitude of the paretic TA may indicate the production of the paretic 
dorsiflexion torque, yet not latency.  
 
5.7 Aims 3 and 4: Clinical Applications, Methodological Considerations, and 
Future Work 
 Findings from this study may provide insight into the understanding of the 
descending drive to the paretic SOL and TA, two muscles that have an important role 
during various motor tasks and are impaired after stroke. Furthermore, the findings may 
have important clinical applications. Up until now, the studies that attempted to elucidate 
this matter in clinical populations were limited only to associations with clinical measures 
and the TA (Arac et al., 1994; Barthelemy et al., 2013; Barthelemy et al., 2015; 
Barthelemy et al., 2010; Beaulieu et al., 2014; Hendricks et al., 2003; Piron et al., 2005; 
Steube, Wietholter, & Correll, 2001). First, numerous factors other than just 
neuromechanics may affect the outcome of the clinical measures; therefore, an existing 
association between the descending drive and a clinical measure may not elucidate the 
exact relationships between the MC and the target muscle during a motor task. Second, 
although TA has a crucial role during the GC, especially during the swing phase, 
exclusive focus on the descending drive to the TA does not clarify fully what the the 
cortical contributions are during the whole GC, both stance and swing phase. This issue is 





phase of gait. Therefore, investigating the relationships between the descending drive and 
the neuromechanics of both muscles during two motor tasks that may require neural drive 
in different patterns may shed light on to what extent MC in a lesioned brain contributes 
to the activation of the SOL and TA during a functional and isolated motor task. Limited 
evidence exists only in healthy individuals (Capaday et al., 1999). Here, we demonstrated 
statistically that only TA MCE could indicate neuromechanical patterns during walking. 
Our study is the first that has investigated the descending drive to the ankle antagonist 
muscles and the associations with specific neuromechanical measures during walking and 
MVIC in individuals post-stroke. Two MCE measures of the paretic TA were strongly 
associated with the same neuromechanical measure (AAV) only during walking. This 
finding implies that motor cortical contributions from a lesioned brain can strongly 
indicate an impaired mechanical pattern of the paretic ankle, during a specific phase of 
walking. Thus, these findings may have clinical implications; however, the clinical 
relevance of the SOL results may not be as clear. As the latency of the descending drive 
to the paretic SOL increased, the activation of the paretic SOL during the stance phase of 
walking also increased. However, it is not clear whether a reduction in latency would 
mitigate or exacerbate the motor function of that muscle during walking. Conversely, a 
delayed descending drive to the paretic TA does detrimentally influence the mechanics of 
the paretic ankle during the swing phase. Therefore, an intervention that can strengthen 
the conductivity of the descending drive to the paretic TA may improve mechanical 
patterns during specific motor tasks in people post-stroke. 
 An potential neurophysiological approach is the use of non-invasive brain 





direct current stimulation (Feng, Bowden, & Kautz, 2013); both technologies can 
modulate the excitability of intracortical networks. Within the last few years, a few 
studies investigated whether these two techniques can improve walking ability in people 
post-stroke. The results demonstrated that brain modulation enhanced both 
neuromechanical and clinical measures of walking (Chang, Kim, & Park, 2015; Chieffo 
et al., 2014; Kakuda et al., 2013; van Asseldonk & Boonstra, 2015; Wang et al., 2012). 
Although the results from these studies are promising and interesting, further 
investigation is required on this topic.   
 A few methodological considerations were present in Aims 3 and 4. The first is 
the relatively small sample size used for the correlational analyses of each muscle. Power 
analysis using results from the few studies that examined the relationships between the 
descending drive to TA and a mechanical measure in either stroke or SCI (Barthelemy et 
al., 2013; Barthelemy et al., 2015; Barthelemy et al., 2010; Beaulieu et al., 2014), 
demonstrated a minimum of 12 participants should be recruited to detect a statistical 
significance. Of the 15 recruited stroke participants, data from 14 participants were 
collected. Yet, the final sample size for SOL and TA was 10 and 13, respectively, due to 
no MEP responses detected for some stroke participants on day 2. Thus, the correlational 
analyses were limited to stroke participants with detectable MEPs in the paretic SOL and 
TA. Interestingly, the four participants with no detectable MEPs in either muscle 
successfully completed both walking and MVIC tasks; they activated both muscles and 
produced force similar to a healthy adult, especially during walking. There is some 
evidence that stroke participants with a discontinued CST are able to produce walking 





stated, no detecting a MEP does not necessarily imply absent MCE for that target muscle. 
Multiple methodological (e.g., not strong enough coil) and physiological (e.g. low level 
of arousal) factors could explain the undetectable MEP responses in these four stroke 
participants.   
 A second methodological consideration is that the SOL and TA MCE were not 
assessed during the task that the SOL and TA neuromechanics were calculated. We do 
acknowledge that this discrepancy may affect the results, yet we chose this methodology 
for several reasons. First, we did not have access to the equipment used for TMS 
application during walking. To the best of our knowledge, only one group has this 
technology in the United States (Hajela, Mummidisetty, Smith, & Knikou, 2013; Hanna-
Boutros et al., 2015; Knikou et al., 2013). Along with the application of TMS during off 
task, the application of TMS during a motor task may not necessarily elucidate fully the 
cortical contributions to that muscle during that task. Nevertheless, findings from this 
study, in which methodology was tightly controlled, may assist in the improvement of the 
methodology of studies that use TMS during walking. 
 Another methodological consideration specific to the walking task was the large 
range of SSWS (0.20 – 0.95 m/s) of the stroke participants. In general, walking speed has 
an effect on walking neuromechanics (Kirtley, Whittle, & Jefferson, 1985; Panizzolo et 
al., 2013; Peterson, Kautz, & Neptune, 2011). Although we did not run any between-
subject comparisons, having participants walk at the same speed could potentially reduce 
the between-subject variance of neuromechanical measures. A similar methodological 
consideration is the potential between-subject variance within the EMG data, due to 





subcutaneous fat thickness is negatively associated with sEMG amplitude; the greater the 
subcutaneous fat tissue, the smaller the sEMG amplitude (Hemingway, Biedermann, & 
Inglis, 1995; Nordander et al., 2003). In our study, we did not measure the subcutaneous 
fat tissue thickness; therefore, stroke participants with thick subcutaneous fat tissue over 
the target muscles might have smaller sEMG amplitudes. However, small sEMG 
amplitudes might not be a true indication of low muscle activation. A solution to this 
issue is to measure subcutaneous fat tissue thickness using a skinfold caliper, which is 
easy to use, inexpensive, and better tool than ultrasound for calculating fat tissue 
(Nordander et al., 2003). Future studies should measure the thickness of subcutaneous fat 
tissue and use it as a covariant within their statistical analyses. A last methodological 
consideration is that we did not normalize walking EMG to MVIC EMG, which is the 
most commonly used normalization method. Though we do acknowledge the pros and 
cons of EMG normalization (Cronin, Kumpulainen, Joutjarvi, Finni, & Piitulainen, 2015; 
Sousa & Tavares, 2012), we decided to use the raw EMG values in the correlational 
analyses.        
 Future work should extend the understanding of these relationships between the 
descending drive and neuromechanical measures of SOL and TA. Correlational analyses 
are limited to the description of the relative strength and direction between two measures. 
An alternative is regression analyses, which could be used for a deeper understanding of 
that relationship using the basis of prediction, yet to run regression analysis a larger 
sample size is required than for a correlational analysis. Since we found a significant and 
strong association between the MEP latency of the paretic TA and the angular velocity of 





these two measures. Of course, a larger sample size than the one used here should be 
utilized. For example, if a normalized latency of the paretic TA is shown to be a strong 
predictor of the angular velocity of the paretic ankle, this finding implies that stroke 
participants who have delayed descending drive to the paretic TA will demonstrate 
impaired ability to move the paretic ankle during swing. If this is the case, 
neurorehabilitation scientists can use these findings to develop either a behavioral or a 
neurophysiological intervention to reverse this relationship. Furthermore, future work 
should further investigate whether these relationships are present in other clinical 
populations, such as SCI and Parkinson’s.    
5.8 Conclusions 
 The present study was a first attempt to thoroughly quantify certain MCE 
measures of SOL and TA in both healthy controls and stoke participants, and to elucidate  
the relationships between reliable MCE measures and the neuromechanics of the paretic 
SOL and TA during walking and MVIC. Despite the fact that nearly all MCE measures 
are currently used in studies to quantify the MCE of these two muscles, findings from this 
study showed that only a few measures can be reliably measured, and can detect 
differences between a neurologically intact and impaired nervous system. Furthermore, 
using correlational analyses, we found that certain relationships exist between the 
descending drive and neuromechanical measures of the paretic SOL and TA in stroke 
participants. Future studies may use our findings to accurately quantify the SOL and TA 
MCE in either healthy or stroke participants and to expand knowledge about the role of 
the descending drive to SOL and TA during motor tasks in neurologically impaired 
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Medical University of South Carolina 
Center for Rehabilitation Research for Neurological Conditions 
MRI Screening Questionnaire 
 
 
Study:___________________________  Investigator:_______________ 
             Subject ID:________________________ Date:_____________________ 
             Subject Weight: ____________________            Subject Age: _______________ 
 
MRI Screening Questionnaire: Directions- Ask participant the following questions and record 
the answers accordingly. Any additional notes may be written at the lower ‘Notes’ section.  
 Yes No 
1. Have you had prior surgery? (If yes, state type and date of surgery in 
‘Notes’) 
  
2. Have you ever had ear surgery (cochlear implant or staples)?   
3. Do you have metal clips in your head or brain from previous surgery?   
4. Do you have a pacemaker or replacement valve?   
5. Have you ever been exposed to metal being welded, drilled, or cut?   
6. Is there any possibility of metal/metal pieces in your eyes?   
7. Have you ever been treated for metal in your eyes?   
8. Have you ever been shot?   
9. Do you have any metal in your body (like shrapnel, bullets, or 
implants)? 
  
10. Do you have a permanent tattooed eyeliner, wig, or hairpiece?   
11. Do you have an infusion pump implant for taking insulin or 
medication? 
  
12. Do you have a nerve stimulator implant (TENS unit)?   
13. Do you have a false eye, especially one that is magnetic?   
14. Do you have dentures or removable dental bridges?   
15. Do you think you are claustrophobic?   
16. Do you have any trans-dermal patches (i.e. nicotine patch)?   
17. Female: Are you pregnant?   
18. Female: Do you have an IUD?   




____________________________________   _________________________ 





Medical University of South Carolina 
Center for Rehabilitation Research for Neurological Conditions 
TMS Screening Questionnaire 
 
Study Name: __________________________________________________________________ 
Pro#: _____________     Subject ID: ____________________ 
Your head will be exposed to a strong magnetic pulse.  To maximize safety, please answer the 




Do you have, or have you ever had, any of the following?  If Yes, please explain. 
Y N 1. Metallic or plastic hardware, plates, or prosthetics on your scalp? 
Y N 2. Cardiac Pacemaker 
Y N 3. Implanted medication pumps, intracardiac line, or central venous catheter 
Y N 4. Prior diagnosis of seizure or epilepsy 
Y N 5. Any electrical, mechanical, or magnetic implants 
Y N 6. Any body or clothing metal above your shoulders.   
Y N 6a.  If yes to #6, are you willing and able to remove the item(s) for testing? 
Y N 7. Any metal on your body (i.e. watch or jewelry, hair holders or pins, eye 
glasses, body piercings, wallet, keys)? 
Y N 7a. If yes to #7, are you willing and able to remove the item(s) for testing? 
Precautions: 
Do you have, or have you ever had, any of the following?  If Yes, please explain.  
Y N 1. Previous brain neurosurgery 
Y N 2. Is there any possibility you are currently pregnant? 
Y N 2a. If yes to #2, what is the date of the last menstrual period?_______________ 
Y N 3. Migraine Headaches 






Please list current medications: We are looking for the presence of any medicines that affect 
seizure threshold such as tricyclic antidepressants and neuroleptics). 
_______________________________   _______________________________ 
_______________________________   _______________________________ 
_______________________________   _______________________________ 
_______________________________   _______________________________ 
_______________________________   _______________________________ 
 



































Medical University of South Carolina 
Center for Rehabilitation Research for Neurological Conditions 
Fugl-Meyer Lower Extremity Assessment Form 
 
TOTAL SCORE OF THE LOWER EXTREMITY:  Tally 1_____________(Max = 34) 
(Check addition – Tally 2 MUST EQUAL Tally 1)      Tally 2_____________(Max = 34) 
MOTOR FUNCTION - Lower Extremity  
TEST ITEM SCORE SCORING CRITERIA 
I. Reflex Activity Achilles  0-No reflex activity can be elicited 
2-Reflex activity can be elicited Patellar  
II. A. Flexor Synergy (in supine) Hip flexion  0-Cannot be performed at all 
1-Partial motion 
2-Full motion Knee flexion  
Ankle dorsiflexion  
II. B. Extensor Synergy 
(in sidelying) 
Hip extension  0-No motion 
1-Weak motion 
2-Almost full strength compared to normal Adduction  
Knee extension  
Ankle plantar flexion  
III. Movement combining synergies 
(in sitting: knees free of chair) 
A. Knee flexion 
beyond 90° 
 0-No active motion 
1-From slightly extended position, knee can be 
flexed, but not beyond 90° 
2- Knee flexion beyond 90° 
B. Ankle dorsiflexion  0-No active flexion 
1-Incomplete active flexion 
2-Normal dorsiflexion 
IV. Movement out of synergy (in 
standing, hip at 0°)  
A. Knee flexion  0-Knee cannot flex without hip flexion 
1-Knee begins flexion without hip flexion, but does 
not reach to 90°, or hip flexes during motion 
2-Full motion as described 
B. Ankle dorsiflexion  0-No active motion 
1-Partial motion 
2-Full motion 
V. Normal Reflexes (sitting) Knee flexors 
Patellar 
Achilles 
 0-At least 2 of the 3 phasic reflexes are markedly 
hyperactive 
1-One reflex is markedly hyperactive, or at least 2 
reflexes are lively 
2-No more than one reflex is lively and none are 
hyperactive 
     
VI. Coordination/speed - Supine: 
Heel to opposite knee (5 repetitions 
in rapid succession)  
A. Tremor  0-Marked tremor 
1-Slight tremor 
2-No tremor 
B. Dysmetria  0-Pronounced or unsystematic dysmetria 
1-Slight or systematic dysmetria 
2- No dysmetria 
C. Speed  0-Activity is more than 6 seconds longer than 
    unaffected side 
1-(2-5) seconds longer than unaffected side 
2-Less than 2 seconds difference 
 
Total Maximum Score of the Lower Extremity = 
0-34 
 
